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Orientia tsutsugamushi is an obligate intracellular bacterium that is spread by mites and 
causes a life-threatening human disease, scrub typhus. This disease affects at least one million 
people annually with a high risk of mortality if not treated promptly. Orientia is poorly 
understood compared to many other pathogens due to genetic intractability. This bacterium only 
propagates and replicates within host cells. they are predominantly found in endothelial, 
dendritic, and monocyte/macrophage cells, and stay inside infected cells for seven days or longer 
before exiting by a budding mechanism.  
The developmental differentiation of the intracellular infection cycle of Orientia has not 
been studied previously. My thesis research initially focused on how Orientia differentiates into 
distinct subpopulations during the infection cycle, how distinct subpopulations of Orientia affect 
the infection in host cells, and different protein profiles of bacteria in distinct stages during the 
infection cycle. My research demonstrates that O. tsutsugamushi differentiates into five distinct 
subpopulations: early entry, pre-replicative, replicative, maturation, and extracellular, 
representing a new model for developmental differentiation in the intracellular cycle of Orientia 
tsutsugamushi. Each subpopulation relates to different degrees of metabolic activity, replication, 
infectivity, including morphology, presence of marker gene, and subcellular localization. The 
transition between the subpopulations likely results from an integration of signals from the host 
cell environment and the bacteria which leads to morphological and physiological changes 
through the regulation of genes and proteins. This work allows us to understand the 
fundamentals of bacterial development and the regulation mechanism of differentiation of 
Orientia tsutsugamushi, which could be beneficial for the improvement of diagnosis and 
treatment.  
Genetic tools have not been developed previously for Orientia, but genetic manipulation 
in the most closely related bacteria, rickettsial species, has been successfully established in the 
last decade. My work on genetic manipulation of Orientia is described in the second part of this 
thesis. The transposon mutagenesis vector and nucleotide analog (BNA) were used to manipulate 
the genome of Orientia. Unfortunately, the transposon mutagenesis system failed to integrate 
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into the Orientia genome, whereas BNA was able to down regulate the expression of the targeted 
protein (TSA56). Using a nucleotide analog to target a specific gene is the first step to manipulate 
the genome of Orientia, and this has led to the study of other targeted genes involving virulence 
and pathogenicity.  
Due to the genetic intractability of Orientia that limits the molecular dissection of bacteria 
pathogenesis, virulence, and host-pathogen interaction, sequencing technologies provide a 
promising way to understand the molecular processes of the disease. This motivated the third 
part of this thesis, in which dual RNA-seq was applied to two clinical isolates grown in cultured 
HUVEC cells. This study revealed the transcriptomic profile of Orientia and identified the different 
immune response networks in response to each strain. Differential activation of the immune 
response in cultured cells between the two strains was shown to correlate with differences in 
virulence as measured in a mouse model of infection. These findings will help to understand the 
mechanism of bacterial pathogenesis in Orientia tsutsugamushi and may be used for 
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Chapter 1: Literature review 
1.1  Overview of scrub typhus  
Scrub typhus was first mentioned in Japan in the 1800s to describe vector-associated fevers 
(1). The term scrub refers to the type of vegetation that retains the vector, and the word “typhus” 
is derived from the ancient Greek word typhos (smoke, mist, fog) which was used by Hippocrates 
to denote clouding of consciousness (2). Scrub typhus, also known as tsutsugamushi disease, is a 
neglected infectious disease caused by infection with the gram-negative obligate intracellular 
bacterium Orientia tsutsugamushi, previously called Rickettsia tsutsugamushi. Scrub typhus is 
transmitted to humans by larval stage Leptotrombidium mites. The term tsutsugamushi is derived 
from two Japanese words; “tsutsuga” meaning dangerous and “mushi” meaning insect (2). Scrub 
typhus is considered a serious public health problem in the traditional endemic area, the Asia-
Pacific region, and in recently identified endemic regions in Africa, the Middle East, and South 
America (3). It affects people of all ages including children and pregnant women (4). The disease 
remains a major underdiagnosed and undifferentiated fever in Asia due to a lack of accurate and 
accessible laboratory diagnosis. The symptoms present from mild to fatal illnesses. The infection 
can be life-threatening if patients are left untreated with appropriate antibiotics (5, 6).  As a 
neglected disease, the knowledge of scrub typhus still has wide gaps. Many unknown aspects of 
the disease are needed to be discovered, including diagnosis, treatment, molecular infection 
mechanism, and developmental life cycle. 
1.1.1 Vector and transmission 
Leptotrombidium mites (the larval form of which are commonly known as chiggers), which 
belong to the family Trombiculidae, are the primary reservoir and vector of O. tsutsugamushi. 
Their life cycle consists of four main stages; eggs, 6-legged larvae, 8-legged nymphs, and 8-legged 
adults (2). The larval stage is the only stage of the mite that feeds on humans and small mammals, 
whereas nymphs and adult mites are free-living in soil and feed on the eggs of insects. Infected 
mites can maintain Orientia throughout their life cycle. The adults pass the infection to offspring 
via a process called transovarial transmission, and transstadial transmission occurs through the 
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nymph and adult stages (7). Both types of transmission are associated with vertical transmission. 
The feeding period on rodents is usually 3-6 days and feeding on humans is typically 2-10 days 
(8).  
Once the infected mites attach to the host skin for nutrient uptake, they insert their 
mouthpart or stylostome into the host’s skin at the base of a hair follicle or pores and release 
Orientia from their saliva glands.  Orientia invades dermal cells and infects the antigen-presenting 
cells (APC) in the sub-epidermal zone, basal epidermis, and superficial dermis, causing an 
inflammatory lesion known as eschar. Orientia infects several cell types in host cells including 
professional phagocytic cells (macrophage, dendritic cells, and neutrophils) and non-phagocytic 
cells (endothelial, epithelial, fibroblast cells) (9, 10). Orientia causes disseminated systematic 
infection in many organs such as lung, brain, heart, and kidney.  
There is no strong evidence to support O. tsutsugamushi is being maintained in nature via 
horizontal transmission, which happens when mites receive Orientia from the infected host, and 
their progeny infects a new host (11). Humans are considered to be a dead-end host because 
bacteria rarely if ever infect a newly attached uninfected mite. However, mite-to-mite 
transmission can occur during co-feeding in rodents (12). There is still no evidence of 
transmission of scrub typhus from person to person (13). The transmission of Orientia depends 
on the season which may reflect the local mite ecology, for instance, the increasing outbreaks in 
Thailand and Lao PDR during the rainy season, a case report during the cold season in the south 
of India, and two different occurrences in early and late autumn found in the north and south of 
Japan (14-16). 
1.1.2 Epidemiology 
The traditionally recognized endemic area of scrub typhus particularly occurs throughout 
Asia, Australia, and islands in the Indian and Pacific, known as the Tsutsugamushi Triangle (17), 
however, evidence indicating the presence of the disease has been reported in Africa, South 
America (Chile and Peru) and the Middle East (UAE).  The recent new species Orientia chuto was 
isolated from a patient in Dubai. Another species that was found in Chile is closely related but 
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not identical to O. chuto and other Orientia (3, 18-20). This reflects the genetic diversity of scrub 
typhus across the global geographic distribution. The estimation of newly infected cases per year 
is about one million in Southeastern Asia, and about one billion people in endemic areas are at 
risk of infection (2). Given the increase of new cases and reports of scrub typhus in regions not 
previously thought to be endemic for the disease, scrub typhus is considered a global health 
problem.  
1.1.3 Clinical symptoms  
Scrub typhus is characterized as an acute undifferentiated febrile illness with nonspecific 
clinical manifestations.  Symptoms are usually noticeable after 6-21 days of incubation and range 
from a mild to a severe illness (13). The early clinical signs and symptoms are an eschar, cough, 
fever, headache, nausea, rash, myalgia, and lymphadenopathy (13, 21). The eschar typically 
presents as a cigarette-burn-like lesion which is useful for diagnosis; however, it is not present in 
every infection. The range of eschar detection varies from 7-80% and depends on the host 
immunity and possibly the infecting serotype (22). If untreated the disease can progress from 
mild to fatal illness. Severe complications present an acute inflammation that can lead to 
multiorgan failure, with severe complications including acute renal failure, acute respiratory 
distress syndrome (ARDS), pneumonitis, meningoencephalitis, and disseminated intravascular 
coagulation (13, 23).  
The non-specific clinical presentation of scrub typhus leads to difficulties of differentiation 
from other infectious diseases such as dengue, melioidosis, malaria, typhoid, and leptospirosis. 
The disease mostly occurs in rural areas where access to the hospital, diagnostics, and treatment 
are limited. These factors contribute to a high number of undiagnosed or untreated cases with a 
range of mortality rate from 1% to 50%. The severity depends on bacterial strains, patient status, 
and the endemic area (5, 24, 25).  
1.1.4 Diagnosis 
Diagnostic methods of scrub typhus are based on serological and molecular assays (26). The 
indirect immunofluorescence assay (IFA) is the current gold standard test for the diagnosis of 
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scrub typhus (27). IFA detects the signal from a fluorescent-labeled anti-human antibody that 
reacts with antibodies from patient serum bound to a smear of scrub typhus antigen from several 
different serotypes (28). Even though IFA is sensitive, the method can generate a false negative 
due to the antigenic variation of O. tsutsugamushi strains (28, 29). IFA fails to detect early stage 
infection because the antibody response takes 5-10 days to reach a detectable level (29). IFA is 
reported as with other serological tests against a cut-off antibody titer. However, the cut-off 
titers used varies between laboratories and endemic regions and there is a lack of standardization 
of the antigens used. In addition, IFA is expensive, complicated, and requires technical training, 
and thus is not suitable for use in resource-poor rural areas (30).  
There are other serological assays such as the Weil-Felix test (WF), enzyme-link 
immunoassays (ELISAs), the indirect immunoperoxidase assay (IIP), and several commercial rapid 
diagnostic tests (RDTs). The Weil-Felix agglutination assay is based on the cross-reactions 
between anti-Orientia antibodies in the patient’s serum and antigens of the Proteus mirabilis OX-
K strain. This assay is cheap but lacks specificity and sensitivity (31). The IIP is a variant of the IFA 
which uses peroxidase instead of fluorescein. The results are read under a normal microscope 
and therefore the IIP can be used in laboratories lacking a fluorescence microscope. The though 
one study reports that the sensitivity of IIP is higher than IFA with acute sera, at 79.6% and 68.5% 
respectively (32). 
ELISA is a high throughput assay and more standardized compared to IFA and IIP. The 
principle of ELISA is similar to IFA but the antigen used varies more between assays, ranging from 
whole-cell lysate from several strains of Orientia to recombinant p56 kDa and other outer 
membrane proteins. ELISA has been used for seroprevalence and surveillance studies with large 
scale sampling (32). The widely used the InBios Scrub Typhus Detect™ immunoglobulin M (IgM) 
ELISA kit is easy to use, cost-effective, and provides sufficient accuracy for screening and 
diagnosis (33). As ELISA provides adequate sensitivity and specificity in several studies, it has the 
potential to be an alternative gold standard test and may replace the IFA and IIP assays. 
Molecular diagnostics for scrub typhus are usually based on the PCR (Polymerase chain 
reaction). Several assays have been used in rickettsiology including nested PCR (nPCR), 
15 
 
quantitative real-time PCR (qRT-PCR), restriction fragment length polymorphisms (PCR/RFLP), 
and multilocus sequences typing (MLST). Of these, qRT-PCR is currently used for the diagnosis of 
scrub typhus, though it is expensive and requires special equipment and training (34, 35).   
PCRs usually target the outer membrane proteins genes (tsa56, tsa47), groEL, or 16S rRNA. 
The tsa56 gene is primarily used for the strain identification because it contains high antigenic 
variability, however, the sequence variability may affect primer annealing (36). Early in the 
disease PCR provides better sensitivity and specificity for the detection of rickettsiae compared 
with serological tests. It can detect bacterial loads of 1-10 genomes per reaction in skin 
biopsy/eschar, whole blood, and buffy coat (37).  
The potential for detecting bacteria by qPCR depends on sample types. PCR is able to detect 
bacteria in eschar at the early phase before antibody response. Whole blood samples are positive 
only in the rickettsaemic period (34). Using buffy coat samples could enhance the sensitivity 
compared with whole blood as bacteria circulate in monocytes or detached endothelial cells (38). 
In addition, the sensitivity of PCRs reduces during antibiotic treatment (39).   
1.1.5 Treatments 
 Orientia is treatable with specific antibiotics including chloramphenicol, doxycycline, 
tetracycline, and azithromycin. There is no established evidence of a difference in treatment 
outcomes between these antibiotics (40). Doxycycline is commonly used for treating scrub 
typhus, though some studies from northern Thailand have reported a decreased efficacy of 
doxycycline in both in vivo and in vitro (41). Azithromycin and other macrolides are considered 
safe in pregnant women or children and have been shown in several studies to be as effective as 
doxycycline and chloramphenicol (42, 43).  
Orientia is known to be beta-lactam antibiotic resistant due to a minimal level of 
peptidoglycan in the cell wall (44). Several reports also suggested other antibiotic resistance in 
scrub typhus (41, 45, 46), (47). However, a recent finding revealed that doxycycline resistance is 
a misconception. The evidence against doxycycline resistance has been shown in several studies 
by testing with O.  tsutsugamushi strains Karp, Gilliam, Kato, UT76, TA763, AFC-3, and AFSC-4 (46, 
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48). Apparent antibiotic resistance in Orientia needs to be investigated with reference to other 
determinants of slow fever clearance such as bacterial strain, host, and pharmacological factors. 
Until now, no vaccine is available for rickettsial infection and scrub typhus. There have been 
considerable efforts to develop a vaccine to prevent scrub typhus infection. In the past 70 years, 
numerous studies have evaluated several types of vaccines such as formalin-killed, live, 
attenuated, and subunit vaccines but all tests failed to produce protective heterologous 
immunity against Orientia. Some results showed short-term homologous protection but failed to 
stimulate cross-protective immunity against other strains. The major barrier to vaccine 
development is the high antigenic variation of Orientia strains in different endemic regions or the 
difference in bacterial strains in the same endemic area (49, 50).  
1.1.6 Orientia classification and genetic profiles 
Orientia tsutsugamushi is a member of Class α-proteobacteria, Order Rickettsiales, Family 
Rickettsiaceae, and Genus Orientia which is currently shared only with Orientia chuto (Fig. 1). 
Historically, Orientia was classified in the genus Rickettsia and was named Rickettsia 
tsutsugamushi. In 1995, it was assigned to its own genus Orientia based on DNA-DNA 
hybridization differences (51). Orientia is distinct from rickettsia in four major ways. First, the 
difference in 16S rRNA sequences (52). Second, the genome size of Orientia is almost double the 
size of Rickettsia (53). Third, the cell wall structure of Orientia has reduced levels of peptidoglycan 
(44) and Orientia cannot produce LPS due to an absence of genes required for LPS biosynthesis 
(54, 55). Lastly, Orientia exits host cells by a budding mechanism which is not found in other 




Figure 1. Summary of bacteria phylogenetic tree. The marked red box indicates the Rickettsiales 
Order to which Orientia tsutsugamushi belongs. Image modified from (57) 
Most obligate intracellular bacteria tend to have a highly reduced genome of around 1 
Mbp which is the result of niche-specific adaptation. Repetitive genes and pseudogenes are a 
common feature of gene degradation. The reductive genome has been shown in other bacteria 
such as Rickettsia prowazekii and Chlamydia trachomatis (58).   
The complete genome has been reported in Orientia strain Boryong and Ikeda using short-
read sequencing technology. However, the highly repetitive genomes make sequencing difficult 
with short read technology (59). To generate a high quality genome, PacBio single molecule long-




Genome analysis revealed that O. tsutsugamushi has an unusual genome compared with 
the other species in the order Rickettsiales. It has a single circular chromosome consisting of 1.93-
2.47 million base pairs (depending on the strain) which is the largest genome size compared with 
the other obligate intracellular bacterial genomes (Fig.2). The G+C content is 30-31%. Orientia 
contains a unique feature of repeated sequences totaling around 42% of its genome. The 
repeated sequences consist of the integrative and conjugative element (ICE) named RAGE 
(Rickettsia amplified genetic element), short repetitive sequences, and transposable elements 
(including insertion sequence, miniature inverted-repeat, and group II intron). These repetitive 
sequences can induce genome shuffling, gene duplications, and gene deletion. (55, 61).   
The RAGE module has been found in some other rickettsial genomes such as Rickettsia 
bellii and R. massiliae. RAGEs are highly divergent and have been found in multiple copies across 
Rickettsia and Orientia genomes. Many genes in RAGEs are degraded due to gene insertions or 
gene deletions (62). RAGE encodes an integrase gene (int), transposase genes (tra genes) of an 
F-T4SS (F-type type IV secretion system), and tra-associated genes of effectors proteins including 
ankyrin repeat (AR), tetratricopeptide (TPR) domains, histidine kinase (HK) (55, 63). 
Ankyrin repeat-containing proteins (Anks) are predominantly found in eukaryotes and 
play an important role in several processes such as signal transduction, transcriptional regulation, 
vesicular trafficking, and cytoskeleton integrity.  However, Anks are also found in intracellular 
pathogens and are thought to be acquired from eukaryotes via horizontal gene transfer. Anks 
play a role as a virulence factor during intracellular infection by employing several types of 
secretion proteins to transfer Anks into host cells. Legionella pneumophila, Anaplasma 
phagocytophilum, Coxiella burnetii, and Rickettsia spp. transfer their ANK-containing protein via 
the Type IV secretion system, T4SS (64-66). It has been reported that Ank is transcriptionally 
expressed in O. tsutsugamushi and is secreted via T1SS during infection in L929 cells (67). 
Exogenously expressed Ank proteins have been found to localize in the cytoplasm, nucleus, 
endoplasmic reticulum, and Golgi apparatus (66, 68). T4SS has been reported to be expressed in 
Orientia. The function of this T4SS secretion system is unknown.  
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Repetitive sequences, transposons, and conjugative elements are likely to be a major 
factor of numerous homologous recombinations via horizontal gene transfer in Orientia. The high 
level of recombination sequences among bacterial strains could be a potential reason why 
Orientia serotypes have high antigenic diversity (69, 70).  
Over the past 10 years, genetic tools have been successfully used in other rickettsial 
bacteria, for example, the transformation in R. prowazekii using Tn mutagenesis (a mariner-based 
Himar1 Tn system) carrying a green fluorescent protein gene (GFP) to knock down virulence 
genes and to study host-pathogen interaction (71). However, genetic manipulation in Orientia 
has not yet been achieved. Low transformation efficiency is a major problem for the development 
of genetic tools in obligate intracellular bacteria. The possible reasons could be host cell 
restricted growth which requires a long term culture to expand small transformant populations 
compared with other free-living bacteria, the suboptimal electroporation conditions, the purity 
of transformants, and restriction/modification systems that degrade integrated DNA (72). 
Developing a genetic tool in O. tsutsugamushi requires technical improvement to increase the 





















Figure 2. Schematic overview of genomic events in Rickettsial evolution including the different 
genome sizes and phylogenetic tree of Rickettsial bacteria. Rickettsiaseae and mitochondria 
presented a close relationship about 200 million years ago. Amoeba-like protozoa are the first 
hosts of rickettsia ancestors and arthropods appeared to have a symbiotic relationship with a 
member of Rickettsiales later. The rickettsial genome shows gene loss, gene duplication and  
genome reduction throughout the obligate intracellular lifestyle within different hosts. SPG: 
spotted fever group, TG: Typhus group. Yellow boxes illustrate genomic changes. Diagram 
adapted from ref (53). 
1.1.7 Morphology 
 O. tsutsugamushi is a Gram-negative coccobacillus about 0.3-0.5 µM in width and 0.8-2 
µm in length. If cells grow without division, the cells may be considerably longer, up to 3 µm. 
Flagella or pili are not found in Orientia (73, 74). The morphology of Orientia is slightly different 
from Rickettsia spp., with Orientia more coccobacillus-shaped than the rickettsias. In general, 
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rickettsias have a rod or bacillus shape, however, they occasionally present long forms during 
infection which has been found in R. felis and R. prowazikii (75, 76).  
 The cell wall structure of Orientia is different from other Rickettsia spp.. Orientia has been 
thought to lack peptidoglycan and lipopolysaccharide and to be insensitive to the β-lactam 
antibiotic penicillin (77, 78). In addition, three important groups of enzymes are absent in the 
Orientia genome; amino acid racemases, glycosyltransferase, and some genes in the meso-
diaminopimelic (meso-DAP) biosynthesis pathway. However, almost a complete set of genes 
required for the peptidoglycan synthesis pathway is present in Orientia genome (44, 55). 
A recent finding from our group revealed that O. tsutsugamushi contains a minimal 
peptidoglycan-like structure. The evidence was strongly confirmed by the detection of 
peptidoglycan-specific amino acid DAP, and the important peptidoglycan biosynthesis genes 
(pbp2, murD, murF, and ddl) also expressed during the infection cycle. Bioinformatics analysis led 
to the hypothesis that Orientia is intrinsically resistant to β-lactam antibiotics due to a mutation 
in penicillin-binding proteins (PBP2 and PBP3) (44). 
The ultrastructure of budding Orientia has been observed by transmission electron 
microscope (TEM) and found that the budding cells are surrounded by the host cell membrane. 
In other rickettsia  (R. prowazekii and R. rickettsii), the electron-lucent zone, called a slime layer, 
surrounds the cells inside and outside of the host cytoplasm. The main composition of the slime 
layer is polysaccharides. This was proven by positive staining with ruthenium red which is used 
for staining mucopolysaccharides. Presenting the slime layer may prevent phagocytosis from 
host immune cells or it may facilitate the attachment to host cells. However, there is no evidence 
of a slime layer on Orientia cells (73, 79).  
1.1.8 Surface proteins  
 The outer membrane proteins of Orientia play a key role for bacterial internalization, and 
have been used as the antigen to activate the humoral immune response for diagnosis or vaccine 
development (80). Historically, immunoblot analysis of Orientia whole-cell lysate with patient 
serum identified protein antigens with the molecular size.  Among these antigens, the type-
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specific antigen (TSA)22, TSA47, and TSA56 are the major outer membrane surface proteins of 
Orientia (81). Most of their functions remain uncharacterized.  
 The TSA56 protein is the most abundant protein on the outer membrane (10-15% of the 
total cellular protein content) and is the main source of antigenic heterogeneity among different 
strains. The sequence of TSA56 consists of the signal sequence (SP) in the N-terminal end, 
transmembrane domains (TMs) in the C-terminal end, four variable domains (VDs), and three 
extracellular antigen domains (ADs) (81, 82). The variable domain in TSA56 has been used for 
distinguishing the strains of Orientia (83). This supports TSA56 being a strain-specific antigen.  
TSA56 protein plays a primary role in bacterial adhesion to host cells which implies that 
TSA56 is a virulence protein of Orientia. Upon attachment, the surface antigen domain (TSA-ADs) 
directly binds with fibronectin and facilitates the invasion of Orientia into host cells. It has been 
shown that the TSA56-ADI (residue 19-114) had a stronger adhesion ability to host fibronectin 
and antibody response than TSA56-ADIII (residue 237-366). TSA56 is recognized as a highly 
immunogenic surface protein. Antibodies to TSA56 are major components of the humoral 
immune response measurable in scrub typhus patient serum and Orientia-inoculated animal 
serum. Taken together, TSA56 antibodies are important for diagnostic marker and TSA56 
antigens are a candidate vaccine antigen against scrub typhus (81, 84).  
 The TSA47 protein belongs to the HtrA (High-temperature requirement A protein/heat 
shock protein) family of serine proteases. The sequences of TSA47 are homologous to human 
HtrA1 protein and contain a trypsin domain. TSA47 is a transmembrane protein highly conserved 
across strains and is used for species identification (85, 86). This protein also contains a strain-
specific B-cell epitope. Immunization with TSA47 antigen induces both long-term cellular and 
humoral immune responses in mice and cynomolgus macaques (87). One study has reported that 
TSA47 antigen provided good homologous protection and cross-protection against four 
heterologous strains in the mouse model. Because of a relatively strong immune protection and 
cross-reactive epitopes, TSA47 could be a vaccine candidate for broad protection against Orientia 
infection (88). However, cross-reactivity of TSA47 with human serine protease may occur due to 
the sequence homology.  
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The TSA47 protein may mediate Orientia adhesion to host cells, but the adhesion ability 
of TSA47 to host fibronectin is lower than that of TSA56 (81). It has been demonstrated that a 
protein containing a TSA56 antigen fused with a TSA47 was efficient in eliciting humoral and 
cellular immunity against scrub typhus, suggesting that TSA47 may associate with TSA56 to 
facilitate the attachment of Orientia (89).  
The TSA22 protein has no conserved domain and its function remains unknown. It has 
been reported that TSA22 contains B- and T-cells epitopes (90), and the recombinant TSA22 
protein induced antigen-specific proliferation of T-cells that produce IL-2 and IFN-γ. However, 
this antigen could not induce any immune protection when used as a DNA vaccine in CD1 Swiss 
mice. TSA22 also inhibited the protective effects of other scrub typhus vaccine candidates (91). 
The mechanism of inhibition of protective effects is unknown, and further investigation is needed 
(73).   
Another major group of outer membrane proteins (Omp) of Orientia are autotransporter 
proteins, known as surface cell antigen (Sca), which have been identified in Rickettsia genomes 
including OmpA, OmpB, Sca1, Sca2, and Sca4. The major Sca proteins OmpA, OmpB, and Sca4 
have been used for species identification of Rickettsia (92). These proteins are involved in 
bacterial adhesion and invasion during bacterial entry in nonphagocytic host cells (93, 94). The 
set of Sca proteins may be different among Orientia strains.   
Similar to Rickettsia spp., O. tsutsugamushi encodes five multiple autotransporter 
domains (ATD) proteins (ScaA – ScaE) based on the completed genomes of the Boryong and Ikeda 
strains. Recently, a new Sca protein, ScaF, has been identified based on the partial genomes of 
the Sido, Karp, and AFSC7 strains (95). 
The autotransporter proteins contain a signal sequence at the N-terminal end followed 
by a surface-localized passenger domain (α domain) and a highly conserved autotransporter 
domain (β-barrel domain) at the C-terminal end. The signal sequence directs the protein to 
bacterial periplasm. The autotransporter domain inserts itself into the outer membrane to form 
a channel. After insertion into the outer membrane, the passenger domain is translocated and 
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exposed to the bacterial surface (96). The passenger domain is associated with virulence 
phenotypes, for example, bacterial adhesion, invasion, cytotoxicity, and biofilm formation.  
ScaA is the largest protein among Orientia Scas and functions as a bacterial adhesion 
factor. ScaA provides protective immunity against Orientia infection in mice, suggesting that ScaA 
could be a novel vaccine candidate (97). The ScaB gene is present in around one third of Orientia 
isolates. Its function and role in immunity have not been studied (95). The ScaC gene is the 
smallest Orientia Sca and is highly conserved. ScaC plays an essential role in bacterial virulence 
by facilitating the attachment of bacteria to host fibronectin but not the invasion of 
nonphagocytic cells. ScaC is a potential candidate antigen either on its own or in combination 
with ScaA for serological diagnostic assay and vaccine development (98). ScaD has a variable 
passenger domain. The biological properties and immunogenicity against ScaD are not well 
characterized (95). The ScaE gene is also well conserved but the size is larger than the ScaC gene 
so is difficult for cloning and purification for serodiagnostic and vaccines. Like ScaB, ScaF is found 
in few Orientia isolates, and its function is unknown (95). 
1.1.9 Virulence and host susceptibility 
Virulence factors facilitate bacteria to invade the host, cause disease, and evade host 
defense mechanisms. O. tsutsugamushi isolates can be categorized by their similarity to a 
number of type strains i.e., Karp, Gilliam, Kato, TA763, and TA716. Karp- and Gilliam-related 
strains are the most prevalent groups which cause about 50% and 25% of human infections, 
respectively (21). Each strain was classified into one of three virulence types; high, intermediate, 
and low virulence based on their relative capacity to kill mice. Karp and Kato have been identified 
as high virulence strains because only one infected organism can cause death in mice. Gilliam is 
classified as having an intermediate level of virulence as it causes low mortality in mice. TA716 
and TA763 were classified as low virulence strains as they cannot cause death in mice even when 
infected with high doses of bacteria (99). 
The degree of virulence is related to host cell types because each host cell has differences 
in growth factors, physiology, and immunological defense mechanisms leading to bacterial 
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replication effect. One study showed that only low doses of Gilliam infection could kill mice strain 
C3H/He while infection in mice strain BALB/c required higher doses (100). A better understanding 
of the molecular basis of virulence in each strain could provide a clue to Orientia-host 
relationships. 
1.1.10 Metabolic pathways   
 The general metabolic pathways of Orientia are similar to Rickettsia but differ in the 
carbohydrate metabolism (TCA cycle), the components of cell wall biosynthesis, and transport 
systems. Orientia relies on host nutrients for growth due to reductions in major biosynthetic 
pathway components. This reflects the presence of numerous transporters for nutrient uptake 
from host cells (54, 101). 
Carbohydrate metabolism 
 The complete glycolysis pathway, in which glucose is oxidized to pyruvate, is absent in the 
Orientia genome. This suggests that pyruvate cannot be synthesized by the glycolysis pathway. 
Pyruvate is most likely taken up from the host, or alternatively synthesized from malate which is 
acquired from the host. The presence of malate permease in the Orientia genome may function 
in transporting malate from the host cell. Orientia does not produce acetyl-CoA because it lacks 
the functional pyruvate dehydrogenase complex and needs to import acetyl-CoA from the host 
cell (54).  
Energy metabolism 
 Orientia contains almost a complete set of genes for oxidative phosphorylation as a 
source of energy (ATP) including three proton pumps, ATP synthase complex, and the succinate 
dehydrogenase complex. However, Orientia also uptakes ATP from the host cells through the 
ATP/ADP translocases. Orientia may use the host ATP first and subsequently use its own ATP via 





 Nucleotide metabolism is divided into two pathways; purine and pyrimidine biosynthesis. 
Though Orientia can produce pyrimidine nucleotides (thymine and cytosine) on its own, Orientia 
imports purine nucleotides (adenine and guanine) from the host via ATP/ADP translocases. The 
presence of the gene codA (cytosine deaminase) in Orientia indicates that cytosine could be 
converted into uracil (54, 102).  
 Orientia lacks all enzymes for the pentose phosphate pathway, except for ribose-5-
phosphate isomerase (LacA). Phosphorybosyl pyrophosphate (PRPP), a key metabolite for 
nucleotide synthesis, is probably synthesized therefore by importing ribose-5-phosphate from 
the host cell (54).  
 O. tsutsugamushi is the only bacteria in the order Rickettsiales that encodes a fully 
bifunctional spoT/RelA homolog to produce the guanosine nucleotides (pppGpp and ppGpp). 
These alarmone nucleotides are essential in the bacterial stringent response during starvation 
conditions, for example, amino acid starvation, fatty acid depletion, iron depletion, heat shock, 
and other stress conditions (54, 103). 
Amino acid metabolism 
 Orientia lacks most of the genes for amino acid metabolism. It is likely to import 
cytoplasmic amino acids from the host cells due to the upregulation of many amino acid 
transporters in the genome (101). Both Rickettsia and Orientia lack the alanine racemase (Alr), 
which functions by converting L-alanine to D-alanine. These amino acids are a key component of 
peptidoglycan. However, Orientia has the enzymes (ddl, murD, and murF) for incorporating D-
variants of amino acids into peptidoglycan. This suggests that Orientia may uptake D-amino acid 






Lipid metabolism and cell wall components 
 Most of the enzymes for the fatty acid biosynthesis pathway are present in Orientia, with 
only the β-oxidation system of fatty acid for energy production being absent. Based on the 
genomic analysis (54, 55), Orientia lacks the genes for the LPS biosynthesis such as lipid A.  
 Even though D-amino acids are not likely to be synthesized in Orientia and Orientia lacks 
PBP1, a class A bifunctional enzyme that contains both glycosyltransferase and transpeptidase 
activity, the genes involved in cell wall biosynthesis are almost completely present in the Orientia 
genome including murA-G genes, the ftsW/RodA gene from the SEDS (shape, elongation, division, 
and sporulation) family of proteins, and the penicillin-binding proteins (PBP2 and PBP3). Together 
with the evidence of a minimal level of meso-DAP in Orientia, this indicates that Orientia 
possesses the ability to synthesize peptidoglycan (44, 54).  
1.1.11 Immune responses to Orientia infection 
Innate immune responses  
The innate immune system is the first line of defense against bacterial infection. The main 
functions of the innate immune system are to prevent the spread of pathogens, which include 
the recruitment of immune cells at the site of infection, the activation of the complement 
cascade, and co-signaling with the adaptive immune system.  
 Dermal tissue serves as a niche for Orientia replication where the early inflammatory 
response occurs. The eschar biopsies have shown that Orientia presents the cellular tropism for 
professional phagocytic cells (dendritic cells, macrophage, and monocytes) and vascular 
endothelium (9). These cells may contribute to local immunity and systematic dissemination from 
the initial inoculation site toward the bloodstream lymph node and other organs (105).  
Generally, professional phagocytic cells sense bacterial infection through pattern 
recognition receptors (PRRs) i.e., Toll-like receptors (TLR), nucleotide binding domain (NLR), or 
NOD-like receptor, that recognize pathogen-associated molecular patterns (PAMPs) such as cell 
wall components, nucleic acids, and lipoproteins of invading pathogen, and contribute immune 
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activation in response to multiple signaling pathways (106). NOD1 and NOD2 receptors recognize 
peptidoglycan (PG), a component of the bacterial cell wall. The NOD1 receptor senses PG 
containing iEDAP (γ-D-glutamylmeso-diaminopimelic acid), M-TetraDAP (MurNAc-L-Ala-D-Glu-
mDAP-D-Ala), and M-TriDAP (MurNAc-L-Ala-D-Glu-mDAP). These PG fragments are particularly 
presented in Gram-negative bacteria and some Gram-positive bacteria, for example, Listeria 
monocytogenes and Bacillus spp. NOD 1 receptor also recognizes the small dipeptide iEDAP (D-
Glu-mDAP). The NOD2 receptor binds to Muramyl-TriLys (MurNAc-L-Ala-D-Glu-L-Lys) and 
muramyl dipeptide (MDP), which contains MurNAc, L-alanine, and D-glutamic acid. These 
structures are found in both Gram-negative and Gram-positive bacteria (107, 108).  
The details of the innate immune system recognition of Orientia is unclear. Orientia seems 
to be involved in the activation of cytosolic immune receptor NOD-1, an intracellular receptor for 
bacterial peptidoglycan fragments, based on the supporting evidence as follows: (i) the NLR 
activation by the γ-D-glutamyl-meso-diaminopimelic acid of peptidoglycan (109, 110); (ii) based 
on genome analysis, peptidoglycan may be synthesized from UDP N-acetyl-D-glucosamine (54, 
105); and (iii) the presence of meso-diaminopimelic acid (meso-DAP) and peptidoglycan-like 
structures in O. tsutsugamushi (44). The stimulation of NOD-1 receptors, as well as NF-kB-
mediated pathways, leads to massive production of proinflammatory cytokines including IL-6, IL-
8, IL-12p70, and tumor necrosis factor (TNF-α), and IL-1β (105, 106). A recent study showed that 
the secretion of IL-1β is associated with the inflammasome and phagosomal maturation. Orientia 
induces IL-1β production by macrophages through the activation of caspase-1 and the adaptor 
protein ASC (106). These two proteins are the key components of inflammasome which plays an 
important role in initiating and maintaining the inflammatory response (111). The IL-1β secretion 
also requires Orientia escape from the phagosome during phagosomal maturation and PAMs of 
Orientia may stimulate one of the NLR/NOD receptors in the host cytosol (106).  
Intracellular pathogens or viruses are also recognized by TLRs on phagocytic cells 
(Antigen-presenting cells, APCs) which present the bacterial peptide antigen to the T-cell 
receptors (TCR). T-cell activation requires multiple signals that interact with APCs; signal 1 is the 
interaction between peptide-MHC complex and TCR, signal 2 involves costimulatory molecules 
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(CDs), and signal 3 is mediated by the various cytokine signaling molecules, i.e. interleukins-1, 6, 
12 (IL-1,-6,-12), interferon-α (IFN-α), resulting in the differentiation of naïve CD4+ T-cells (Th0) 
into mature T-cells (T-helper 1, Th1) that produces IFN-γ (112-114). Some studies have shown 
that TLR-2 and TLR-4 were related to protective immunity in Rickettsia akari and R. conorii 
infections. The role of TLRs in recognizing Orientia infection is poorly characterized. TLR-2 seems 
to increase the susceptibility of Orientia infection or enhance pathology in a mouse model. One 
study showed that the release of TNF-α and IL-6 from infected dendritic cells (DCs) derived from 
C57BL/6 mice requires TLR-2  (105).  
PRRs and TLRs of APCs recognize the pathogen resulting in the activation of APCs. 
Orientia-infected DCs stimulate the DCs’ activation by upregulating the expression of major 
histocompatibility complex (MHC) class II, costimulatory molecules (CD40, CD80, CD86, and 
CD83) (115, 116), and chemoattractant molecules (CCL3, CCL5, CCL19, CCL21) (105). The antiviral 
type I interferon pathway of infected DCs is also upregulated via the phosphorylation of p38 
mitogen activated protein kinase (MAPK) to produce IFN-β (105). After activation, DCs move 
toward lymph nodes to present antigen to naïve CD4+ T-cells resulting in the release of type II 
interferon (IFN-γ) from Th1 cells. The activated T-cells facilitate the elimination of the pathogens. 
Orientia is likely to inhibit the maturation, migration, and T-cell activation of infected DCs, but 
Orientia potentially activates DCs more than other bacteria that reside in the vacuole, including 
Coxiella burnetii, Brucella abortus (105, 117). 
 Orientia-infected macrophages/monocytes induce the upregulation of the expression 
level of chemokines (CCL2, CCL3, CCL4, CCL5, and CXCL2) through the induction of NF-κB 
transcription factor (118). The MAPK pathways are involved in the upregulation of IFN-β and                               
TNF-α at the transcriptional level and posttranscriptional levels (119). Orientia also activates the 
immunosuppressive molecule, IL-10, to inhibit TNF-α and increase bacterial survival inside 
phagocytic cells (120). This strategy is similar to other intracellular pathogens, for example, 
Mycobacterium tuberculosis, Coxiella burnetii (121), and Yersinia enterocolitica (122). However, 












Figure 3. Schematic of early inflammation response following O. tsutsugamushi infection. 
Orientia has shown tropism for dendritic cells and monocytes at the inoculation site. Impaired 
DCs promotes rickettsial dissemination. DCs release proinflammatory cytokines and stimulate a 
type I IFNs response. Monocytes are recruited to the infection zone, which results in 
mononuclear cell infiltration  and upregulation of proinflammatory genes and the recruitment of 
other immune cells. Schematic figure from (105). 
Endothelial activation plays an essential role in pathogen clearance and immensely 
influences the activation of cytokine signaling molecules. During infection, the intercellular 
adhesion molecule (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and other adhesion 
molecules are upregulated to promote the binding of leukocytes and chemokines (105). VCAM-
1 and ALCAM (activated leukocyte cell adhesion molecule) have been associated with the severity 
of scrub typhus and could be a biomarker of clinical prognosis and disease severity (123).  
IL-32 plays a role in endothelial activation by inducing several proinflammatory molecules. 
The binding of Orientia-NOD1 may activate the production of IL32 but the mechanism has not 
yet been elucidated (124). Upregulation of IL-33 during Orientia infection may modulate the 
inflammatory response, and induce the apoptotic response of endothelial cells. The activation 
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and dysregulation of endothelial is controlled by Ang-1 (vascular stabilizing factor), and Ang-2 
(vascular destabilizing factor). Ang-2 is usually stored in the cells but is released in response to 
inflammatory signals to stimulate endothelial activation (125, 126). High expression of Ang-2 and 
Ang-2/Ang-1 ratio indicates excessive inflammation and loss of endothelial integrity. This 
indicates that endothelial cells are a key mediator of the inflammatory response (105, 127). The 
excessive inflammation, apoptosis, and massive release of pro-inflammatory cytokines can also 
contribute to acute infection in many organs, for example, hepatitis, meningoencephalitis, and 
acute respiratory distress syndrome (128).  
Adaptive immune responses  
 The adaptive immune response is the second line of defense against pathogens. The 
major function of the adaptive immune system is to destroy invading pathogens and the toxic 
molecules produced by pathogens. The adaptive immune system is divided into two classes; 
humoral immune responses (HIR, antibody responses) and cell-mediated immune responses 
(CMIR). HIR and CMIR are carried out by lymphocytes, and B-cells, and T-cells, respectively (129).  
 HIR plays an important role in providing immune protection against homologous infection 
(infection by the same pathogen) and heterologous infection (infection of different pathogens) 
with O. tsutsugamushi, mediated by antibodies to TSA56, a strain-specific epitope. TSA56 
antibodies targeting TSA56 surface protein can inhibit the entry of Orientia into cells and 
neutralize infectivity, as well as increasing the uptake of Orientia by macrophages and 
neutrophils. However, the concentration of strain-specific antibodies against Orientia wanes a 
few years after infection, and the heterologous immune response is maintained for only a short 
time (73).  
The antibody profiles of animal models challenged with Karp strain have reported that 
Th1 response is significant for IgG2c/IgG1 subclass switching in acute lethal effect, which suggests 
that the Th1 cytokine profile (IFN-γ) is important in serious disease development. The high level 
of IgG1 in response to Th2 indicates a sublethal effect (130). Recently, a study of the antibody 
response to ScaA and TSA56 in scrub typhus patients showed that anti-TSA56 IgG mainly 
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consisted of IgG1 and IgG3 subclass and the antibodies were maintained for up to one year after 
recovery, whereas the anti-ScaA IgG consisted of IgG1 and did not respond to other subclasses 
(131). Until now, the role of antibody responses remains unclear in human protective immunity 
and animal infection models. 
 CMIR has an essential role in T-lymphocyte-dependent cross protection against divergent 
strains in O. tsutsugamushi. Both homologous and heterologous Orientia antigens can induce the 
proliferation of T-cells that produce cytokines and interferon.  Immunization of Orientia (Gilliam 
and Karp strains) in mice and cynomolgus macaques produces a high level of IFN-γ from T-cells, 
indicating that the upregulation of IFN-γ provides protection against Orientia infection (105). In 
human scrub typhus patients, IFN-γ and IFN-γ-inducing cytokines (IL-5 and IL-18) present an early 
response during the acute phase of infection (105). T-cell recruitment in Orientia infection is likely 
to be enhanced by the inflammatory chemokines, CXCL9, and CXCL10, which are commonly 
secreted by macrophages, monocytes, and T-cells. These two chemokines are structurally related 
and share the same receptor (CXCR3) on T-cells. The interaction of CXCL-9,-10, and CXCR3 ligand 
induces T-cell polarization (132). The cytotoxic activity of CD8+ T cells is an important mechanism 
for eliminating cytosolic pathogens. Scrub typhus patients show a high level of granzymes A and 
B that are released from cytotoxic T-cell (CD8+ T cells), possibly due to the cytosolic sensing of 
Orientia. There are few studies of CD8+ T cell response in Orientia. A high response of CD8+ T cells 
in the spleen and lung has been shown in BaLB/c mice infected Karp, which suggests that CD8+ T 
cells response is required to control infection and protect the mice from fatality (105).  
 Based on the infection cycle and systematic dissemination of O. tsutsugamushi, it is clear 
that host immunity requires an efficient cross-talk between HIR and CIR, with a tight control of 
effector cells, in order to eliminate the bacteria. However, the mechanisms of T-cell and 
cytotoxicity responses against Orientia infection are not fully understood and should be 





1.2 Orientia tsutsugamushi infection cycle 
 
1.2.1 The entry and cell invasion  
 
 In the early stage of infection, Orientia enters host cells by a clathrin-mediated zipper-like 
mechanism which requires interaction between bacterial surface proteins, host cell receptors, 
and extracellular matrix components. This interaction induces a series of signaling cascades that 
culminate in endocytosis (61).   
TSA56, the major outer membrane protein of Orientia, directly binds to host fibronectin 
and facilitates the invasion of Orientia into host cells through integrin-mediated signaling. 
Fibronectin is a large heterodimer glycoprotein that is located on the surfaces of cells, in the 
extracellular matrix (ECM), and body fluids. A range of cells secretes fibronectin as a disulfide-
bonded dimer (133). Fibronectin is involved in several cellular interactions with ECM and plays 
an essential role in the adherence and entry of several pathogens, such as R. conorii (134), 
Escherichia coli (135), Staphylococcus aureus(136), and Neisseria gonorrhoeae(137). Fibronectin 
contains multifunctional domains including two major heparin-binding domains that interact 
with heparan sulfate proteoglycans (HSPGs), a collagen binding domain, two major fibrin-binding 
sites, a well-known motif for binding with syndecans, and central-cell-binding Arg-Gly-Asp (RGD) 
motifs which interact with α5β1 integrin receptors, the host’s transmembrane receptors (133).  
Fibronectin facilitates Orientia internalization through the interaction between its RGD 
motif and β1 subunit of the integrin receptors. This was confirmed using the Arg–Gly–Asp-Ser 
(RGDS) peptides and a blocking antibody against α5β1 integrin receptors to inhibit Orientia 
infection (138). The antigen domain (AD) corresponding to the extracellular domain of TSA56 
serves as the fibronectin-binding region. The ADIII and the adjacent c-terminal region (amino acid 
residues 243-349) of TSA56 presented the adhesion ability to fibronectin. This was determined 
by a ligand-binding blot using the TSA56-glutathione S-transferase (GST) fusion proteins (138).  It 
has been reported that the short peptide of TSA56-ADIII (amino acid residues 312-341) interacted 
with fibronectin and significantly inhibited bacterial invasion in L929 cells, possibly by blocking 
TSA56-fibronectin interaction (139). Also, the peptides containing TSA56-ADI (amino acid 
residues 19-114) induced a strong antibody response against the patient’s sera and could be a 
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potential region in adhesion/invasion. However, it is not known whether ADI of TSA56 binds to 
fibronectin or not (81).  
ScaC (surface cell antigen) autotransporter proteins potentially participate in Orientia 
attachment to host cells, through binding with fibronectin, but not in cell invasion. The 
interaction between fibronectin and ScaC has been confirmed using yeast two-hybrid screening 
and GST pulldown assays (98). However, the details of the binding mechanism remain unknown. 
Another Rickettsia spp., R. conorii internalizes into host cells via the interaction between rOmpB, 
an autotransporter protein, and its mammalian receptor (K70).  This K70 receptor shares 
sequence homology with integrin A domain, von Willebrand factor A1 and A3 domains that 
potentially bind to fibronectin (134). Orientia may process the internalization via the ScaC-
fibronectin-integrin interaction.  
Orientia may interact with the heparan sulfate (HS) moiety of HSPGs which are 
ubiquitously expressed in the ECM and on the cell membrane of host cells. HSPGs consist of HS 
proteoglycan (GAG) polysaccharide chains and each HS chain contains a polymer of repeating N-
acetylglucosamine (GlcNAc)-D-glucuronic acid (GlcA) disaccharide units (140). Bacterial invasion 
inhibition assays have shown that preincubation of the purified Orientia with HS and heparin 
significantly inhibits Orientia attachment in L929 cells in a dose-dependent manner. Other 
supporting evidence demonstrated the reduction of Orientia attachment in mutant Chinese 
hamster ovarian (CHO) cell lines that were deficient of HS and all GAGs synthesis (141). This 
suggests that HS is potentially involved in Orientia attachment and may mediate endocytosis, 
however, the specific ligand on the Orientia surface membrane involved in the binding of HS is 
still unknown.  
Besides HS, the syndecan-4 may participate in Orientia attachment to host cells. 
Syndecans-4, a transmembrane-HSPG, is numerously expressed on the surface membrane of 
host cells. It has been shown that the infectivity of Orientia depends on the expression level of 
syndecan-4 on the host cell surface (142). Syndecan-4 also interacts with fibronectin via the α5β1 
integrin receptor (143). This could suggest that Orientia may utilize Syndecan-4 as a co-receptor 
to adhere to host cells.  
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Overall, Orientia manipulates its surface proteins to interact with fibronectin, integrin, 
HS, or syndecan-4 for attachment and internalization/invasion into host cells. However, the in-
depth molecular mechanisms of these interactions remain to be elucidated.  
 
1.2.2  The internalization of Orientia into host cells 
The interaction of TSA56 and fibronectin activates integrin-mediated signal transduction 
pathways. Activation of the α5β1 integrin receptor induces the activation of the downstream 
signaling molecules at the inner surface of the plasma membrane, including focal adhesion kinase 
(FAK), Src tyrosine kinase, and RhoA GTPase. The signaling transduction adaptors talin and paxillin 
are also recruited to the invasion site, which promotes tyrosine phosphorylation of FAK and Src 
proteins resulting in the actin cytoskeleton reorganization, and these consequently induce the 
internalization of Orientia into host cells via clathrin-mediated endocytosis (139). The 
recruitment of actin occurs 10 minutes post infection and Orientia is completely internalized by 
30 minutes post infection. FAK/Src plays an important role in integrin-mediated signaling, where 
RhoA GTPase is a key regulator of actin rearrangements by promoting actin stress fiber formation 
and focal adhesion assembly (139, 144). The exact downstream mechanism of integrin-RhoA 
GTPase activation remains unknown.  
Calcium (Ca2+) plays an essential role in many cellular functions, including cytoskeletal 
reorganization, vesicular trafficking, and gene expression (145). Other facultative intracellular 
bacteria such as Shigella flexneri, Listeria monocytogenes, and Campylobacter jejuni induce 
intracellular Ca2+ level during the invasion in non-phagocytic cells (146). Likewise, Orientia also 
induces the release of cytosolic Ca2+ in Hela cells and also activates phospholipase C (PLC-γ1), a 
key enzyme regulating Ca2+ that is released from the endoplasmic reticulum. These activations 
might contribute to the actin cytoskeleton rearrangement during the early phase of Orientia 
infection. However, the specific bacterial proteins and host receptors of Ca2+ activation are 
unidentified (146).  
Orientia internalizes host cells via clathrin-mediated, but not caveola-mediated, 
endocytosis which occurs rapidly. The colocalization of Orientia with clathrin and adaptor protein 
2 (AP-2) has been found within 30 min post infection. This was confirmed by the inhibition assay. 
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The results showed that the infectivity of Orientia was remarkably decreased by clathrin-
mediated endocytosis inhibitors, but not by filipin III, an inhibitor that blocks caveola-mediated 
endocytosis (147). Upon internalization, Orientia enters endosomal compartments and 
colocalizes with the early endosome markers, EEA1, within 10-30 minutes post infection. The 
majority of Orientia remain inside endosomes for up to two-hour post infection, and this was 
shown by the colocalization with LAMP2, a late endosomal marker.   
1.2.3 Endosomal and autophagic escape 
The strategy of Orientia to escape from the endosome is not known. In other intracellular 
pathogens, L. monocytogenes use the listeriolysin and phospholipase C protein to escape the 
early endosome. Based on genome analysis, Orientia encodes a hemolysin gene (tlyC) and a 
potential gene encoding phospholipase D (PLD). Presumably, Orientia may use hemolysin and 
phospholipase to disrupt the endosome membrane and subsequently release into host cytosol 
(147).  
The low endosomal pH causes the conformational changes and triggers membrane fusion 
of bacterial membrane and endosomal membrane (148).  The acidification of the endosomal 
lumen is driven by proton(H+)-pumping ATPase that is located in the endosomal membrane. It 
has been demonstrated that Orientia requires a low pH condition in the endosomal lumen to 
escape the endosome. When the acidification of endocytic compartments was inhibited by NH4Cl 
or bafilomycin, Orientia was not able to escape the endosome, and the infectivity of Orientia was 
significantly reduced. This implies that low pH and H+ pumps are the key compartments for the 
endosomal escape of Orientia (147).  
 Once Orientia is free in the host cytoplasm, Orientia induces and escapes autophagy, 
which plays a critical role in the innate defense mechanism against invading pathogens. The 
immunoblot with antibody to LC3-II protein, an autophagosome marker, showed that Orientia 
induced LC3-II during the early infection of Orientia in nonphagocytic and phagocytic cells. The 
LC3-II level was significantly high at 30-60 min post infection, gradually decreasing 2-4 hours post 
infection. Most of the internalized Orientia did not colocalize with LC3-positive autophagosome 
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throughout the infection, suggesting that Orientia can actively escape from the autophagosome 
and only a few bacteria remain captured. In the presence of tetracycline, it blocks bacterial 
translation, inhibits Orientia invasion, and enhances bacterial entrapment by autophagosomes. 
This indicates that the active escape of Orientia is likely mediated by bacterial gene expression 
or Orientia may use some factors that block autophagic recognition (115, 149). 
Unlike many other intracellular pathogens such as Anaplasma phagocytophilum, 
Chlamydia trachomatis, and Francisella tularensis that reside in vacuoles and survive within 
autophagy (149), Orientia is able to escape autophagy, which is similar to Rickettsia (150) and 
other obligate intracellular pathogens such as Shigella flexneri and Listeria monocytogenes (149). 
Shigella avoids autophagic recognition by secreting IcsB protein via T3SS, which competitively 
binds to its surface proteins. Shigella also blocks the interaction of the autophagy-related 
proteins, VIG, to prevent autophagosome maturation (151). Listeria also uses its proteins to 
interact with host cytosolic proteins to prevent autophagic recognition, for example, the binding 
of Listeria protein ActA with cytosolic actin protein complex, and the linking of Listeria protein 
InlK with cytoplasmic ribonucleoprotein WVP (152).   
1.2.4 Intracellular transportation  
Many other obligate intracellular pathogens such as Listeria monocytogenes, Shigella 
flexneri, and Rickettsia conorii hijack host actin and can polymerize actin into the propulsive actin 
comet tails for transport within the cell and evasion to neighboring cells (cell-cell spread), whilst 
Orientia is not able to recruit and polymerize host actin but colocalizes with host microtubules 
instead.  
After escaping autophagy, the cytosolic Orientia manipulates host microtubules to 
translocate to the perinuclear region where bacterial replication occurs. It has been proposed 
that Orientia interacts with cytoplasmic dyneins to accumulate near the microtubule organizing 
center (MTOC), which is typically located at a perinuclear region (153). Orientia moves to the 
MTOC within 90 min post infection, suggesting that Orientia requires microtubules for 
redistribution during the early stage of infection (153). However, it is still unclear how Orientia 
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interacts with dynein, why Orientia needs to replicate at the MTOC, which surface proteins on 
Orientia interact with microtubule-binding proteins, and how these proteins are regulated.  It has 
been suggested that Orientia employs the host cytoskeleton to move to a glycogen and ATP-rich 
perinuclear region for a metabolic reason (153). Additionally, Orientia is particularly located in 
the glycogen-packed area which is devoid of lysosomes and other cytoplasmic organelles (154). 
Chlamydia trachomatis manipulates host microtubules and dynein to travel to the MTOC 
and interacts with host cell vesicular transport pathways for promoting its effective growth. 
Chlamydia hijacks host sphingomyelin and cholesterol from the Golgi complex that localizes near 
the MTOC, and fragments the Golgi complex into ministacks, which are normally designated for 
the plasma membrane of chlamydial inclusions. This suggests that the main purpose of the 
location near the MTOC is to uptake nutrients (155).  
 Recently, Orientia has been demonstrated to colocalize with the Golgi complex and 
translocate backward to the endoplasmic reticulum (ER) before exiting host cells (105). Orientia 
disturbs Golgi structure by destabilizing the membrane of Golgi and ER through the interaction 
of the effector protein Ank-9 and COPB2, a host protein that mediates Golgi-to-ER transport. This 
process occurs during the first 24-48 hours post infection. Destabilization of Golgi also benefits 
Orientia replication (156).  
 Orientia replicates by binary fission with a doubling time of about 9-10 hours (74). 
Orientia has been found to form a microcolony near the nucleus. It has been proposed that the 
polysaccharide (N19) which is released from Orientia, promotes self-aggregation along with 
bacterial microcolony (157).  
1.2.5 Escape from host cells 
  After replication is complete, Orientia migrates to the periphery of the cells and slowly 
protrudes from the host cell surface, resulting in extracellular bacteria in which the host cell 
membrane is still intact (158).  Each bud contains a single bacterium. It is thought that the host 
membrane enclosing budding bacteria remains for a long period, and may protect bacteria from 
the fluctuating environment outside of host cells (159). The membrane-coated Orientia may have 
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benefits for reinfection by phagocytosis. The host membrane enclosing Orientia may be lysed 
before the infection of new host cells, or alternatively, Orientia may be released without host 
membrane from the heavily infected cells due to host cell membrane damage.  
 The virus-like budding mechanism of Orientia is unique among other bacteria in the 
Rickettsial family. Similar to Chlamydia spp. that extrudes from host cells by pinching off, though 
the extrusion of a single chlamydial inclusion releases around a hundred bacteria (56). It has been 
reported that Chlamydia mediates the host actin cytoskeleton by the extrusion(160). Possibly, 
the budding mechanism of Orientia may involve actin (56).  
 Lipid rafts are sections of the plasma membrane that consists of cholesterol, 
sphingolipids, glycosylphosphatidylinositol (GPI)-linked molecules, and caveolin-1 (161). Many 
pathogens utilize lipid rafts to enter into host cells but not to exit from them. For example, E.coli 
binds to CD48 which is associated with GPI-linked lipid rafts and Chlamydia trachomatis enters 
host cells via caveolin and cholesterol (162, 163). Orientia also uses lipid rafts from the host 
membrane during the exit but not entry (164). Two Orientia surface proteins, TSA47 (HtrA) and 




Figure 4. The model of intracellular cycle of O. tsutsugamushi. The top right inset shows a 
schematic view of the cell envelope of O. tsutsugamushi. The large inset represents the overview 
of the attachement and internalisation process. Red arrows indicate unknown pathways.                                        
LPS, lipopolysaccharide; ScaC, surface cell antigen C; TSA56, type surface antigen 56. Image from 
ref (61). 
1.3 Bacterial heterogeneity  
Generally, bacteria live in fluctuating environments and they have to adapt to a wide 
range of external conditions for survival. As a result of successful adaptation driven by changes 
in the environment, bacterial cells undergo a cellular differentiation process by altering cell 
morphology and/or physiology during the developmental cycle (165). 
 Caulobacter crescentus is an aquatic gram-negative bacterium that lives in nutrient-poor 
environments, and it is one of the best models to study the bacterial developmental cycle, 
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regulatory networks controlling the bacterial cell cycle, and cell differentiation (166). Caulobacter 
exhibits a dimorphic cell cycle (swarmer and stalk cells), and each cell presents a distinctive 
appearance based on the developmental stage (167, 168). This property allows easy 
synchronization of populations and follows up gene expression, gene regulation, protein 
subcellular localization, cell division, and growth over the course of infection (169).  
Pathogens exhibit mixed populations (population heterogeneity) to cope with rapidly 
changing environments. This adaptation can be explained by the fact that bacterial cells require 
a longer time to initiate recognition of and response to environmental changes by common signal 
transduction pathways. The response process may be costly because bacteria need to waste 
energy to produce proteins that would allow them to survive in a restricted condition. These 
processes may not allow bacterial cells to adapt in time.  Bacteria need an alternative strategy by 
generating subpopulations which rely on genetic and phenotypic variations to ensure that the 
whole population is not killed by stressors (170).  
 The heterogeneity within bacterial populations is driven by genetic diversity at the 
population level and/or phenotypic differences between genetically identical bacterial cells.  Two 
broad strategies have been described for how bacteria undergo heterogeneous adaptation upon 
the environmental changes.  First, the bet-hedging strategy in which some individuals of bacterial 
populations express genes which facilitate their survival under stress conditions. The variability 
of bacteria cells occurs within a genetically identical population to ensure that some individual 
bacteria will adapt and will survive under given conditions, and eventually reproduce more 
offspring. This process happens before bacteria is exposed to stress environments during 
infection.  On the other hand, heterogeneity results from changing environments. A small 
population within a bacterial cluster changes the gene expression profile after exposure to 
environmental stress such as limited nutrient availability and changing pH, temperature, and 





1.3.1 Genetic diversity within bacterial populations  
Bacterial gene expression is normally regulated at the transcriptional level through a 
promoter control mechanism. Bacteria increase several genes for adaptation to more than one 
environment. This strategy is typically controlled by all-or-none mechanisms and phase variation 
is an example of this mechanism (172). 
 Phase variation is a stochastic mechanism for generating heterogeneous populations and 
involves reversible alteration to the genome. Phase variation describes the switching of protein 
expression from an ON to an OFF phase in response to rapid environmental changes. This process 
is caused by reversible mutation where the mutation switches off the expression of a gene and 
inversely the mutation switches a gene back on again, leading to a variation in the expression 
level of one or more proteins between individual cells. Phase variation occurs randomly at a high 
frequency with approximately 10−5 per generation (172, 173).  
 Pathogenic bacteria frequently use phase variation to alter their cell surface structures, 
such as outer membrane protein, lipopolysaccharide (LPS), flagella, and pili. This helps bacteria 
evade the host immune recognition due to antigenic specificity changes. Phase variation of lic1 
locus has been demonstrated in Haemophilus influenza. The lic1 locus is required for the addition 
of phosphorylcholine (ChoP) to LPS. The presence of ChoP on LPS enhances immune resistance 
by reducing  sensitivity to C-reactive protein–mediated complement killing (174). Neisseria 
meningitides can switch Opas, adhesin proteins on bacterial surface membrane, to avoid 
phagocytosis and complement fixation during the course of infection. The Opas proteins exhibit 
antigenic variation and have different tissue tropism. Phase variation of Opas could allow bacteria 
to adapt to different niches during the infection cycle (174). 
Obligate intracellular bacteria also employ the phase variation strategy to survive in host 
environments. It has been demonstrated that phase variation contributes to a rapid adaptation 
of Chlamydia trachomatis by mediating the regulation of lipid A biosynthesis and the functionality 
of cytotoxin (175). The major surface protein 2 (msp2) in Anaplasma phagocytophilum exhibits 
antigenic variation by recombination of pseudogene into the msp2 operon-linked expression site. 
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This allows bacteria to escape Th cell recognition and results in life-long persistence in host cells 
(176). The antigenic variation of major outer membrane protein, TSA56, in O. tsutsugamushi 
might be processed through phase variation to avoid host immune recognition, however, there 
is no evidence to support phase variation in Orientia.  
1.3.2 Phenotypic heterogeneity within bacterial populations 
The stress in host microenvironments may promote a different growth rate in a 
subpopulation of pathogenic bacteria. Perhaps the most common form of phenotypic 
heterogeneity is the presence of slow-growing cells/non-replicating cells within a majority of 
replicating cells.  
Subpopulations of bacteria differentiate into distinct morphological cell types to adapt to 
the niche environments in which they reside. Many bacteria present two distinct morphotypes 
in their life cycle which consists of replicating and non-replicating forms. For example, sporulating 
and vegetative cells in Bacillus subtilis (177), stalk and swarmer cells in Caulobacter 
crescentus(168), infectious extracellular (the elementary body-EB) and noninfectious 
intracellular replicating form (the reticulate body-RB) in Chlamydia trachomatis (178), a Large-
cell variant (LCV) and Small-cell variant (SCV) in Coxiella burnetii, and Anaplasma spp. and 
Ehrlichia spp. which both have a large reticulate (RC) and smaller dense-core (DC) form (178-
181). However, the Orientia life cycle appears not to have a biphasic life cycle because there is 
no obvious alteration of their morphotype among the subpopulation during the infection cycle. 
This feature is also found in the closely related bacteria, Rickettesia spp. (182). Persister cells 
have been implicated in chronic infection especially bacteria that produce biofilm formation, 
such as E.coli, B. subtilis, and Pseudomonas putida (171). Subpopulations of bacteria in 
macrocolony biofilm differentiate into distinct morphological cell types. Stationary phase-like 
cells in the surface of the biofilm are small and round while post-exponential-phase cells at the 





1.4 Detection of bacterial heterogeneity 
 The most common strategies that have been used to identify distinct bacterial 
subpopulations are based on utilizing fluorescent probe/reporter of distinct subpopulations such 
as FISH (Fluorescent in situ hybridization) or detection of fluorescent signals that follow up the 
expression of specific genes or monitor cell division (171).  
 The FISH method is used for the detection and quantification of nucleic acid in the cells. 
This principle is based on the hybridization of nucleotide probes that are complementary to 
target sites on DNA or RNA. The reaction is directly detected by fluorescently labeled probes or 
radioactively, or it can be indirectly visualized using antigen binding or biotin-streptavidin 
interactions (184).  FISH was shown to be a useful tool to study the individual cells including the 
developmental cycle of obligate intracellular bacteria, such as using a set of 16S rRNA-targeted 
oligonucleotide probes to detect Chlamydia spp. in Hela cells (185). The advantage of FISH is that 
it can be applied with multiple methods such as immunofluorescence, mass, single cell RNA-seq 
and Mass spectrometry. Also, FISH does not need a strain specific construction and can label 
several conditions in fixed cells. FISH can be applied with multiple probes labeled with different 
dyes to reduce the risk of false-positive signals, which are caused by nonspecific binding of host 
components. Even though the detection of specific 16s rRNA sequences can define the identity 
of individual cells, FISH cannot distinguish closely related species or cells with identical rRNA 
sequences (171).  
 The fluorescent reporter can be used to study the growth rate of individual bacteria by 
monitoring DNA replication rate, a change in ribosomal protein or RNA content, and fluorescent 
signal dilution upon cell division (186). Fluorescence reporter can monitor a change in ribosomal 
RNA content which is a very effective method to observe the individual cell differentiation, 
especially when the ribosomal proteins significantly change in bacterial cells under different 
growth phases. For example, the insertion of destabilized GFP at the ribosomal RNA (rRNA) locus 
has been used to determine ribosome biosynthesis. GFP-tagged single strand binding protein 
(SSB) can label replication forks of DNA to monitor DNA replication in active dividing bacteria 
(187).  However, the SSB method may not be suitable for fast-growing bacteria because of a poor 
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fusion of SSB. Fluorescent signal dilution effectively monitors bacterial replication up to 10 
generations, however, the fluorescent signal usually reduces below the limit of detection after 
10 divisions. Additionally, this method is efficient when the fluorescent proteins are stable with 
very low turnover rates, which allows a ratio of fluorescence observed/initial fluorescence to be 
a good readout of the number of cell divisions (171, 188).  
 In obligate intracellular bacteria, the fluorescent protein-based method has been used to 
study the life cycle and host-pathogen interaction. However, this approach does not work for 
genetically intractable bacteria including Orientia tsutsugamushi (189). The immunofluorescence 
approach is currently the main tool for labeling obligate intracellular bacteria by targeting the 
surface protein on bacterial membrane such as Omps in Rickettsia spp., and TSA56 in Orientia. 
Additionally, the surface proteins of each organism always present antigenic diversity, and 
antibodies against targeted proteins need to be optimized and validated for new strains. The 
clickable methionine probe is an alternative tool to label the obligate intracellular bacteria. It can 
be used as a universal probe to label the pathogens and differentiates the metabolic activity 
within bacterial populations (190). 
1.5 Cell growth and bacterial cell cycle 
 Cell growth depends on the capability of cells that can proceed with successive rounds of 
the cell cycle. The bacterial cell cycle generally consists of a series of events during cell growth 
which is divided into three stages: the initiation of DNA replication (B period), genome duplication 
and chromosome segregation (C period), and completion of replication and cell division (D 
period). DNA replication and cell division are the two key processes that have to be synchronized 
with cellular growth, to ensure that the reproduction of progeny occurs along with the 
maintaining of cell size and shape. Coordination between cell growth and rapid changing 
environmental conditions are important processes for bacteria to survive. Bacteria must quickly 
adjust the cell cycle dynamic and growth parameters to accommodate changes in nutrient 




1.5.1 DNA replication  
 DNA replication is coordinated with cellular growth and has to be tightly regulated to 
ensure that the replication occurs only once per division cycle, as well as, both nucleoid 
segregation and cell division must be completed to facilitate the stability and integrity of the 
offspring’s chromosome. These processes also require sufficient nutrients to drive the cell cycle, 
suggesting that the replication is coordinated with the nutrient availability and metabolic status 
(191, 192).  
 The initiation of replication is activated by a highly conserved initiator protein DnaA which 
is a member of the AAA+ family of ATPase and probably found in most prokaryotes. DnaA binds 
to the origin of chromosome replication (oriC) at the high-affinity binding sites, Dna-ADP and 
Dna-ATP, to unwind the double DNA helix and allow the formation of replisome which consists 
of helicase to unwind DNA strand, polymerases to duplicate the DNA and nuclease and ligase 
enzymes to process DNA duplication on lagging strand  (192, 193).  
 Nutrient availability has a significant effect on DnaA level during cell growth. Upon amino 
acid starvation, the DnaA synthesis diminishes and inhibits DNA replication. In E.coli, DnaA is 
regulated by (p)ppGpp. The synthesis of (p)ppGpp is stimulated by amino acid starvation through 
RelA synthetase enzyme or is triggered by carbon starvation through SpoT synthetase enzyme. It 
has been demonstrated that the transcription of dnaA is inhibited by (p)ppGpp but the 
mechanism remains unclear (194). Overexpression of RelA induces (p)ppGpp and also blocks the 
replication initiation(195). This supports that DnaA and initiation of replication are controlled by 
(p)ppGpp. There are other regulatory mechanisms that work together to regulate DnaA synthesis 
and activity such as autoregulation of dnaA transcription and positive control by DiaA, an initiator 
activity of DnaA protein (192).  In Caulobacter, DNA replication is tightly controlled by the CtrA 
protein, which is an important response regulator. CtrA binds to the origin of replication and 
prevents the initiation of new rounds of replication (196, 197). CtrA also controls the expression 
and cell cycle progression by binding about 55 cell-cycle-controlled operons including flagellum 
and pili biogenesis (198, 199). The activity of CtrA is essential for the swarmer-to-stalked cell 
transition, which must be tightly coupled with other pathways involved in polar differentiation, 
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growth, and cell division. This allows various events to be synchronized during cell cycle 
progression (169).   
1.5.2 Chromosome segregation and cell division 
 Unlike chromosome segregation in eukaryotic cells, chromosome segregation in 
prokaryotic cells occurs continuously along with DNA replication. After completion of the 
replication by binary fission, sister chromosomes in bacterial cells move to opposite ends of the 
cell before separation. The cells divide into two progeny cells of about similar size. As a 
consequence, the mid cell region has free space which allows the polymerization of FtsZ, a tubulin 
homologue protein, into the Z-ring at the future septation region (200). 
The cell division process is controlled by divisome, a protein complex that is essential for 
division and is located at the cytoplasmic membrane. In E. coli, the divisome consists of more 
than 10 proteins such as FtsZ, ZipA, FtsN, FtsK, FtsQ, and FtsI. If cells lack these proteins, cells can 
continue to grow without dividing and form filamentous cells and may ultimately lyse (201). 
There are two phases of the divisome assembly which have been demonstrated in E. coli,                             
B. subtilis, C. cresentus and other bacteria (166). The first phase is the formation of proto-ring. 
The Z-ring is generated along with the accumulation of membrane-associated proteins (ZipA, 
FtsZ, and FtsA) at the cell envelop. In the second phase, late divisome proteins (FtsK, FtsQ, etc.) 
that involve peptidoglycan synthesis are recruited to generate septum, as well as other proteins 
that coordinate between proto-ring and peptidoglycan synthetase such as FtsN, FtsI, etc. (202). 
In E. coli, the regulation of cell division involves two main systems; the Min complex and 
nucleoid occlusion. The Min complex consists of the MinC, MinD, and MinE proteins. On the 
cytoplasmic membrane, MinD binds to MinC (a division inhibitor) and forms a cap-like polymeric 
layer to prevent the formation of FtsZ ring at the pole of cells. MinE forms as a ring-shape that 
slowly displaces MinCD from the middle to the polar region of the cell. The second system, 
nucleoid occlusion, consists of the SlmA protein which binds to the chromosome and directly 
interacts with FtsZ, maintaining septum formation until chromosome segregation is nearly 
finished.  The integrated function of SlmA and Min complex proteins targets FtsZ ring at midcell 
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to make sure that the divisome formation is retained to the last phase of the replication cycle 
(200, 202).  
Caulobacter commonly divides into two distinct cell types; swarmer and stalked cells. A 
swarmer cell lives in the environment searching for nutrients and cannot replicate before it 
differentiates into a stalked cell.  When the conditions are favorable, the stalked cells initiate 
chromosome replication, and the divisome protein complexes are recruited to mid-cell after 
chromosome segregation (166). FtsZ ring forms a ring-like structure in the midcell and recruits 
many other divisome components that are essential for membrane fission, peptidoglycan 
remodeling, and cell separation (203). Instead of the Min or nucleoid exclusion system, the 
regulation of cell division in Caulobacter is controlled by ATPase MipZ, which belongs to 
Mrp/MinD family(204). MipZ acts as a checkpoint and coordinates the assembly of divisome. 
MipZ interacts with the polar ParB-ParS complexes. ParB functions by stimulating the formation 
of ATP-bound MipZ dimer, which are retained at the pole, and this allows Z-ring formation at the 
mid cell region (205).  
In cell-wall-less obligate intracellular bacteria such as Chlamydia spp., Wolbachia spp. and 
Orientia there is a lack of FtsZ. The question has been raised as to how these bacteria process the 
division. It has been reported in Chlamydia that MreB actin-like protein and its regulator RodZ of 
bacterial actin complex partially substitutes for the function FtsZ in the septation process during 
cell division (206, 207). Evidence of the FtsZ ring in Orientia remains to be found. 
1.5.3 Growth  
 Two fundamental types of bacterial growth have been described: growth in biomass in 
which individual cells increase in mass, and growth in cell number which results from binary 
fission (208). Bacterial growth rate depends on the environmental conditions especially nutrient 
availability. Nutrient-rich conditions result in a reduction of mass doubling time and increase in 
the cell size, whereas starvation conditions diminish the growth and reduce cell size (192).  
 The typical growth curve of bacteria consists of four main phases; lag, log, stationary, and 
death. The lag phase is when cells adapt themselves to the growth conditions and cells might 
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have little or no cell reproduction during this stage. In the exponential phase, cells begin to rapidly 
multiply by binary fission which leads to an exponential increase in the number of cells. During 
the stationary phase, the metabolic activity is high and the DNA, RNA, cell wall components, and 
other important proteins are produced for cell division. This phase can last for several hours or 
several days, depending on bacterial species. The stationary phase occurs when nutrients are 
depleted or other conditions such as the accumulation of toxic waste products and stress factors, 
results in limiting the number of cells or stopping growth. However, metabolism is still active. 
The rate of cell division is equal to the rate of cell death. Pathogenic bacteria begin to produce 
substances or virulence factors that help them survive among harsh conditions. Finally, the death 
phase represents an exponential decline in the number of cells due to cell death (209).  
 The physical and molecular changes of bacterial cells during the stationary phase have 
been a recent focus of research due to the importance of adaptation strategies for survival under 
stress conditions. Major physical changes of the cells during the stationary phase include the 
reduction of cell size, development of spherical shape, the reduction of membrane fluidity, an 
increase of cross-links of the cell wall and an increase in the thickness of the peptidoglycan layer 
(210). Bacterial cells also activate the stringent response mechanism which allows bacteria to 
reprogram the gene expression pattern to survive in stress conditions. The key regulators of gene 
expression during the stationary phase are transcriptional factors. Sigma factors are upregulated 
in several bacteria, for example, σH ,σs, σN in E. coli and  σE,σH,σs in Pseudomonas aeruginosa (211, 
212). In C. crescentus, a large number of alternative sigma factors of the extracytoplasmic 
function (ECF) have been implicated in stress responses. Three ECFs (σF, σT, and σU) are known to 
be involved in stationary-phase survival (213), and σT, which is similar to σs in E.coli, has been 
demonstrated to be the master regulator to stress response (214). The DNA is highly condensed 
due to a high condensation of cytoplasm. This leads to a reduction in protein synthesis. At the 
translational level, the ribosome is inactivated to reduce protein synthesis. There is little known 
about the proteins that are involved in chromosome organization and interaction with DNA 




1.6 Genetic tools in obligate intracellular bacteria. 
1.6.1 Transformation  
 Over the past 20 years, genetic manipulation of obligate intracellular bacteria including 
Chlamydia spp., Coxiella spp., Anaplasma spp., Ehrlichia spp., and Rickettsia spp. and Orientia 
spp. has proven immensely difficult due to their genetic intractability.  The limitations of genetic 
manipulation in obligate intracellular bacteria can be described as follows; (i) bacteria must be 
propagated and manipulated intracellularly (189), (ii) the growth of intracellular bacteria takes 
longer than other facultative intracellular bacteria and free-living bacteria, for instance, Rickettsia 
and Orientia have a replication time of 8-19 hours, which is 2-3 times that of Legionella 
pneumophilia (216), (iii) obligate intracellular bacteria must be purified from host cells before 
performing the transformation, thus, bacteria could be damaged during the purification process 
and might become non-infectious (189), (iv) mutating genes that are vital for bacterial invasion 
and growth may compromise the survival of transformants (189), (vi) selecting appropriate 
promotors is a key factor in enabling the inserted elements and reporter to function during 
transformation (189).  
  A genetic transformation is a common approach in which exogenous DNA is transferred 
into prokaryote and eukaryote cells, resulting in alteration to the specific targeted-gene in 
recombinant strains. Transformation methods that have been successfully performed in obligate 
intracellular bacteria include electroporation, chemical transformation, and PAMAM 
(polyamidoamine) dendrimers mixed with a plasmid vector (189).  
 Chemical transformation commonly involves the use of calcium chloride to increase the 
permeability of bacterial membranes. Calcium ions will bind to both foreign DNA and bacterial 
cell surface which changes cell membrane permeability. This allows DNA uptake into bacterial 
cells (217). The advantages of this method are that it is simple, inexpensive, and rapid. However, 
amongst obligate intracellular pathogens chemical transformation has been used only for 
Chlamydia trachomatis L serovars (218).  
 PAMAM dendrimers are highly branched polymers that are used for the delivery of small 
molecules or DNA into mammalian cells. Dendrimers enter targeted cells via endocytosis and can 
51 
 
be modified to enhance the transfection efficiency in different cell types. Dendrimer-plasmid 
complexes have been used to transform Chlamydia spp. (C. trachomatis and C. pneumonia) and 
A. phagocytophilum. These achievements highlight the potential of dendrimer to penetrate the 
host membrane and the vacuole-bacteria. In addition, bacterial cells are less damaged by 
PAMAM dendrimer-mediated transformation than by chemical transformation or 
electroporation, and this method does not need bacterial isolation and reinfection (219, 220).  
 Electroporation or electropermeabilization is a method that uses high-intensity electrical 
field pulses to transiently destabilize cell membranes, leading to temporary pores and allowing 
cells to uptake exogenous DNA. This technique is rapid and easy but requires bacterial isolation 
and antibiotic selection. Many obligate intracellular bacteria have been successfully transformed 
through electroporation such as C. trachomatis, R. prowazekii, A. phagocytophilum, and E. 
chaffeensis (221-224).  
Transformation is easy to perform in free-living bacteria. However, proceeding with this 
approach in obligate intracellular bacteria is challenging due to host cell restricted growth, which 
causes low transformation efficiency and requires long-term culture to expand small 
transformant populations. There are several factors that need to be considered in transforming 
obligate intracellular bacteria, such as plasmid types, bacteria purification, host cell types, host 
cell confluence, MOI (multiplicity of infection), antibiotic selection markers, promoter selection, 
and detection of positive transformant population (72). 
Plasmids/ shuttle vectors have been used successfully to manipulate the genetics of obligate 
intracellular bacteria. However, the plasmids are sometimes lost after long periods of passage 
and cannot mutate essential genes that are important for bacterial growth (189).  
Transposon insertion is another molecular tool used for random mutagenesis in the bacterial 
genome. This approach is effective and widely used for studying bacterial pathogenesis and 
bacterial virulent factors (225). Himar1 is a transposon element that was originally isolated from 
Haematobia irritans that has been extensively used to mutagenize large numbers of bacteria 
including many obligate intracellular bacteria, such as C. burnetii, Anaplasma spp., Ehrlichia 
chaffeensis, and Rickettsia spp.. Generally, the Himar1 transposase system consists of 
transposase enzyme and transposon which contains antibiotic resistance cassette and 
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fluorescent markers flanked by inverted repeat regions. The Himar1 transposase functions by 
randomly inserting transposon into AT dinucleotide sites in the bacterial genome via a cut-and-
paste mechanism. The fluorescent gene marker in the transposon provides a visual detection and 
identification of insertion loci in the bacterial genome (189).  
Several genetic approaches have been established in many obligate intracellular bacteria, 
however, genetic manipulation has never been successful in Orientia and still needs to be 
elucidated (Fig. 5).  
 
Figure 5. A summary of genetic tools in obligate intracellular bacteria. Successful genetic 
manipulation is yet to be shown for O. tsutsugamushi. Image from ref (189).  
1.6.2 Antisense technologies 
Synthetic nucleotides are an essential tool for molecular biology, oligonucleotide-based 
therapies, and clinical diagnostics. Oligonucleotides are widely used in primer-based techniques, 
such as PCR, library construction, nucleotide polymorphism, and many others. Aside from these 
methods, oligonucleotides have been extensively used in gene-silencing approaches.  
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In recent decades, several nucleic acid analogs have been developed that can target cellular 
DNA/RNA and these include locked nucleic acids (LNAs), peptide nucleic acids (PNAs), 2’-fluoro 
N3-P5-phosphoramidites, 1’, 5’-anhydrohexitol nucleic acids (HNAs), and the latest generation 
known as Bridged Nucleic Acids (BNA) (226, 227).  
LNAs or locked nucleic acids (Fig. 30) are bicyclic nucleotide analogues containing a furanose 
ring that is modified by adding a methyl group linking 2‘-oxygen and 4’-carbon (2’-O, 4’-
methylene-β-d-ribofuranosyl nucleotides). LNAs are designed to reduce the flexibility of the 
ribose residue and remain in a locked N-type conformation, which facilitates the stability of the 
LNA-DNA/RNA duplex. LNA-containing oligomers have been used in many applications including 
hybridization of probes/primers, mutagenesis, and SNP genotyping. However, non-specific off-
target binding of LNA-containing nucleotides can cause toxic effects, especially in human diseases 
(228).  
Antisense Peptide Nucleic Acids (PNAs) are DNA analogues that consists of a peptide 
backbone instead of sugar-phosphate and side chains of nucleic acid bases (Fig. 30). The 
properties of PNAs are high specificity, high sensitivity, chemical stability, thermal stability, and 
resistance to nucleases degradation when delivered inside cells (229). The use of PNAs is an 
effective method to inhibit gene expression involved with DNA replication, fatty acid synthesis, 
and RNA synthesis by binding at specific mRNA sequences in several free-living organisms i.e. 
Escherichia coli and Bacillus subtilis (230). The advantages of PNAs include no antibiotic selection 
is required, the delivery process can be done by electroporation, protein reduction can be seen 
within one day, and partial protein reduction could help the further study of essential genes. 
PNAs have been designed that are complementary to ribosomal binding sites of OmpB and rickA 
in R. typhi and R. montanensis, respectively, and they have successfully repressed OmpB and 
rickA expression as measured by Western blot (231). However, PNAs exhibit poor cellular uptake, 
low binding efficiency to targeted sequences, and poor solubility in the aqueous phase. 
Bridged nucleic acids (BNAs) are the latest modified oligomers which are more effective 
than earlier generations of synthetic oligomer (PNA and LNA). BNA has high-affinity to DNA and 




has been modified in many derivatives as BNANC with different substitutions at the N position 
(Fig. 6).  A six-member ring (2',4'-BNANC) is the most widely used to date and exhibits less toxicity 














Figure 6. The overall structure of protein, PNA, BNA and DNA. Top panel; A comparison of 
PNA, DNA and protein structure. PNA consists of an amine-terminus (N-terminus) and a carboxy 
terminus (C-terminus), corresponding with the 5'- and 3'-ends of the DNA oligonucleotide, 
respectively. Low panel; 2’,4’-BNANC (BNANC)  is a derivative of the LNA, 2’-O,4’-aminoethylene 




1.7 RNA-seq technology 
 Pathogens commonly subvert host cellular pathways for survival and growth, and host 
cells also respond to the invading pathogens through several cascading pathways. These result 
in changing the transcriptomic profiles and gene expression of two interacting organisms. 
Understanding the complexity and dynamics of host-pathogen interaction during the infection is 
very important for improving diagnostic, treatment, and vaccine development (232).  
Recently, microarrays have been extensively used for measuring gene expression profiles, 
studying the mechanism of bacterial infection, and host response to infection (233, 234). 
However, the profiling of both pathogen and host RNA measured by microarray are inadequate 
due to cross-hybridization, and high background signal. In addition, the analysis of both pathogen 
and host cannot be done at the same time (235) and it cannot detect noncoding RNA (ncRNA) 
classes (234). Tiling arrays are another subtype of microarrays but the probe can be used for 
interrogation of the genomic region for transcription (236), and alternative splicing (237). This 
method was developed to solve the detection of ncRNA transcripts, however, this assay is very 
expensive for studying a large size of the host genome (238). Tag-based sequencing was 
developed to allow individual transcripts to be digitally counted with a broad range of RNA, but 
this method cannot discriminate between mRNA isoforms, as well as the inability to annotate 
ncRNA (239).  
RNA-seq or deep sequencing is based on next-generation sequencing (NGS) platforms (240). 
In principle, total RNA in the sample is reverse transcribed into cDNA, and the cDNA may or may 
not be amplified before deep sequencing which depends on the platform. After sequencing, the 
sequencing reads are mapped onto a reference genome. Then, the data are normalized and 
quantified to obtain the expression of any given transcripts in the sample (240). RNA-seq 
overcomes many limitations of microarray-based and Tag-based sequencing assays. This 
approach provides high sensitivity and can define the transcriptome of the targeted organisms 
with less bias across various experimental conditions and cell types (241, 242). The annotation of 
RNA-seq is independent and this allows the identification of novel transcripts without relying on 
preexisting annotation (243). RNA-seq is commonly used to study either pathogen or host after 
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physical separation (240). In fact, RNA-seq should profile all RNA classes in both pathogen and 
host, but the approach commonly focuses on messenger RNA (mRNAs) for studying protein 
expression, resulting in a majority of RNA output from noncoding regions being neglected (244).  
 Dual RNA-seq is defined as a simultaneous RNA-seq analysis of both pathogen and host 
(240). This method has proven the ability to capture host and pathogen transcriptomes 
simultaneously (245).  The analysis of dual RNA-seq is a little different from conventional RNA-
seq, as follows; sequencing reads are cleaned, normalized, and mapped, differential expression 
of transcripts identified, and functional analysis performed to aid data interpretation (245, 246). 
Analysis of multiple genome sequences at the same time is a key challenge of dual RNA-seq 
design and must be done carefully. It is essential to determine the selectivity of read mapping of 
both host and bacterial genomes because cross-mapping reads potentially affect transcript 
quantification (245). After finishing mapping, the data must be normalized and quantified, for 
example, using a within-sample normalization approach to obtain an overview of the 
transcriptional dynamic (TPM-transcription per million) (247, 248), and using a scaling 
normalization method to solve “batch effects” between RNA-seq experiments (249).  
The differential expression analysis is the core of RNA-seq analysis and can be performed 
using packages from the Bioconductor framework for the R statistical programming language 
(250). The common analysis packages are edgeR (251), DESeq (252), and limma/voom (253). 
Differential expression analysis provides a long list of genes of both host and bacteria. These 
genes need to be interpreted for identifying gene function using the Gene Ontology (GO) (254) 
and the Kyoto Encyclopedia of Genes and Genomes (KEGG)(255). To determine which gene sets 
are differentially expressed during infection, the gene analysis must rely on a proper statistical 
analysis (245) and should follow the benchmark of gene set enrichment methods (256).  
Dual RNA-seq data can be used to link genes through a network interference (NI) assay which 
helps to create the global regulatory network from the expression data in several conditions 
(257). Dual-RNA-seq can be integrated with proteomics. Even though the pairwise integration of 
RNA-seq and proteomic is controversial, this integrative approach can be used to identify novel 
mRNA isoforms or detect unreported peptides (246). Moreover, data integration between 
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transcriptomics with metabolomics has been demonstrated to identify pathways that regulate 
both gene expression and metabolite level (258).  
Dual RNA-seq has been successfully performed on several intracellular pathogens such as a 
study of small noncoding regulatory RNA (sRNA) during Salmonella infection of host cells (244) 
and the investigation of transcriptional adaptation of Mycobacterium bovis in the THP1 human 
macrophage cell line (259). The use of Dual RNA-seq in obligate intracellular bacteria was first 
demonstrated in Chlamydia trachomatis to study the transcriptional dynamics of metabolic 
metabolism during early infection in (232). This opens an avenue for applying Dual RNA-seq in 
other obligate intracellular bacteria, including genetically intractable bacteria such as Orientia 
tsutsugamushi.  
1.8 Thesis outline and objectives  
Developmental differentiation of Orientia tsutsugamushi (chapter 3-5) 
O. tsutsugamushi has an obligate intracellular lifecycle that requires host cells for 
replication and growth. The model of the intracellular infection cycle of O. tsutsugamushi is 
described in the literature review and includes attachment and entry of bacteria into host cells, 
the downstream signaling upon entry, the mechanisms of escaping the host immune response, 
and the exit of infective bacteria from host cells. However, some mechanisms during the infection 
cycle are unknown, lack details, or are poorly characterized, including a precise understanding of 
the developmental differentiation of Orientia which has never been described in detail. Thus, this 
study will focus on how O. tsutsugamushi differentiates during the course of the intracellular 
infection cycle. 
To observe the developmental differentiation in O. tsutsugamushi over the course of its 
infection cycle (5-7 days), several techniques have been performed in this study including 
immunofluorescence labeling, confocal microscopy, SIM (Structured illumination microscopy), 
STORM (Stochastic optical reconstruction microscopy), TEM (Transmission electron microscopy) 
and mass spectrometry. 
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The key findings in this study correspond to the following four objectives:  
1. To characterize O. tsutsugamushi subpopulations of both intracellular and 
extracellular populations. 
2. To study how O. tsutsugamushi differentiates into a specific maturation stage 
(extracellular stage). 
3. To investigate how O. tsutsugamushi senses the entry into the host cytoplasm. 
4. To distinguish the stages of growth in intracellular bacteria. 
The outcomes of this study show that O. tsutsugamushi differentiates into five distinct 
subpopulations which have different degrees of metabolic activity, replication, and infectivity. 
The extracellular population is distinct from the intracellular population. Intracellular bacteria 
present a marker protein (ScaC) at the maturation stage prior to exiting to the extracellular stage. 
In addition, the intracellular bacteria senses the host reducing environment after entry into host 
cells.  
Developing genetic tools for O. tsutsugamushi (chapter 7) 
Until now, the molecular mechanisms of host-pathogen interaction in Orientia tsutsugamushi 
has been understudied due to the lack of genetic manipulation tools and its unique lifestyle, as 
bacteria normally grow in host cells only. In addition, the transformation efficiency of obligate 
intracellular bacteria is normally low compared with free-living bacteria and requires long term 
culture (72). Developing genetic tools for O. tsutsugamushi is an important research need which 
has now been successfully achieved in other intracellular bacteria. For instance Rickettsia spp. 
and Anaplasma spp. have been randomly mutated using a transposon system (Tn mutagenesis) 
carrying a fluorescent gene. This has been used to provide novel information on virulence 
mechanisms and host-rickettsia interactions (260, 261).  
This study aims to develop genetic tools for O. tsutsugamushi using Transposon base system 
and an alternative new tool, Bridged Nucleic Acid (BNA) technology, and these two methods rely 
on genetic transformation systems to introduce the foreign DNA into bacteria. This step is not 
easy to conduct in obligate intracellular bacteria compared with free-living bacteria, and needs 
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to be carefully optimized including electroporation conditions, voltages, antibiotic selection 
markers, and confirmed PCR of fluorescent protein being expressed in bacteria. The development 
of a novel genetic tool of Orientia will be crucial for research into the intracellular cycle and 
disease pathogenesis, and this could benefit the development of future treatment options and 
vaccines. 
The findings in this study correspond to the following two objectives: 
1. To manipulate O. tsutsugamushi genome using transposon-based vector (pCis-mRuby2-
MurA-HimarI) via electrotransformation. 
2. To down regulate specific genes in O. tsutsugamushi using BNA technology. 
The outcomes of this study illustrate that the transposon-based vector is unable to 
manipulate the Orientia genome successfully. BNA is able to reduce the expression of the 
targeted protein (TSA56).  
 
Dual RNA-seq provides insight into the biology of the neglected intracellular human pathogen 
Orientia tsutsugamushi (chapter 8) 
Given the lack of genetic tools to manipulate the Orientia genome, RNA sequencing is a 
potential approach to study the transcriptome of an organism, which helps to understand the 
bacterial infection cycle and pathogenicity. Dual RNAseq is a novel approach to study host and 
pathogen transcriptomes which are both analyzed in parallel. The advantages of this approach 
include detection of transcripts with low abundances, higher sensitivity than microarray and 
Northern blot assays, and no requirement for predesigned species-specific probes (240, 245). 
Dual RNAseq allows monitoring of specific transcripts and gene expression of both host and 
pathogen in mixed samples at different time points throughout the infection processes.   
 In this study, the differences in clinical isolate strains (Karp and UT-176), were used to 
compare the transcriptome structure and gene expression profiles between infected cells and 
uninfected cells using dual RNAseq combined with proteomics and bioinformatics. Both strains 
were propagated in a human endothelial cell line (HUVEC) which is the most closely related to 
the pathology of Orientia infection in humans. 
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The findings in this study correspond to the three objectives: 
1. To measure the growth and observe the infection in vitro of two clinical isolates of O. 
tsutsugamushi strain Karp and UT176.  
2. To investigate the transcriptional profile of O. tsutsugamushi grown in cultured cells. 
3. To compare the host cell response to infection two clinical isolates (Karp and UT176) in 
cultured cells.  
The outcomes of this study demonstrate that dual RNA-seq can provide the transcriptomic 
profile of Orientia during the infection cycle, identifying bacterial non-coding RNAs, and 
discovering distinct host immune responses to each bacterial strain. This was related to 













Chapter 2: Materials and methods 
2.1 Cell culture 
 Mouse fibroblast L929 cells (ATCC CCL-1), a gift from Prof. Stuart Blacksell at the Mahidol 
Oxford Tropical Medicine Research Unit, Bangkok, Thailand and HeLa cells, which were provided 
by Mitchison Laboratory Harvard were maintained in Dulbecco’s modified Eagle medium (DMEM; 
Thermo Fisher Scientific, 21013024, USA) supplemented with 10% heat-inactivated bovine serum 
(FBS; Thermo Fisher Scientific, 16140071, USA) in 25 or 75 cm2 flasks at 37 °C and 5% CO2. Potoroo 
kidney Ptk2 cells (Sigma Aldridge, 88031601) were cultured in Minimum Essential Medium 
(EMEM; Sigma M0325, USA) with 10% heat-inactivated FBS in 25 cm2 flasks at 37 °C and 5% CO2. 
2.2 Bacterial propagation  
 The Karp-like clinical isolate Orientia tsutsugamushi strain UT76 was routinely propagated 
in L929 cells in 25 or 75 cm2  culture flasks at 37°C and 5% CO2 using DMEM medium 
supplemented with 10% FBS. The intracellular fraction of infected cells were taken 5-6 days post 
infection. Bacteria purification was performed as follows; scraping infected host cells from the 
flask, lysing them by bullet blender tissue homogenizer (NextAdvance, USA) at power 8 for one 
minute or lysing with 0.1 mm glass bead with vortex for one minute, removing host debris by low 
speed spin at 300 rcf for five minutes, and collecting bacteria in the supernatant fraction. Bacteria 
were resuspended into fresh media or buffers. The resuspension volume depends on the bacteria 
concentrations which are measured by qPCR of the 47 kDa gene (Table 2). The details of the 
protocol are described here (262).  Propagation of bacteria from the extracellular fraction 
(supernatant) proceeded the same as the intracellular fraction.  
2.3 Microscopy  
2.3.1 Immunofluorescence labelling 
 Bacteria were grown on 4-well or 8-well chambered coverslip/µ-Slides (ibidi, 80426:4-
well, 80826: 8-well, USA) containing L929 cells or Ptk2 cells. Cells were fixed with 4% 
formaldehyde (Thermo Fisher Scientific, 28906, USA) for 10 minutes at room temperature. After 
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fixation, cells were washed with 1X PBS (pH 7.4) three times and permeabilized in 0.5% Triton-X 
for 15-20 min on ice. Then samples were incubated in blocking buffer (1X PBS + 1 mg/ml BSA or 
1XPBS with serum from host species of the labeled antibody diluted to 1:20) for 15-20 mins at 
room temperature. Primary antibodies were added and incubated at 37°C for one hour. The in-
house antibodies, rat monoclonal antibody against TSA56, and rabbit polyclonal antibody against 
Orientia ScaC were diluted 1:200. The commercial antibodies, LAMP1 (Thermo Scientific 
monoclonal mouse MA1-164) were diluted 1:200. After washing excess primary antibody with 
1XPBS twice, appropriated fluorescent secondary antibodies (goat anti-mouse IgG superclonal 
Alexa Fluor 647 conjugate, Thermo Fisher A28180; goat anti-rat Alexa Fluor 488, Thermo Fisher, 
A11006; goat anti-rabbit, Alexa Fluor 594, Thermo Fisher A11012) were diluted 1:1000 and 
incubated with samples at 37°C in the dark for 30 mins. The nuclear stained Hoechst (Thermo 
Fisher Scientific, H1399) was diluted to 1:1000 and added with secondary antibody incubation. 
Then, samples were washed with 1X PBS twice to remove the excess secondary antibody. Before 
adding mounting media (20mM Tris, pH 8.0, 0.5% N-propyl-gallate, 90% glycerol), samples were 
washed twice with 1XPBS. Labeling samples were imaged using Zeiss Observer Z1 LSM700 
confocal microscope with HBO 100 illuminating system, equipped with a 63x/1.4 Plan-
APOCHROMAT objective lens (Carl Zeiss, Germany) and 405 nm, 488 nm and 555 nm laser lines, 
and a Leica TCS SP8 confocal microscope (Leica Microsystems, Germany) equipped with a 63x/1.4 
Plan-APOCHROMAT oil objective lens with 1.4 mm working distance, and 405 nm, 488 nm, 552 
nm, and 638 nm laser lines.  
The measurements of fluorescence intensity were performed manually using Fiji Image-J 
software. Each single bacterium was quantified by determining the brightest pixel intensity 
within the area of bacteria. All images within each experiment were obtained under the same 
laser intensity and image acquisition conditions. Bacterial length was measured manually using 
Fiji Image J software (263).  
2.3.2 STORM imaging and analysis 
 The 3D-STORM data was obtained using a homebuilt multi-color T that is based on an 
inverted microscope (Nikon, Ti-E), a high NA objective (Nikon, CFI-Apo 100X, NA 1.49), a 405 nm 
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photoactivation laser (Coherent, OBIS 405 LX 100mW), a 488 nm excitation laser (MPB, 2RU-VFL-
P-20000642-B1R), and an EMCCD camera (Andor, iXon Ultra-888). The immunolabelled samples 
with Alexa 488 were mounted on the microscope, transferred to STORM buffer 
(OxyFluor/Oxyrase, 50mM BME (Sigma), 2.5mM COT (Sigma)), and illuminated with a strong 488 
nm laser to record single-molecule fluorescence blinking events at 25Hz frame rate. The 
illumination at 405nm was intercalated with pulsed 488nm excitation to enhance 
photoactivation of Alexa 488 without exacerbating background signal. A cylindrical lens 
(Thorlabs, LJ1516RM-A) was placed in front of the camera in order to determine the z-
coordinates of fluorescent molecules through the elongated point spread function (PSF) method. 
Each STORM image was reconstructed from single-molecule localization data obtained by the 
analysis of 30,000 frames with custom Matlab code. Briefly, bright single fluorescence spots were 
identified by thresholding methods, and their 3-D coordinates were determined by 2-D elliptical 
Gaussian fitting along with a pre-calibrated conversion table between eccentricity and z-
coordinate. Focus drift was actively stabilized with Perfect Focus System (Nikon) while acquiring 
the data, whereas xy-drift was post-corrected using redundant cross-correlation algorithm. Each 
localization event was represented as a 2-D Gaussian of 20 nm standard deviation in STORM 
images. For the analysis of bacteria morphology, we picked cells that showed clear cell boundary, 
manually adjusted the z-coordinate to find the cell midplane, and measured the length of long 
and short axes. 
2.3.3 SIM imaging and analysis 
L929 cells were grown on coverslips (High precision Deckglaser No. 1.5H, 18x18 mm) 
coated with fibronectin 50 µg/ml in 6-well plate for one day before infection with O. 
tsutsugamushi at MOI 10:1 and 100:1. Infected cells were fixed with 4% formaldehyde and 
permeabilized in 0.5% triton on ice for 15-20 min and washed twice with 1XPBS + 1mg/ml BSA 
prior to immunofluorescence labeling. After labeling, coverslips were transferred from each well 
and placed on cleaned standard microscope slides (75mm x 25mm). Residual PBS on coverslips 
was removed before mounting using pipette tips and slides were sealed with nail polish. Imaging 
was performed using SIM microscope (DeltaVision OMX™). ImageJ software was used to analyze 
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the lengths and widths of bacterial cells. Due to poor resolution in the z axis using these 
approaches we only measured the dimensions in the x-y plane. This results in an underestimation 
of cell length because the dimensions of any cells that are not positioned exactly in the horizontal 
plane will appear reduced in length. Therefore, these numbers do not represent the exact 
dimensions of O. tsutsugamushi but indicate relative changes in dimensions over time. 
2.3.4 iclick labeling  
 The methionine click-labeling assay is based on the Click-iT HPG Alexa Fluor Protein 
Synthesis Assay Kits (Molecular Probe by Life technologies). The alkyne-containing amino acid, L-
homopropargylglycine HPG was added to infected cells at a specific time point.  Infected cells 
were grown in a specific medium without L-methionine (Dulbecco’s Modified Eagle Medium, 
DMEM, Cat. no. 21013) containing 25µM HPG for 30 min at 37°C. After incubation, labeled 
bacteria were washed twice with PBS+ 1mg/ml BSA to remove excess HPG probe. Cells were fixed 
with 4% formaldehyde and permeabilized with 0.5% Triton-X for 20 min on ice. Cells were washed 
again with PBS+1 mg/ml BSA and Click-iT reaction cocktail added for 30 min at room temperature 
protected from light. The details of Click-iT reaction cocktail is based on Click-iT HPG Alexa Fluor 
Protein Synthesis Assay Kits cat. C10428. The conjugated-Azide dye (Alexa Fluor 488) was used 
at the final concentration of 5µM. After washing twice with PBS + 1mg/ml BSA, cells were ready 
for immunofluorescent labeling and imaging.  
2.3.5 Electron microscopy  
 Cell culture medium was aspirated from infected cells grown in T75 cm2 flask. The cells 
were directly incubated with pre-warmed (37°C) fixative buffer (2% Glutaraldehyde, 4% 
formaldehyde in 0.1M Sorensen’s Phosphate Buffer; pH 7.4) for one hour on ice. The fixed cells 
were gently scraped in long continual stripes using the scraper to get sheaths or rolls of cell 
monolayer as compact as possible. Cell sheaths were transferred into a 15ml tube using plastic 
Pasteur pipette or cut P1000 tips to avoid sheer forces, and briefly spun cells down at 100g. Cells 
were kept in fixative buffer at 4°C overnight. The cells were then washed three times in 0.1M 
Sodium Cacodylate buffer (pH 7.4) at room temperature to remove phosphate and further 
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incubated with post-fixative buffer (1% OsO4 + 0.1% Ruthenium red) for one hour at room 
temperature. After post-fixation, cells were dehydrated with cold graded series of ethanol 
solutions (30%, 50% and 70%) each for 15 min, and incubated with 4% Uranyl Acetate in 75% 
EtOH overnight in the dark at 4°C. Cells were dehydrated with 80, 90, 95, 98% ETOH, each for 
15min and 100% EtOH 3 X 20mins. Samples were embedded in a low-viscosity Epon mixture and 
polymerized at 60°C for 48 hrs. Ultrathin sections (60 to 90 nm thick) were cut on ultramicrotome 
(UC7 Leica) and imaged in FEI TECnai 20 electron microscope operated at 100kV. 
2.3.6 RNA FISH  
 The RNA FISH protocol was modified from the protocol described in ref (264). Cells were 
grown in chamber coverslips for two days before infection with bacteria at MOI 100:1. These 
infected cells were washed twice with 1X PBS before fixing with 4% formaldehyde for 10 mins at 
room temperature and subsequently incubated with 70% ethanol for one hour on ice. Cells were 
further permeabilized with 0.5% triton for 15-20 mins, incubated with 1 mg/ml lysozyme for one 
hour at room temperature, and washed with 1X PBS in between. These samples were labeled 
using immunofluorescence and further performed RNA FISH labeling. After complete 
immunofluorescence, cells were fixed with 4% formaldehyde again to stabilize the 
immunofluorescence signal. Then samples were equilibrated in washing buffer containing 2X SSC 
and 10% formamide at room temperature for 5-10 min before hybridization. An in-house RNA-
FISH probe containing 33 oligos was designed to target O. tsutsugamushi 16s gene strain UT76 
and labeled with TexaRed (Table 1). The probe was resuspended in hybridization buffer 
containing 10% Dextran sulfate (w/v) (Sigma, D8906), 1mg/ml Escherichia coli tRNA (Sigma, 
R8759), 2mM Vanadyl ribonucleoside complex (New England Biolab, Ipswich, MA, Catalogue 
Number, S142, 0.02% RNase free BSA (Ambion, AM2618), 10% formamide and used at a final 
concentration of 2ng/µl. Samples were pre-incubated with the probe at 50°C for 3-4 hours and 
further incubated at 37°C for 18-24 hours in the dark. Cells were then washed with washing buffer 
twice for 10 min at room temperature in the dark prior to adding mounting media. The labeled 




Table 1: Details 16s RNA FISH probe containing 33 oligos. 








































2.4 Gene expression analysis by RT-qPCR 
 Infected cells were collected at each time point and were stored in RNAProtect Bacteria 
Reagent (Qiagen, catalog number 76506) at -80°C before extraction. Total RNA was extracted 
using the Qiagen RNeasy Plus kit (Qiagen, catalog number 74136) following the manufacturer’s 
instruction. To remove the DNA contamination, total RNA sample (10 µg) was treated with 
DNaseI (Thermo Fisher Scientific, catalog number AM2238) at 37°C for 30–60 min. The purified 
RNA was then taken for cDNA synthesis using the iScript reverse transcription supermix (Biorad, 
catalog number 170-8841) with random primers. cDNA was verified to confirm no DNA 
contamination by using a reverse transcriptase-free control reaction. No amplification of PCR 
products was an indication of an absence of DNA contamination in RNA samples. cDNA was kept 
at -20°C until used. A certain cDNA amount of each sample was taken to amplify targeted genes 
using gene-specific primers for TSA22, TSA47, tsa56, ScaA, ScaE, ScaD, murA, murD, murF, ddl, 
and pbp2. qPCR was performed using SYBR green qPCR mix (Biotools, Houston, USA, catalog 





Table 2: A summary of primers that used for RT-qPCR analysis. 
Primer name Primer sequences (5’ to 3’) 
TSA22_FW TGGGTGTAGCTGCAGGCATAC 
TSA22_RV GTTGATACACTAGCTGAAGATGATG 
TSA47 forward TCCAGAATTAAATGAGAATTTAGGAC 
TSA47 reverse TTAGTAATTACATCTCCAGGAGCAA 
TSA56 forward TGCCCAACAAGAAGAAGATG 
TSA56 reverse TTTAACTTGGCCGACAATCA 
ScaA forward ACCGCATTCAAACAGTGATCT 
ScaA reverse CAGTTTTTCCGCCATGAGTTG 
ScaC forward AAGTGTAAATATCCTCAGGCAGAGG 
ScaC reverse CAGTATTTCTTGCTAGTGCTTGCTC 
ScaD forward GAGCGACTACGAATGCATCA 
ScaD reverse CAGTTGCATCGTTGTTTTGG 
ScaE forward AGACCACGCAGTAACATGCTT 
ScaE reverse ACTGCGCGCCATTGTTGATT 
50S_Ribosome/L25 FW CCAAGGTAAGGTTCCAGGAG 
50S_Ribosome/L25 RV CACGCTTAATTCCCAACGAC 
murA forward AACGCATGCATCACTTAGACC 
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murA reverse CAGGAATTCTTTGGACTCTTGC 
murD forward GCTGGAGGAGTTGCTAAAGAAG 
murD reverse CCCACTTTGATCAGATTCAGC 
murF forward GCCGGTTGATCAGTTGTTG 
murF reverse TTCGATGACTTGCCAAAGC 
ddl forward GGAGAGGATGGATGTATTCCTG 
ddl reverse TATCAAATGCAGCAGCAGAAGT 
pbpA2 forward CGCCTACCCAACATAAACAAG 
pbpA2 reverse TCCTGCTAAACCACGCATATC 
mipZ forward GTGGTGCAGGTAAGACTACTGTTG 
mipZ reverse GTGAATGCTGACGTGAATCAG 
 
2.5 Western blot analysis 
Both infected and uninfected cells were mechanically lysed in a Bullet Blender at power 
8 for one min and pelleted, washed with PBS 1–2 times, and resuspended in 1X PBS. The protein 
concentration was measured by nanodrop analysis and the sample volume was adjusted to 
ensure equivalent loading. Samples were resuspended with SDS-PAGE buffer with or without 
20% ß-mercaptoethanol and samples were then loaded on 12% Mini-PROTEANVR TGXTM Precast 
Protein Gels (Bio-Rad, USA, 4561043). Western blots were probed using a rat monoclonal 
antibody against the major surface protein TSA56 and then probed with a secondary antibody 
conjugated with alkaline phosphatase (Promega, USA, catalog number S3831) and developed 
using an alkaline phosphatase detection kit (Promega, USA, catalog number S3841). 
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2.6 Proteomics sample preparation and analysis 
2.6.1 Sample preparation 
 O. tsutsugamushi strain UT76 was propagated in L929 cells at MOI 10:1 and 50:1. Infected 
cells were maintained in 75 cm2 flasks at 37°C and 5% CO2, using DMEM media supplemented 
with 10% FBS. Isolation of intracellular bacteria (Int) was taken at 3, 5 and 7 days post infection 
and purified as described previously. Extracellular bacteria (Ext) were harvested from the 
supernatant by centrifugation at the same time points. Purified bacteria were then washed with 
0.3 M sucrose three times, resuspended in PBS, and subsequently lysed with 1% Triton X-100 at 
4°C for 30 mins. Precipitation of bacterial proteins was performed by resuspending in 80% ice-
cold acetone at 4°C for 30 mins and followed by centrifugation at 13,000g for 10 min. Protein 
pellets were collected and dissolved in 50% trifluoroethanol in 100 mM TEAB buffer. Proteins 
were dissolved in reducing agent, 20mM TCEP, and alkylating agent, 55 mM CAA. Then, proteins 
were digested with LysC (1:50 of LysC:protein) at 37°C for four hours and further digested with 
trypsin (1:100 of trypsin:protein) at 37°C overnight. Samples were acidified in 1% TFA. After 
centrifugation to get rid of any precipitant, samples were desalted using Water HLB in 96 well 
plate format as follows; activation with 500 µl of 100% acetonitrile and equilibration with 500 µl 
of 0.5% acetic acid, loading samples on the plate, washing sample on selected well with 500 µl of 
MS grade water, and elution of peptide mixtures using 800 µl of 80% acetonitrile in 100 mM TEAB 
buffer.  
In preliminary runs, 2.5% total volume (20 µl) of each peptide mixture was dried in a 
speedvac and pellets dissolved in 15 µl of 100 mM TEAB. Two sets of samples were from bacterial 
culture at MOI 10:1 and MOI 50:1. Each set consists of six samples including ExtD3, IntD3, ExtD5, 
IntD5, ExtD7, and IntD7, and each sample was labeled with 10 µl selected isobaric TMT tags 
(Thermo Fisher Scientific, USA) of TMT10-126, TMT10-127N, TMT10-128C, TMT10-129N, TMT10-
130C, and TMT10-131, respectively. All reactions were incubated at room temperature for one 
hr. For each MOI set, 2µl of each labeled sample was taken and added into 50µl of 10mM 
ammonium formate (pH 10) to a total volume of 62µl per set. Each pooled sample set was 
desalted through high pH C18 reverse-phase material stage tips (C-18 ReproSil-Pur Basic, Dr. 
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Maisch, 10µm). In brief, C18 desalting tips were equilibrated with 50 µl of 100% acetonitrile and 
subsequently dissolved in 50µl of 10mM ammonium formate pH 10 (Solution A). The pooled 
samples in solution A were loaded onto equilibrated C18 tips, the tips were then washed with 
80µl of solution A, and eluted with 50µl of 10mM ammonium formate in 50% acetonitrile 
(Solution B.) Lastly, both sample elutions were completely vacuum dried and pellets were 
resuspended with 5µl of [0.5% acetic acid, 0.06% trifluoroacetic acid, 1% acetonitrile] for LC-
MS/MS. Protein frequency distributions from preliminary runs were used to normalize sample 
loadings in actual experiments thereafter.  
Intracellular and extracellular bacterial samples harvested at 4 d.p.i were harvested from 
three independent replicates of UT76 infecting L929 cells at MOI 50:1 with the same growth 
conditions as those previously described for samples of 3, 5, and 7 d.p.i.. Lysis condition and 
sample preparation were also performed in the same way but with label-free quantitative mass 
spectrometry.  
2.6.2 LC-MS/MS and data analysis 
Protein samples were separated in 120 min gradient (0.1% formic acid in water and 99.9% 
acetonitrile with 0.1% Formic Acid) on 50 cm x 75 um id Easy-Spray RP column (C-18, 2 µm 
particles, Thermo) using Easy nLC1000 (Thermo) chromatography system coupled online with 
Orbitrap Fusion mass spectrometer (Thermo). Data dependent mode was used in a time loop 
mode -3 s cycle using the Orbitrap analyzer for both scans with the following ion targets and 
resolutions (OT-MS 4xE5 ions, resolution 60K, OT-MS/MS 8E4 ions, resolution 15k). Peak lists 
were generated using Proteome Discoverer 2.2 software (Thermo). Searches were done with 
Mascot 2.6.1 (Matrix Science) against forward/decoy Mouse Uniprot and Orientia UT76 database 
with the following parameters: precursor mass tolerance (MS) 20ppm, OT-MS/MS 0.06 Da, 3 
miscleavages; Static modifications: carboamidomethyl (C), TMT6plex. Variable modifications: 
Acetyl N-terminal, oxidation (M), deamidation (NQ). Forward/decoy searches were used for false 




2.7 Transposon mutagenesis.  
 To make competent cells, purified O. tsutsugamushi was resuspended in sterile sucrose 
(200 – 500mM) and kept on ice. Orientia cells were transformed using a mariner-based Himar1 
transposon system (Fig. 7) via electroporation. The plasmid was modified from the original 
plasmid (pCis-Cherry SS-himar), a gift from Ulrike G. Munderloh at the department of 
entomology, University of Minnesota, USA. Competent cells were pre-incubated with 0.1µg of 
transposon plasmid in electroporation 0.2cm gap sterile cuvette for 15 min on ice, and cells were 
electroporated with 1.2-2kV using the BioRad Gene Pulser II. After electroporation, bacterial cells 
were recovered with 100µl of culture medium and centrifuged at 500g for five mins. Cells were 
then left at room temperature for 15 mins and directly incubated onto L929 cells in a 6-well plate 
containing DMEM + 10%FBS. After 24 hrs of incubation at 35°C, fresh media containing 
fosfomycin 250 – 500µg/ml was added, and the infection was further incubated for seven days 
at 35°C. Each week cells were collected to check the bacterial level and the presence of a 
fluorescent gene (mRuby) by qPCR, and cells in each well were continued passaging and 
expanded by inoculation on fresh L929 cells in the presence of fosfomycin. The culture was 
examined microscopically to see the fluorescent signal of mRuby gene in the transformants. 
Images were acquired with Zeiss Observer Z1 LSM700 confocal microscope with HBO 100 
illuminating system.  
2.8 BNA synthesis and electroporation 
 BNA synthesis was carried out by Bio Synthesis (Lewisville, TX). The BNA oligomers were 
designed to be complementary to the tsa56 gene (Fig. 8).  Purified Orientia (1x 107 copies) was 
mixed with 2-8µM BNA in total volume 100µl of 250mM sucrose in pre-chilled 0.2cm gap sterile 
cuvette. Cells were incubated for 15 min on ice before electroporation with 4-5ms pulse.  The 
BNA-Orientia suspension was transferred to a microcentrifuge tube and resuspended in 400µl of 
culture media (DMEM + 10% FBS) for recovery at room temperature for one hour.  After 
incubation, BNA-Orientia was transferred to a 12-well plate containing L929 cells and incubated 
at 35°C for four days. Bacterial cells were then harvested to measure gene expression level and 









Figure 7. Plasmid pCis mRuby-murA-A7-himar used for transformation of O. tsutsugamushi. The 
transposon consists of mRuby2 gene and fosfomycin resistance gene, both driven by Orientia-
Eftu promoter. The transposon is flanked by the left and right Himar repeats which are recognized 








Figure 8. (A) The design scheme of nucleotide 2’4’-BNA that contains a six member bridged 
structure with a unique N-O bond in the ribose sugar moiety at C3, which is important in DNA 
binding as a conjugation site (B)  BNA/DNA structure in this study which contains peptide 
conjugate (H-(KFF)3, linker, targeted DNA region and BNA.  
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2.9 RNA-seq sample preparation and RNA isolation 
 The clinical isolate strains (Karp and UT176) of Orientia tsutsugamushi were cultured in a 
confluent monolayer of host cells (HUVEC, Human Umbilical Vein Endothelial Cells; ATCC PCS-
100-010) for five days at MOI 100:1. Cells were cultured in Media200 (Thermo Fisher, Catalog no. 
M200-500) supplemented with LVES media (Thermo Fisher, Catalog no. A14608-01) at 35°C                   
and 5% CO2. The infectivity was determined by qPCR of the single-copy Orientia gene 47kDa at 
day 5-7. 
Bacterial propagation for RNA isolation was prepared using bacteria from frozen stocks 
and were pregrown in HUVEC cells in a T25 cm2 culture flask. At five days post infection, bacteria 
were harvested and immediately propagated onto HUVEC cells for a second round of growth. 
Each condition in this experiment was done in 2 x 6-well plates (12 wells). The MOI of infections 
was estimated by measuring the number of bacteria in the pre-growth supernatant one day 
before bacteria were harvested. The exact inoculum was subsequently confirmed by using qPCR, 
and it was determined that the MOI for infection was 35:1 bacteria: host (Karp) and 32:1 bacteria: 
host (UT176). Note that the actual number of bacteria that entered into host cells is likely to be 
less than this because not all bacteria are viable for infection. At three hours post infection, 
bacteria that did not enter host cells were washed away with fresh media. Both uninfected cells 
and infected cells were harvested and quickly resuspended in RNAprotect Bacteria Reagent 
(Qiagen, catalog no. 76506). Samples were stored at -80°C until use. RNA extraction was 
performed using the Qiagen RNeasy Plus kit (Qiagen, catalog number 74136) according to the 
manufacturer’s instructions and as described previously (44). 
The procedure of bacterial propagation for growth curve measurements was carried out 
in the same way by using bacteria five days pregrowth in HUVEC cells, but bacteria in the second 
round of growth were propagated in 24-well plates. The MOI was subsequently measured to be 
8:1 (UT176) and 25:1 (Karp). At each time point bacteria were isolated and the bacterial genome 




2.10 RNA processing and sequencing  
The DNase-treated RNA samples were measured for the integrity using Bioanalyzer 
(Agilent). All RNA samples had RIN (RNA integrity number) values ≥8.0. Ribosomal RNA was 
removed using the Ribo-Zero Gold (epidemiology) kit (Illumina). 500ng of total DNase-treated 
RNA was used as an input to the ribo-depletion procedure. rRNA-depleted RNA was subsequently 
precipitated in ethanol for 3 h at -20°C. 
cDNA libraries for Illumina sequencing were produced by Vertis Biotechnologie AG, 
Freising-Weihenstephan, Germany. To generate a range of 200- to 400 nucleotide (nt) RNA 
fragments, rRNA-free RNA samples were first sheared via ultrasound sonication (four 30s pulses 
at 4°C). The short fragments of 20 nt were eliminated using the Agencourt RNAClean XP kit 
(Beckman Coulter Genomics), followed by ligation of the Illumina TruSeq adapter at the 3’ ends 
of the remaining fragments. First-strand cDNA was synthesized using M-MLV reverse 
transcriptase (NEB) wherein the 3’ adapter served as a primer. The first-strand cDNA was purified, 
and the 5’ Illumina TruSeq sequencing adapter was ligated to the 3’ end of the antisense cDNA. 
The resulting cDNA was PCR-amplified to about 10 to 20ng/µl using a high fidelity DNA 
polymerase. The TruSeq barcode sequences were part of the 5’ and 3’ TruSeq sequencing 
adapters. The cDNA library was purified using the Agencourt AMPure XP kit (Beckman Coulter 
Genomics) and analyzed by capillary electrophoresis (Shimadzu MultiNA microchip). 
For sequencing, cDNA libraries were pooled in approximately equimolar amounts. The 
cDNA pool was size fractionated in the size range of 200 to 600 bp using a differential cleanup 
with the Agencourt AMPure kit (Beckman Coulter Genomics). Aliquots of the cDNA pools were 
analyzed by capillary electrophoresis (Shimadzu MultiNA microchip). Sequencing was performed 
on a NextSeq 500 platform (Illumina) at Vertis Biotechnologie AG, Freising-Weihenstephan, 





2.11 Non-coding RNA prediction 
Noncoding RNAs were annotated using Rockhopper, ANNOgesic (v0.7.17), and Infernal 
(v1.1.2) searching sequences against the Rfam database. These provided inconsistent predictions 
of intergenic sRNAs. Intergenic sRNAs were manually curated by visual comparison of the 
predicted sRNA coordinates with the read coverage in the Integrative Genomics Viewer (v2.5.2). 
Infernal predicted the core housekeeping ncRNAs tmRNA, RNaseP, SRP, and 5S rRNA. The 
quantification of the bacterial transcriptomes complemented with predicted ncRNAs was 
performed using Salmon. 
2.12 Differential gene expression 
For the bacteria, differential gene expression analysis was performed between 
orthologous genes identified by Poff. Genes that were predicted as an orthologous group (more 
than two genes) were removed from the analysis. Additionally, duplicates (transcripts with 
perfectly identical sequence), that were identified by Salmon in either strain, were removed. For 
both human and bacterial RNA-seq data, differential gene expression analysis was performed 
with the edgeR package (v3.20.9) using robust quasi-likelihood estimation, including genes with 
CPM (Counts Per Million) > 10 (for Ot) or CPM > 1 (for HUVEC) in at least three libraries. To 
identify biological processes that differ between two Orientia strains, gene set analysis was 
determined using KEGG and GO terms that contain at least four expressed genes using the fry 
test in the edgeR package.  
2.13 Host Network/Pathway analysis 
To identify pathways that are affected in Karp and/or UT176 infected host cells, genes 
differentially expressed with an adjusted p-value of < 0.05 were analyzed using Ingenuity 
Pathway Analysis (IPA) software (Ingenuity® Systems, Inc. Redwood City, CA) as described 




2.14 Mice and ethics statement.  
All animal research was performed strictly under protocol approved by the Armed Forces 
Research Institute of Medical Sciences (AFRIMS) Animal Care and Use Committee and carried out 
in accordance with the Thai laws, the Animal Welfare Act, and all applicable U.S. Department of 
Agriculture, Office of Laboratory Animal Welfare and U.S. Department of Defense guidelines. The 
protocol number was PN16-05. The animal research was conducted in compliance with All animal 
research adhered to the Guide for the Care and Use of Laboratory Animals, NRC Publication (8th 
Edition). AFRIMS is an AAALAC International-accredited facility located in Bangkok, Thailand. 
Mice were cohoused (4 mice/case, 2 cases/group) in standard polycarbonate microisolator cages 
with filter tops and natural ventilation and stainless steel metal feeding hoppers and water bottle 
holders at 21 °C, and relative humidity was maintained within the range of 30–70%. The 
acceptable range is 21 °C ± 1 °C or 20–22 °C.  
Female C57BL/6NJcl mice (Inbred) at age of 6–8 weeks (lot numbers 2-37, 2-41,and 2-45) 
were purchased from Nomura Siam International, Bangkok, Thailand. Mice were housed under 
specific pathogen-free (SPF) in an animal biosafety level 2 facility, AFRIMS and moved to an 
animal biosafety level 3 containment, AFRIMS 2 days before the inoculation. Female mice at 6–8 
weeks of age were used in these experiments. Two group offemale mice (n=8 per group) were 
intravenously injected in the tail vein with 1.25 × 106 genome copies of O. tsutsugamushi of 
either Karp strain or UT176 strain. The O. tsutsugamushi inoculum was derived from                                     
O. tsutsugamushi-infected L929 cells (kind gift from Stuart Blacksell, Mahidol Oxford Tropical 
Medicine Research Unit, Bangkok, Thailand). Clinical signs and body weight were evaluated daily. 
After 12 days post inoculation, all mice were killed. Blood and tissue samples including lungs, 
liver, spleen, and kidneys were collected for bacteria quantification and histopathology. Adult 
mice were humanely euthanized with CO2 inhalation. Gas flow at 2 l/min (at 15 psi CO2) were 
maintained in the euthanasia chamber at least 5 min after the animals stop breathing. Death 
were confirmed by physical examination (the absence of a heartbeat) and ensured by an 




Chapter 3: Characterization of O. tsutsugamushi subpopulations (extracellular 
and intracellular populations) 
This research has been preprinted on bioRxiv under the title of Developmental 
differentiation in a cytoplasm-dwelling obligate intracellular bacterium: Giengkam S, 
Wongsantichon J, Atwal S, Jaiyen Y, Goh WI, Wright G, Chung T, Huh H, Lee S, Sobota R, Salje J. 
Developmental differentiation in a cytoplasm-dwelling obligate intracellular bacterium. bioRxiv. 
2020 Jan 1. 
 
Orientia can be classified into two subpopulations (extracellular and intracellular bacteria) 
based on their location. Extracellular populations are the bacteria that exit from infected cells by 
a budding mechanism and become metabolically inactive. Intracellular populations are the 
bacteria that enter into host cells, live in intracellular compartments of the host, and become 
metabolically active. These can be observed by transmission electron microscopy (TEM) (Fig. 9). 
The definition of metabolically inactive/active bacteria in this work is based on the detection of 
nascent protein synthesis by a clickable methionine-alkyne (HPG) probe. The extracellular 
populations that exhibit a low metabolic activity may not be detected by this method. The goal 











Figure 9.  Transmission microscopy images (A, B,C) of O. tsutsugamushi after 5 days post infection 
in Hela cells. Black arrowhead and red arrowhead point to the extracellular bacteria (EC) and 




3.1 Extracellular bacteria and intracellular bacteria have a different shape. 
In the current model of the intracellular infection cycle, the morphology of Orientia does 
not change throughout the course of infection but this may be because the shape and size of 
Orientia among subpopulations have never been measured and analyzed in detail. 
Characterization of the shape and size of Orientia will help to understand a cellular infection 
pattern that might correspond to different subpopulations and will help to distinguish bacterial 
stages in the life cycle.  
Due to the small size of Orientia (1-2 µm), structured illumination microscopy (SIM) was 
used to observe the morphology of Orientia together with confocal microscopy because SIM 
provides a high-resolution image and gives greater image contrast of small structures than 
confocal microscopy. SIM does not need a special fluorescence probe to improve the resolution, 
it only requires an optical approach to reconstruct fluorescence images (266).  
In this study, O. tsutsugamushi strain UT76 in L929 cells was labeled with the surface 
protein TSA56 or a protein synthesis probe, HPG, (described later) throughout the infection cycle 
(Fig. 10). The primary antibody against TSA56 protein, which is detected by fluorescent 
conjugated secondary antibody, can label both extracellular and intracellular bacteria while HPG 
only labels the active dividing intracellular bacteria as shown in figure 6 (190). The confocal and 
SIM images show that intracellular bacteria are small and round at the early stage of infection, 
and start elongation over time through the process of replication after 1-2 days post infection, 
while the extracellular bacteria remain small and round over the course of infection. A 
quantitative analysis of confocal images showed that the average length of extracellular cells was 
1.2-1.3 µm and the elongated cells were not found in extracellular populations. The average 
length of intracellular cells during early post infection (3-24 hrs) was 1.3 µm and the average 
length of cells during elongation (day1-day7) was 1.6 µm. Also, some elongated cells were 4-5 











Figure 10. Confocal microscopy images of metabolically active and inactive bacteria by clickable 
methionine-alkyne (HPG) probe. HPG can be used as an indicator of metabolically active bacteria. 
O. tsutsugamushi in L929 cells 7 days post infection were labeled with HPG probe which reacted 
with an azide-conjugated fluorophore (green). Bacteria were counter stained with TSA56 
antibody (red). Host cell nuclei are shown in blue (DAPI). The arrowhead indicates that 

























Figure 11. The shape of O. tsutsugamushi in L929 cells during the infection cycle. A. Large images 
are confocal images of intracellular bacteria labeled with the protein synthesis probe (HPG).  HPG 
reacted with an azide-conjugated fluorophore to reveal cells actively undergoing protein 
synthesis (green). Scale bar (6 hrs and 1-5 days post infection) = 5 µm and scale bar (6-7 days post 
infection) = 2 µm. The inset images are structured illumination images of bacteria labelled with 
TSA56 antibody (green). Scale bar of in set images = 2 µm . B. Graph shows cell length of 
extracellular and intracellular populations labeled with TSA56 antibody at different time after 
infection from confocal images. Quantification involved  measuring the length of 100 bacteria of 
from each single time point. Statistical significance was determined using an unpaired t test 







 To observe the morphological pattern of Orientia in other cell lines, the length of Orientia 
during the infection cycle was observed in Potoroo epithelial cells (Ptk2) which are derived from 
the kangaroo kidney. Orientia has never been inoculated in Ptk2 before, therefore, the growth 
of Orientia was monitored to see whether Orientia can grow in Ptk2 cells or not. Intracellular 
Orientia taken from day 6 post infection was used to infect Ptk2 cells, and the growth curve was 
monitored by qPCR throughout the 7-day infection cycle. The results showed that the growth of 









Figure 12. Growth curves showing the growth of O. tsutsugamushi in L929 and Ptk2 cells by 
measuring bacterial copy number in one well of a 6 well plate over time. Bacteria were taken 
from the intracellular fraction after 6 day post infection pregrowth in L929 or Ptk2 cells. The 
intracellular bacterial cells were measured. 
 Next, Orientia strain UT76 in Ptk2 cells was labeled with TSA56 during the 7 day infection 
cycle. The results revealed that the morphology of Orientia in Ptk2 cells is similar to that in L929 
cells (Fig. 13A). Amongst the extracellular bacteria, no elongated cells were found and cells were 
small and round over the time course, while the intracellular bacteria were small and round at 
the early time point of infection (3 hours) and became elongated bacteria after 24 hours post 
infection. The average lengths of Orientia cells were 1.2-1.4 µm in the extracellular fraction, 
1.5µm in the intracellular fraction at 3H post infection, and 1.7-2 µm at later time points (1-7 











Figure 13. The shape of O. tsutsugamushi in Ptk2 cells during the infection cycle. A. confocal 
images of extracellular and intracellular bacteria labelled with Orientia surface protein TSA56 
(green). Scale bar = 5 µm. B. Graph shows cell length of extracellular and intracellular populations 
labeled with TSA56 antibody and measured from confocal images. Quantification involved 
measuring the length of 100 bacteria of each single time point. Statistical significance was 
determined using an unpaired t test analysis. P values are represented as follows: ns (P>0.05); * 





 Even though SIM microscopy provides a high-resolution image, it also has a limitation 
when imaging aggregated bacteria. Figure 14 shows that an individual bacterium in a tightly 
packed microcolony near the nucleus cannot be distinguished by SIM. To solve this problem, the 
localization-based super-resolution technique, stochastic Optical Reconstruction Microscopy 
(STORM), was used to distinguish Orientia morphology over the time course. Based on the 
localization approach, a single fluorescence probe switches between on and off states onto target 
molecules (267). This process is repeated many times until most fluorescence probes have been 
imaged. STORM can resolve the localization of a single-molecule with high precision even in 
dense populations (268, 269). Therefore, STORM was chosen to provide a precise localization of 







Figure 14.  Comparison of SIM (left) and STORM (right) images of aggregated O. tsutsugamushi 
after 5 days post infection in L929 cells.  (Left) Bacteria are labelled with anti-O. tsutsugamushi 
human serum (green) and anti TSA56. (Right) Bacteria are labelled using an antibody against 
surface protein TSA56. Scale bar = 5µM. The inserts show a zoomed in of aggregated bacteria.   
STORM imaging (Fig. 15) of the Orientia infection life cycle (3 hours to 7 days post 
infection) provides a better image resolution which allows quantification of bacterial size in a 
tightly packed microcolony. Quantitative analysis of Orientia cell length showed that intracellular 
bacteria are round at three hours post infection and become elongated at day 1 to day 7 post 
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infection. The length measurement of bacteria in a crowded area was not significantly different 
from the length measurement of single isolated bacteria (Fig. 16). 
 
Figure 15. STORM images of O. tsutsugamushi infection cycle (3 hrs– 7 days post infection) in 
L929 cells showing the round and elongated morphology  of bacteria during the infection. 
Intracellular bacteria were labelled using an antibody against surface protein TSA56. White 





Figure 16. STORM images of intracellular and extracellular populations showing the round and 
elongated morphology during the infection. O. tsutsugamushi was infected in L929 cells and 
was labelled using an antibody against surface protein TSA56. 
 The morphology of the extracellular population (day 7 post infection) was compared with 
the intracellular population (3 hours – 6 days post infection) by STORM imaging (Fig. 16). It is a 
feature of Orientia infection that host cell density is always high during the mid stage of infection 
(day 3-day5). This makes it difficult to observe the morphology of extracellular bacteria. During 
the later time points (day 6-7 post infection), more bacteria are budding out of host cells and 
host cells become damaged, leading to easy observation of the extracellular population. The 
results showed that extracellular bacteria after budding out from host cells are small and almost 
spherical whilst intracellular bacteria are round during first 24 hours post infection and become 
elongated over time (day 1-day 7 post infection). This suggests that the morphology of 
extracellular and intracellular populations is slightly different. 
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The reason why some intracellular populations are elongated and others become round 
or coccoid is that bacteria change their shape in response to the hostile environment in which 
they reside in order to survive (270). The small size allows for a better escape from host immune 
cells and allows bacteria to form a pack colony in a restricted host cell volume such as                                        
S. pneumonia reduces the size to avoid the complement-mediated killing by the host (271, 272). 
Unlike biofilm-forming in other bacteria, such as Pseudomonas aeruginosa, E.coli, and 
Staphylococcus aureus, Orientia releases a polysaccharide molecule, NT19, and forms self-
aggregates (157, 273). The function of this protein is unknown but it might be involved in forming 
a biofilm-like structure within host cells. Extracellular bacteria also form aggregation after exiting 
host cells. TSA56 is a major outer membrane protein in Orientia and was previously reported to 
form higher order intermolecular aggregation in the presence of a reducing agent (44, 274). 
TSA56 might be involved in forming aggregated extracellular bacteria via highly cross-linked  
disulfide bond on the bacterial surface membrane.  
3.2 Extracellular bacteria and intracellular bacteria have distinct protein profiles. 
The protein profiles demonstrated differences in metabolic status between the 
extracellular and intracellular populations. Shotgun proteomics analysis was used to compare the 
protein profiles of isolated bacteria at different times after infection (3, 5 and 7 days post 
infection). To achieve bacterial isolation in this experiment, extracellular bacteria were collected 
from the supernatant of infected cells and intracellular bacteria were collected by lysis of infected 
cells. After the lysis step,  host debris and intracellular bacteria were separated by a low-speed 
centrifugation. The limitation of the bacterial purification method is that we cannot completely 
separate the intracellular populations from the extracellular population. Furthermore, a 
subpopulation may be pelleted with host cell debris especially the bacteria at the surface of the 
host cells and those attached to membranes.  
The relative abundance of protein in both fractions was compared at each time point. The 
results revealed that on day 3 and day 5 post infection, extracellular and intracellular bacteria 
show a difference in protein profiles (Fig. 17), suggesting that extracellular and intracellular 
bacteria have distinct developmental stages. In addition, the protein profiles were similar to each 
89 
 
other at day 7 post infection. This revealed that the intracellular stage becomes the extracellular 












Figure 17. A comparison of protein expression levels in extracellular and intracellular populations 
at 3 d.p.i, 5 d.p.i. and 7 d.p.i. (d.p.i = days post infection). Relative protein levels, as determined 
by peptide counts in a normalised proteomic dataset, are compared between extracellular (X-
axis) and intracellular (Y-axis) bacterial fractions. Selected proteins are highlighted in red.  
3.3 Both extracellular and Intracellular populations are infectious. 
The differences in protein profiles between extracellular and intracellular bacteria leads 
to the next question; whether extracellular and intracellular populations have different infectivity 
or not. The isolated intracellular bacteria taken from day 5 and day 6 post infection were used to 
infect host cells. The growth of intracellular and extracellular populations at each single time 
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point (day 1- day 7) was measured by qPCR. Bacteria were selected from day 5 and day 6 post 
infection because the protein profiles of extracellular and intracellular populations at day 5 and 
day 7 are different. This could also reflect a difference of infectivity between mid and late stages 
of infection (5-7 day post infection). The results showed that even though they have different 
protein profiles, both extracellular and intracellular populations were able to infect host cells and 
replicate over time during the 7 day infection cycle (Fig. 18), suggesting that both extracellular 
and intracellular populations are infectious.  
In addition, the growth pattern of bacteria taken from day 5 post infection was slightly 
different among intracellular and extracellular populations, whilst there was no difference in the 
growth from bacteria taken from day 6 post infection. This result supports the hypothesis that 









Figure 18. Growth curves showing the growth of O. tsutsugamushi in L929 cells by measuring 
bacterial copy number in one well of a 6 well plate over time. All time points were performed in 
triplicates. Bacteria were taken from the intracellular fraction after 5 day and 6 day post infection 





3.4 Distinct bacterial gene expression profiles during intracellular stage of infection 
 
Orientia exhibits distinct subpopulations which show a difference of cell shapes, protein 
profiles. This leads to the next hypothesis that Orientia might present heterogeneity in the 
expression of the other genes and it might also be controlled at an appropriate time and place in 
response to a fluctuating host environment during the infection cycle. To determine whether 
other genes were differentially regulated throughout the intracellular cycle, qRT-PCR was used 
to measure the RNA level of specific genes. In this study, two sets of genes were selected: genes 
that encode for bacterial surface proteins (ScaA, ScaC, ScaD, ScaE, TSA22, TSA47, TSA56); and 
genes encoding proteins involved in peptidoglycan synthesis (pbp2, pal, ddl, murA, murD, murF). 
RNA was isolated from infected L929 cells at 1, 3, 5 and 7 days post infection to measure the gene 
copy number relative to the housekeeping gene MipZ. Each gene expression had a different 
pattern (Fig. 19A). The expression of ScaA, TSA47, and TSA56 were increased whilst the 
expression of pbp2, ddl, murA, murD, ScaC, TSA22, and pal were decreased. A group of murF, 
ScaD, ScaE, expressed constantly throughout the time-course. To check the consistency of the 
expression between RNA and protein level, the relative protein levels of ScaC and TSA56 were 
measured by western blot assay. The protein levels were normalized to the bacterial DNA copy 
number. The immunoblot results (Fig.19B) showed that the ScaC level decreased while TSA56 
increased over time. These trends were similar to the RNA levels, suggesting that the expression 
among RNA and proteins in ScaC and TSA56 were consistent. Even though the RNA and proteins 
were measured in different subpopulations within a single time point, the expression patterns 








Figure 19. The intracellular stages of growth by O. tsutsugamushi are associated with changes in 
bacterial gene expression. A. The relative expression of several genes at different times after 
infection by qRT-PCR. Y-axis = relative copy number compared with housekeeping gene mipZ, X-
axis = days post infection (d.p.i). All experiments performed in triplicate. Statistical significance 
when compared with 1 d.p.i is calculated using a parametric unpaired t test. **** p≤0.0001 
***p≤0.001 **p≤0.01 *p≤0.05, ns p>0.05. B. Western blot presenting the relative levels of ScaC 
and TSA56 at 1, 3, 5 and 7 d.p.i. Sample loading was normalized by bacterial copy number as 
measured by qPCR. 
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Chapter 4: O. tsutsugamushi differentiates into a specific maturation stage 
(extracellular stage) 
This research has been preprinted on bioRxiv under the title of Developmental 
differentiation in a cytoplasm-dwelling obligate intracellular bacterium: Giengkam S, 
Wongsantichon J, Atwal S, Jaiyen Y, Goh WI, Wright G, Chung T, Huh H, Lee S, Sobota R, Salje J. 
Developmental differentiation in a cytoplasm-dwelling obligate intracellular bacterium. bioRxiv. 
2020 Jan 1 
4.1 ScaC is a marker gene for identification of the maturation stage 
Based on the evidence above, extracellular bacteria and intracellular bacteria have 
different protein profiles and infectivity at the early stage of infection (day1-day5), but are similar 
at later stages (day6 - day7). This leads to the next question; how do mature intracellular bacteria 
become extracellular? The transition event in which mature intracellular bacteria become 
extracellular is exit via a budding process. To monitor the transition-maturation stage of Orientia 
subpopulations, a polyclonal antibody against ScaC protein was generated to perform 
immunofluorescence labeling throughout the infection time-course for 7 days (Fig. 20). ScaC was 
selected because ScaC is one of the major surface proteins of Orientia and plays a role in bacterial 
adhesion and invasion. Orientia might utilize ScaC, which is the autotransporter outer membrane 
protein, during the maturation stage prior to exit. 
Immunofluorescence microscopy showed that ScaC labeling is only present on 
subpopulations located at the plasma membrane of infected cells. This suggests that ScaC is 
differentially expressed amongst Orientia subpopulations and can be used to identify bacteria in 
the “maturation” stage of development. In addition, bacteria were labelled by the scac antibody 
at the early time point and the labeling disappeared when bacteria localized into the host 
cytoplasm, and this labeling re-presents when bacteria are located at the host cell surface at day 
3-4 post infection. The involvement if any of ScaC in the budding mechanism is unknown, but 
ScaC might help bacteria prepare for re- infection by helping the entry into new cells.  
The reason why ScaC labeling is lost from the bacteria surface shortly after entry might 
be explained as follows; firstly, the transcription level of the ScaC gene decreased during the 
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infection, and this might reflect the depletion of ScaC protein over time (Fig. 21). Thus, the ScaC 
protein level might be too low and undetectable by IFM. Secondly, the autotransporter protein 
may be degraded through a cleavage process. The ScaC antibody in this study targets the epitope 
on the extracellular autotransporter domain which might undergo cleavage, leading to a loss of 
ScaC labeling during infection. Lastly, ScaC might be secreted to the cytoplasm. Orientia has been 




Figure 20. Antibodies used in this study. A. Overview of antibodies details. B. Immunoblot blot 
showing specificity of antibodies generated and used in this study. MBP-fusion proteins 
containing the peptide used for generation of anti-TSA56 and anti-ScaC. These two antibodies 
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Figure 21. The surface protein ScaC is differentially expressed in Orientia cells grown in L929 
cells. Confocal microscopy images of Orientia grown in L929 cells at different times after 
infection. h.p.i = hours post infection and d.p.i = days post infection. Red = ScaC antibody labelled 
cells, green = TSA56 labelled cells, blue = hoescht-labelled DNA. Scale bar= 10µM 
 In order to observethe  ScaC expression pattern, ScaC labeling was further observed in 
Ptk2 cells. This cell line was selected because Ptk2 remains flat throughout the cell cycle when 
grown in monolayer culture (276), whilst many other cell lines become rounded up during cell 
division. The flat dimensions of Ptk2 allow easy visualization of the cellular compartment under 
a microscope.  
 Orientia in Ptk2 cells were labeled with ScaC antibody during a 7-day time course (Fig. 22).  
The immunofluorescence results illustrated that the ScaC antibody can label all extracellular 
bacteria but only a subpopulation of intracellular bacteria. The ScaC antibody also labels the 
mature intracellular bacteria before budding out. However, the labeling pattern of ScaC in Ptk2 
is different from that seen in L929. Intracellular bacteria located near the perinuclear region were 
able to be labeled with ScaC antibody from day 3 to day 7 post infection, whilst intracellular 
bacteria in L929 cells were never labelled. This suggests that ScaC is switched on earlier after 
entry which implies that the maturation stage of Orientia in Ptk2 cells begins earlier than in L929 
cells. Therefore, the host cell type affects the stage progression of the intracellular infection cycle 
of Orientia.  
 Based on the ScaC labelling (Fig. 21-22), the host cytoplasm is also labelled with ScaC 
antibody.  This could suggest that ScaC is secreted into the host cytoplasm. Additionally, the ScaC 
labelling of some populations at the surface of host cells was not clear enough to distinguish 
between the host membrane and bacteria. To solve this labelling issue,  CellMask, which is the 









Figure 22. The surface protein ScaC is differentially expressed in Orientia cells grown in Ptk2 
cells. Confocal microscopy images of Orientia grown in Ptk2 cells at different times after 
infection. h.p.i = hours post infection and d.p.i = days post infection. Red = ScaC antibody labelled 
cells, green = TSA56 labelled cells, blue = hoescht-labelled DNA. Scale bar= 10µM 
 4.2 The maturation stage is involved in dormancy and other mechanisms  
 Bacteria contain dedicated mechanisms to respond to a fluctuating environment for 
survival (277). Several extracellular factors such as limited nutrients, antibiotic stress, 
accumulation of toxic by-products, changes in pH, osmolarity, and temperature activate bacteria 
to reprogram the gene expression pattern and metabolic activities. Examples include reduction 
of phosphate metabolism in E. coli (278) and depletion of catabolic proteins in P. aeruginosa 
(279). In many bacterial species, some populations enter a dormant stage or non-growth 
condition in which cells are metabolically inactive, and these dormant bacteria usually constitute 
about 1% of the whole population in the non-growing stationary phase (277, 280). Reduction or 
cessation of metabolic activity alters bacterial protein levels resulting in a change in their protein 
profiles. Since Orientia enters an extracellular stage and becomes metabolically inactive, Orientia 
might need to use similar mechanisms to survive.  
The proteomic profile of extracellular and intracellular populations was analyzed in detail 
to observe whether or not the subpopulations have a different protein profile. Any differences 
suggest a mechanism of gene regulation, and changes in profiles provide insight into the 
functions of individual proteins during a cell-cycle stage. Protein fractions from both populations 
during the mid-stage of infection (day 4) were compared with one another to see the pattern of 
protein profiles (Table 3-4.). The total number of single-hit proteins from the host, and bacteria 
was 4,190 and 531, respectively. To reduce variation between replicates, the data was 
normalized by median normalization (281).  We found a significant (>2 fold) upregulation of 60 
and 47 proteins in the intracellular and extracellular populations, respectively.  The summary of 
the proteomic analysis revealed that the proteins upregulated in extracellular populations were 
involved in protein synthesis (20), metabolism (13), effectors and secretion system (13), 
oxidation-reaction processes (11), RNA binding and processing (4) including dormancy and the 
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stringent response (3). This finding supported the hypothesis that Orientia might differentiate 
into a dormant, extracellular stage. 
 There are three proteins involved in dormancy and stringent response that were 
upregulated in the extracellular population: SpoT ((p)ppGpp synthetase), RpoH (the alternative 
heat response sigma factor), and the GTPase ObgE. SpoT is a bifunctional enzyme that synthesizes 
and hydrolyses (p)ppGpp or alarmone guanosine tetraphosphate, an unusual nucleotide typically 
produced during starvation or stress that controls the regulation of stress-response related genes 
(282). RpoH is a starvation sigma factor which has been found to upregulate during the stationary 
phase in E. coli and Salmonella typhimurium (215, 283). ObgE is in the highly conserved Obg 
GTPase family (spo0B-associated GTP-binding protein) and acts as an anti-association factor, 
which binds to the 50s ribosome and blocks the formation of the 70s ribosome resulting in 
inhibition of the initiation of translation (284). ObgE has been shown to be regulated by (p)ppGpp 
during the stress response (285).  
The DNA binding protein YbaB/EbfC was highly expressed in the extracellular state. This 
protein has been reported to be a nucleoid-associated protein or DNA-binding protein and plays 
a role in gene regulation during stationary and exponential stages in Borrelia burdorferei (286, 
287). 
 Several effector proteins and secretion system proteins were expressed differently in 
extracellular and intracellular states, for example, tetratricopeptide repeats (TPR3, TPR8) are 
highly expressed in the extracellular state, and Ank1, Ank13 are highly expressed in the 
intracellular state (Table 2-3). TPR mediates protein-protein interaction and is associated with 
the specific interactions of multiple proteins (34). Previous evidence showed that TPR-containing 
proteins play an important role in cell cycle control, transcription, and protein transportation in 
Saccharomyces cerevisiae (288-291). The ankyrin repeats are common protein-protein 
interaction motifs associated with the plasma membrane and promote the interaction between 
the cytoskeleton and integral membrane proteins (292). A large number of ankyrin repeats have 
been found in eukaryotes but there is little evidence in prokaryotes. Ankyrin has been shown to 
be transferred into host cells by type IV secretion system (TFSS) in intracellular pathogens such 
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as Legionella pneumophila and Coxiella burnetii, Anaplasma phagocytophilum and Wolbachia 
(293-296), suggesting that Orientia might use TPR and Ank proteins for interaction with host cells 
at different stages of infection.  
 Several proteins which are involved in protein synthesis such as ribosomes associated 
proteins, are upregulated in the extracellular populations. This evidence suggests that the 
metabolic activity of extracellular bacteria may be active.  The transcription and translation levels 
of the extracellular bacteria might be too low under the detectable level, and this could be a 
reason why the metabolic probe (HPG) cannot detect the metabolic activity of extracellular 
populations. In Chlamydia, the EB lacks metabolic activity but the transcription is active during 
the primary differentiation (178). Chlamydial EB may have a specific mechanism to differentiate 
newly transcribes mRNA from the carryover mRNA. This process involves RNA binding proteins 
that transport the carryover mRNA from ribosomes. Carryover mRNA have a short life and 
normally are below the detectable level by 6 hours post-infection (297). Orientia may present 

























Table 3. Summary of proteins abundant in extracellular bacteria. O. tsutsugamushi was infected 
in L929 cells in independent triplicates. The intracellular and extracellular fractions of infected 
cells were isolated and protein profiles analyzed by shotgun proteomics analysis. Proteins that 
were significantly expressed in the extracellular fraction compared with the intracellular fraction 
(I/E) are presented as fold differences. The cutoff is based on P value at P < 0.0001, P < 0.01 and 
















Table 4. Summary of proteins abundant in intracellular bacteria. O. tsutsugamushi was infected 
in L929 cells in independent triplicates. The intracellular and extracellular fractions of infected 
cells were isolated and protein profiles analyzed by shotgun proteomics analysis. Proteins that 
were significantly expressed in the intracellular fraction compared with the extracellular fraction 
(I/E) are presented as fold differences. The cutoff is based on P value at P < 0.0001, P < 0.01 and 




Chapter 5: O. tsutsugamushi becomes metabolically active shortly after entry 
into host cells 
This research has been preprinted on bioRxiv under the title of Developmental 
differentiation in a cytoplasm-dwelling obligate intracellular bacterium: Giengkam S, 
Wongsantichon J, Atwal S, Jaiyen Y, Goh WI, Wright G, Chung T, Huh H, Lee S, Sobota R, Salje J. 
Developmental differentiation in a cytoplasm-dwelling obligate intracellular bacterium. bioRxiv. 
2020 Jan 1. 
5.1 O. tsutsugamushi undergoes a lag period upon entry into host cells 
Bacteria exhibit an exponential growth phase under normal conditions, however, 
bacterial growth also presents lag, stationary, and death phases under starvation conditions. The 
lag phase is defined as a temporary period of nonreplication or a stage during which bacteria 
have not yet started dividing (298). Bacteria that undergo a lag phase need time to adapt to the 
new environment and prepare for the first replication before starting exponential growth (299). 
At this stage, bacteria could repair macromolecular damage and synthesize the precursors or 
cellular components that are essential for bacterial growth (300). Upon the entry of O. 
tsutsugamushi into new host cells, the metabolically inactive extracellular stage turns into the 
intracellular stage in a short period. Based on previous work, Orientia undergoes a lag phase of 
24 hours post infection and starts replication after 24-48 hours post infection (262). However, 
this study used purified intracellular bacteria only. To identify and difference in the growth of 
extracellular and intracellular subpopulations during the lag phase, both populations were 
isolated and propagated in L929 cells. The growth was measured from 0 hour until 7 days post 
infection by qPCR. The results showed that the bacteria copy number from extracellular and 
intracellular infections did not significantly change during the first 0 - 24 hours post infection, and 
DNA replication initiates after 24 hours post infection. This confirms that the extracellular and 





Figure 23.  Growth curve shows bacterial replication starts 24 hours post infection. This mark 
represents the lag phase. Bacteria were harvested at each time point and the bacterial copy 
number in one well of a 24-well plate measured by qPCR. 
5.2 Verifying the metabolic activity of intracellular populations by Click-HPG protein 
synthesis assay 
O. tsutsugamushi starts DNA replication 24 hours post infection, but metabolic activity 
during the intracellular infection cycle has never been monitored to determine whether Orientia 
initiates protein synthesis before or after the DNA replication process. The alkyne-modified 
methionine analog, L-homopropargylglycine (HPG), which is incorporated into nascent proteins 
during active protein synthesis, was used to measure the metabolic activity of the bacteria. A 
non-toxic HPG probe was directly added to cell culture media (methionine-free media) for 30 
minutes before fixation, and further reacted with an azide-conjugated fluorophore under a 
copper(I)-catalyzed click reaction. The advantage of the click chemistry approach is its use of a 
fluorescence dye bound to a small molecule without permeabilization of cells and resulting in 
simple and rapid sample processing. The triazole linkage between alkyne and azide is very stable 
and specific which allows for the identification of fluorescence signals of individual cell activity.  
In this study, alkyne-modified methionine was incorporated with azide-conjugated Alexa 
Fluor 488 which exhibits a green signal. The intensity of the fluorescence signal corresponds to 
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the level of translational activity of bacteria at each time point. To observe the metabolic activity 
of Orientia during the early stage of entry, HPG was added to Orientia cell culture in L929 cells at 
0, 1, 3 hours post infection and further monitored from day 1 to day 7 post infection. Bacteria 
were co-labeled with a surface protein antigen, TSA56 to demonstrate the whole population. 
HPG-labeling results revealed that a signal in bacteria is strongly detected under the confocal 
microscope after incubation with the HPG probe for 30 minutes (Fig. 24), suggesting that bacteria 
need time to uptake the HPG probe to synthesize new proteins during the translation process. 
Host cells can uptake the methionine-HPG probe and present a green signal but the bacterial 









































Figure 24. Confocal microscopy images of Orientia tsutsugamushi show that Orientia becomes 
metabolically active shortly after entry. A clickable methionine probe (HPG, green) is used to 
identify metabolically active cells. Bacteria were grown in L929 host cells in the presence of HPG 
for 30 minutes. Subsequently, cells were fixed and HPG reacted with an azide-conjugated 
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fluorophore (Alexa Fluor® 488) to reveal cells actively undergoing protein synthesis (green). 
Bacteria are counterstained with a TSA56 antibody (red), hoescht-labelled DNA (blue). Arrows 
indicate metabolically inactive bacteria. Orientia grown in L929 cells. Scale bar = 10µm. 
5.3 Clarification of the stages of O. tsutsugamushi  
Metabolic activity and DNA synthesis were used as a baseline to classify the stages of                                            
O. tsutsugamushi during the infection cycle. Orientia does not synthesis DNA during 0-24 hours 
post infection (lag phase), but protein synthesis is already initiated as early as 1 hour post 
infection. This indicates that Orientia is primed for the resumption of metabolic activity upon 
entry into host cells. This key finding facilitated a classification of three more stages of the early 
infection cycle as follows, early entry, pre-replicative, and replicative stages. The early entry stage 
is defined as when Orientia had entered into host cells but is metabolically inactive. The pre-
replicative stage is the period when Orientia is metabolically active but DNA replication has not 
yet begun. In the replicative stage, Orientia exhibits both metabolic activity and DNA replication.   
Later in the infection, Orientia is still metabolically active as the bacteria located near the 
host cell membrane are labeled with HPG (Fig. 24). Once bacteria exit host cells, extracellular 
bacteria could not be labeled with HPG. This finding suggests that extracellular bacteria are 
metabolically inactive. 
Besides clickable methionine (HPG) labeling, which reflects active translation, nucleotide 
analogs based on click chemistry were used as an alternative tool to study nascent DNA and RNA 
synthesis during the replication process. Nucleotide labeling could be used to monitor active 
nucleotide synthesis in the subpopulations, since the measurement by qPCR and RT-qPCR 
represents only the combined DNA and RNA levels of mixed populations. EdU and EU probes 
were used to observe DNA and RNA synthesis during Orientia infection (0, 1, 3 hours and 3, 5 
days post infection). The EdU (5-ethynyl-2´-deoxyuridine) probe, a thymidine analog, is 
incorporated into DNA during active DNA synthesis. EU (5-ethynyl uridine) probe, a nucleoside 
analog of uracil, is incorporated into RNA during active RNA synthesis. The labeling was optimized 
under several conditions, including the probe concentrations, incubation times, probe carriers, 
and cell permeabilization. The findings revealed that the EdU and EU probes failed to label 
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Orientia at every time point. However, the host nucleus was clearly labeled with both probes, 
indicating that the labeling method was successful (Fig. 25). One of the possible reasons is that 
O. tsutsugamushi cannot uptake these unnatural nucleotides. Either the modified nucleotides 
cannot cross the bacterial cell membrane or the recognition of these analogs during transcription 
and DNA replication is insufficient (301). 
 
Figure 25. A clickable nucleotide probe (EdU) is used to identify nascent DNA synthesis.                                
O. tsutsugamushi was grown in L929 cells for 3 days before labelling with EdU. The EdU probe 
was incubated with the infected cells for 30 mins, cells were fixed, and EdU was reacted with an 
azide-conjugated fluorophore to reveal cells actively undergoing DNA synthesis (green). Bacteria 
are counterstained with a TSA56 antibody (red) and nuclei are labelled with DAPI (blue). Arrows 
indicate a successful labeling of compact DNA on host nucleus but fail to detect bacterial DNA. 
Scale bar = 20 µm. 
5.4 Protein synthesis of Orientia begins immediately upon exit from endosomes 
Orientia enters host cells via a clathrin-mediated endocytosis-like mechanism and 
escapes from the host endocytic pathway by exiting from late endosomes into the cytoplasm. 
Bacteria escape from the endolysosomal pathway  1 to 2 hours post infection and are co-localized 
with early and late endosomal markers, EEA1 and LAMP2, respectively (302). Together with the 
findings in this study (described above in the topic 5.2), this illustrated that metabolic activity is 
initiated during the early infection (30 min post infection onwards). This leads to the next 
question; does Orientia become metabolically active within the endosome or after release into 
the host cytoplasm?  
111 
 
Intracellular and extracellular bacteria at 5 days post infection were isolated and used to 
infect L929 cells. Bacteria were fixed at 15 mins, 30 mins, 1 hour and 24 hours post infection and 
were labeled with the late endosomal marker LAMP1, Orientia maker 16s RNA FISH, and 
methionine probe HPG (Fig 21). Bacteria that co-labeled with LAMP1 are endosomal localized 
Orientia, and HPG labelling represents metabolic activity. The results (Fig. 27) showed that the 
majority of bacteria were colocalised with LAMP1 without HPG (2-8%) during 15 -30 min post 
infection, indicating that bacteria in endosomes are metabolically inactive at the first 15-30 min 
post infection. The colocalisation of LAMP1 and HPG (2-10%) appeared later, from 30 -60 min 
post infection, suggesting that Orientia may initiate metabolic activity while still intact in 
endosomes or this perhaps could happen during the lysis of the endosomal membrane. To prove 
that bacteria inside an endosome could be labeled with HPG, Salmonella typhimurium which is 
known to live in a membrane–bound endosome (Salmonella containing vacuole-SCV) were 
labeled with HPG probe as a control experiment. Salmonella bacteria were inoculated in growth 
media overnight and labeled with HPG for 30 min before fixation. HPG successfully labeled 
Salmonella as shown in figure 28. This result confirms that HPG was able to label bacteria within 
a membrane-bound vacuolar compartment. 
Escape from the vacuole or endosome is a key step for cytosolic pathogens. This process 
occurs shortly after the invasion, and many pathogens are detected free in the cytoplasm within 
30 minutes of entry such as Shigella flexneri, Listeria monocytogenes, and Rickettsia coronii (303). 
Like other cytosolic pathogens, O. tsutsugamushi also escapes endosome within 30-60 minutes. 
The fast rate of endosomal lysis suggests that bacteria are in a battle for survival. Bacteria must 
escape before endosome-lysosome fusion to continue their life cycle within the cytosol. 
A large number of Orientia (70-96%) were HPG positive and LAMP negative at a later time 
(1- 24 hours post infection). This showed that most bacteria had already escaped from endosome 
into the cytoplasm. Overall, the labeling pattern of LAMP1 and HPG in infections with intracellular 
and extracellular bacteria were similar, suggesting that even though bacteria are in different 
states at the point of infection, the magnitude of escape from the endosome during the early 











Figure 26. O. tsutsugamushi becomes metabolically active shortly after entry. Confocal 
microscopy images of intracellular Orientia 15 mins (upper panel) and 1 hour post infection 
(lower panel). Late endosomes are labelled with LAMP1 (magenta), Orientia is counterstained 
with 16S RNA FISH probes (red), and metabolic activity is measured with a clickable methionine 








Figure 27. Quantification of confocal data, measuring the fraction of all bacteria (measured by 
the presence of 16S RNA FISH labelling) that colocalize with LAMP1 and HPG (methionine probe).                                         





Figure 28. Intracellular Salmonella can be labeled with HPG. L929 cells were infected with 
Salmonella typhimurium expressing DsRed (red) for 3 hours and were labeled with the clickable 
methionine probe HPG (green). This was added to the growth media for 30 mins prior to fixation, 
and then conjugated to an Alexa488 fluorophore. 
5.5 Bacterial activation following entry into host cells is triggered by sensing the 
reducing environment of the host cytoplasm 
The evidence that protein synthesis in Orientia begins immediately upon exit from the 
endosome into the host cytoplasm leads to the next question; what mechanism activates the 
resumption of metabolic activity in cytoplasmic Orientia? TSA56 is one of the major outer 
membrane proteins of O. tsutsugamushi. It has been determined that TSA56 forms a disulfide 
crosslink network in Orientia (44). The sulfur-containing residue cysteine on the bacterial 
membrane is particularly sensitive to oxidizing molecules, such as reactive oxygen species (ROS), 
generated by host cells to kill invading pathogens. Several proteins are involved in protecting 
bacterial cell membranes and repairing proteins from oxidative damage including catalase, 
peroxiredoxins, superoxide dismutases (SOD), and oxidoreductases (304). For example in E.coli, 
there are two major cysteine-based reducing pathways in the cytoplasm: the flavoenzyme 
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thioredoxin reductase (trxB) and its redox partners trxA and trxC, and the glutaredoxins and the 
couple glutathione/glutathione reductase (gor) (305). This leads to the next question: whether 
TSA56 and other cysteine-related proteins might be oxidized upon release in the reducing 
environment of the host cytoplasm, and this mechanism might trigger an internal signal to 
activate the metabolism of Orientia.  
 To answer this question, Buthionine sulphoximine (BSO), which is an inhibitor of gamma-
glutamylcysteine synthetase, was used to reduce the tissue glutathione (GSH) level, and this 
consequently depleted the reducing environment in the host cytoplasm. L929 cells were 
pretreated with BSO 4 mM and 10 mM for 24 hours before infection with Orientia. Bacteria were 
observed 1, 3, and 24 hours post infection. The HPG probe was added prior to fixation and stained 
with Azide-488 fluorophore to monitor the metabolic effect. Quantification involved imaging 100 
random bacteria at the same imaging setting for each time point. The brightest pixel intensity 
within the area of the bacterium was measured manually using Fiji ImageJ software. BSO did not 
affect the infection of Orientia in L929 cells. The number of infected intracellular Orientia in L929 
cells did not significantly reduce in the presence of BSO compared with the untreated control 
(Fig. 30). The results (Fig. 29) showed that the HPG intensity significantly reduced in the presence 
of BSO 4 mM and 10 mM, suggesting that the reducing environment mediates the reactivation 
of Orientia after entry into host cells. This may happen by breaking disulfide links between TSA56 
and other surface proteins and inducing structural or signaling changes. Another possible 
mechanism could be redox regulation; the reductive stress in host cytosol might affect the 
cellular NAD+/NADH imbalance by either direct or indirect pathways to enhance bacterial 
glutathione (GSH) synthesis (306). In addition, the enrichment of redox-related gene products 
(ubiB, nuoB, and gstA) in proteomic profile (Table. 4) are uplregulated in intracellular bacteria. 
These particular redox-related proteins may play a role in the redox regulation during the early 













Figure 29. The inhibition of reduced glutathione by BSO leads to reduced metabolic activity in                    
O. tsutsugamushi. The fluorescence intensity of HPG-labelled bacteria in confocal microscopy 
images was quantified at 1, 3 and 24 hours post infection and in the presence of 0, 4 mM or 10 
mM BSO. Quantification involved imaging 100 random bacteria at the same imaging setting for 
each time point. The brightest pixel intensity within the area of the bacterium was measured 







Figure 30. Treatment with BSO does not affect entry of O. tsutsugamushi into host cells. 
Quantification of HPG-label intracellular bacteria 1 hour and 3 hours post infection, assessed by 
analysis of confocal microscopy images. Quantification involved imaging random bacteria from 
50 infected host cells. O. tsutsugamushi was infected into L929 cells and treated with no, 4mM 
or 10mM BSO. 
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Chapter 6: Discussion of chapters 3-5  
By definition intracellular bacteria are organisms that grow and reproduce inside host cells. 
These have been divided into two distinct groups; facultative intracellular bacteria and obligate 
intracellular bacteria. Facultative intracellular bacteria such as Salmonella typhi, Mycobacterium 
spp., Listeria monocytogenes, Yersinia spp., Francisella spp., Neisseria meningitides, and many 
others, are able to live and reproduce either inside or outside host cells. The obligate intracellular 
bacteria, for example, Coxiella burnetti, Chlamydia spp., and members of the order Rickettsiales 
(Anaplasma, Ehrlichia spp., Wolbachia spp., Rickettsia spp., including Orientia tsutsugamushi) are 
able to grow and reproduce only inside host cells (307). This reflects their intracellular cycle which 
always depends on the host cells’ machinery. The complexity of the developmental cycle in 
obligate intracellular bacteria is a key challenge to understanding host-pathogen interaction and 
the mechanism of infection.  
Compared with other obligate intracellular bacteria, the life cycle of O. tsutsugamushi is 
relatively little known, including the developmental differentiation which has not been 
elucidated before. In this thesis, I investigate how O. tsutsugamushi differentiates into distinct 
subpopulations during the course of a 5-7 day infection cycle in host cells. This allows us to classify 
the Orientia infection cycle into 5 distinct stages; stage I-IV (intracellular stage), which represents 
bacteria located inside host cells and stage V (extracellular stage), which represents bacteria 
exiting from host cells by budding. This is equivalent to the well-known biphasic life cycle in 
Chlamydia, which exhibits two morphologically and physiologically distinct stages; infectious 
extracellular and noninfectious intracellular stages, Orientia does not undergo the biphasic 
developmental cycle because it does not present a clear and contrasting biological and 
physiological specialization. The infection cycle of Orientia is unique among the other 
Rickettsiaceae family. One notable feature is the exit strategy. Orientia escapes host cells by a 
slow budding process in which individual bacteria are encased by host cytoplasmic membrane 
while other bacteria in the family Rickettsiaceae exit via other mechanisms, such as actin-based 
protrusion in Ehrlichia, R. rickettsii and R. conorii (56). The membrane-encased exit strategies 
help bacteria avoid host immune recognition that would normally trigger a lytic type of cell death, 
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and could promote the uptake by macrophage or phagocytic cells, and thus facilitate the spread 
of infection. Upon exit, membrane–bound Orientia in the extracellular phase are able to infect 
cells and this could promote systemic dissemination during infection.  
Based on the host-dependent life cycle of O. tsutsugamushi the growth of Orientia relies on 
the host cells to supply metabolism processes with ATP and intermediate molecules. Orientia 
cannot carry out energy metabolism when it lives outside of the host cell because Orientia lacks 
several key components involved in metabolic pathways, for example, the absence of functional 
pyruvate dehydrogenase for producing acetyl-CoA which is an essential coenzyme in several 
biosynthetic pathways, missing enzymes involved in the pentose phosphate pathway which is a 
key metabolite in the synthesis of nucleotides, and lack of many genes involved in amino acid 
metabolism i.e. lysine, histidine, tryptophan, tyrosine, and phenylalanine (54). Thus, the 
extracellular stage V was expected to be metabolically inactive. This was proven using clickable-
methionine (HPG) labeling as a reporter of active protein synthesis in intracellular pathogens 
(190). The HPG probe never labeled the extracellular bacteria. This confirms that extracellular 
Orientia is metabolically inactive.  It is important to note that both intracellular and extracellular 
populations are mainly distinguished by the metabolic activity using a clickable-methionine probe 
(HPG) and the active protein synthesis is detected by imaged-based analysis. This method is fast, 
non-toxic, and sensitive. However, it cannot detect the extracellular populations which present 
low metabolic activity. Additionally, the antibodies (anti-TSA56, anti-human) and RNA-FISH 
(16srRNA) probe were used in this study to represent the whole population of Orientia. However, 
these antibodies and the RNA-FISH probe were not able to label all subpopulations of bacteria. 
Therefore, the antibodies and probe against specific proteins in Orientia are required further 
validation to represent the whole Orientia population. 
The extracellular stage V could be equivalent to the stationary phase in free-living bacteria. 
Upon exit, extracellular bacteria have to cope with stress conditions such as nutrient limitation, 
pH, and osmolality imbalances by altering cell membranes, changing cell morphology, and 
activation of stringent response mechanisms to survive. When Orientia enters into stage V, the 
cell membrane of extracellular bacteria is highly cross-linked. This corresponds to proteomics 
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profiles that show TSA56 is enriched in the extracellular stage. TSA56 is the major surface protein 
of O. tsutsugamushi harboring three cysteine residues and forms disulfide crosslink networks 
(98). By microscopy, the intensity of TSA56 labeling in extracellular bacteria is always brighter 
than intracellular populations. In addition, the membrane-integrated dsbB proteins are found in 
extracellular bacteria. DsbB functions by cooperation with ubiquinone and dsbA to generate 
disulfide bonds which impact protein folding in the periplasmic space (308). This could suggest 
that O. tsutsugamushi regulates disulfide bond formation of surface or periplasmic proteins. 
The morphology of Orientia bacteria becomes smaller and round (coccoid form) after exit. 
The reduction in cell size upon entry to the stationary phase can be explained as a result of two 
distinct processes; reductive division and dwarfing. DNA replication and cell division are initiated 
at the same time during the transition to the stationary phase. Due to a lack of nutrients at the 
stationary phase, bacteria cannot divide but the DNA synthesis is continued because of the 
previous initiation of DNA replication. Bacterial cells may consist of two or even more than two 
chromosomes. Unlike reductive division, in the dwarfing process there is a steady reduction of 
the cell size via degradation of cellular components such as a cytoplasmic membrane or cell wall. 
This process occurs after the completion of the reductive division and is activated by starvation 
(309, 310). Morphological alteration in extracellular Orientia (stage V) may progress through 
either reductive division or dwarfing mechanisms.  
When bacteria enter the stationary phase, the cells have to regulate the transcription process 
through either activation of the genes required for survival or suppression of unnecessary genes. 
In E. coli, around 20% of genes are found to be highly expressed in the stationary phase, for 
instance, DNA repair, glycogen synthesis, heat-resistance, osmotic tolerance, etc. (215). The 
mechanism of regulating the expression of extracellular-stage genes is unknown. Stage V O. 
tsutsugamushi may activate the stress response mechanisms via a group of genes related to 
stringent response and dormancy (SpoT, RpoH, and obgE) which were enriched in extracellular 
populations. These genes have been found to upregulate at the stationary phase in E. coli and S. 
typhimurium (282, 283, 311). Orientia encodes two main sigma factors, RpoD and RpoH. The role 
of RpoH/heat shock-type σ factors is to maintain protein-folding homeostasis under high 
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temperature, functioning as a starvation sigma factor that regulates the response from stress 
during the stationary phase (215, 312, 313). This suggests that RpoH may regulate the gene 
expression of extracellular stage bacteria. At the translation level, the ribosomal assembly may 
be regulated by ObgE which prevents the association of 50S and 30S subunits to form 70S 
ribosome, resulting in blocking of the translation process. ObgE also has GTPase activity and is 
inhibited by (p)ppGpp to prevent correcting ribosome maturation during starvation (284). In 
addition, ribosomal proteins (rmpA; 50S ribosomal protein L27, RplX; 50S ribosomal protein L24 
and RbfA; ribosome-binding factor) are present in extracellular fractions. These proteins may play 
a role in ribosomal inactivation and reactivation during dormancy.  
Genes involved in changing the DNA structure, YbaB/EbfC, are enriched in the extracellular 
fraction. EbfC is a DNA-binding protein. It can form a homodimer or higher structures such as 
tetramers and octamers with DNA called nucleoprotein complex resulting in the condensation of 
the nucleoid (286). This protein has similar functions in DNA compaction to protect DNA from 
damage during the stationary phase (309). Likewise, Orientia may control the nucleoid 
condensation through the EbfC gene for DNA protection and regulation of gene expression. 
ScaC plays a role in adhesion and entry (98), and is upregulated in extracellular fraction. ScaC 
is an important gene in the extracellular stage and exhibits as a marker gene during the 
maturation stage. It was selectively expressed on surface-residing bacteria during the transition 
from stage IV (maturation stage) to stage V (extracellular stage), though the role of ScaC in 
budding out of host cells is unknown. The mechanism that triggers the activation of transition 
into stage IV and V is unknown. Starvation conditions could trigger the essential genes through 
RpoH regulator. The other genes that could be alternative markers of the maturation stage are 
TSA47 and TSA22. These genes encode major outer membrane proteins and also present 
differential expression among the subpopulations. In addition, Tpr8 could be an ideal marker 
protein for the maturation stage due to high expression in the extracellular fraction.  
In the proteomic profiles, peptidoglycan related genes (MurC, MurE) are abundant in the 
extracellular fraction and the qPCR results illustrated that peptidoglycan biosynthesis genes are 
upregulated during early infection. This suggests that cell wall synthesis is an important process 
in the early stage of intracellular growth. Tetratricopeptide (TPR)-repeat proteins (TPR-3 and TPR-
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8) were enriched in the extracellular stage. TPR forms a scaffold on which other proteins may 
assemble. TPR-containing proteins are involved in several cellular functions, for instance, cell 
cycle control, transcription, protein folding, and protein transport (314). It has been shown that 
O. tsutsugamushi encodes TPR proteins and may interfere with host cell metabolism through 
DDx3 RNA helicase after secretion into the host cytosol (60, 315). Given the presence of TPR 
proteins in extracellular bacteria, TPR might play a role in host-pathogen interaction in the early 
stage of infection. A group of genes related to energy metabolism (nuoA, nuoD, idh) and lipid 
metabolism (fabl) are upregulated in the extracellular fraction. This indicates that the 
extracellular bacteria activate metabolic related genes to facilitate infectivity when entering into 
new host cells.  
Another important protein that is enriched in the intracellular fraction is Ank (Ankyrin-
repeat)-containing proteins (Ank1, Ank13). This protein is present in multiple copies in the 
genome of O. tsutsugamushi (60) and has been shown to be exported as an effector protein into 
host cells through the type IV secretion system in intracellular pathogens (293-296). It is possible 
that Ank-containing proteins in intracellular bacteria play an important role as a virulence factor 
acting against host defense mechanisms during the infection cycle.   
The proteomic profile of some subpopulations might not be presented in this study, 
particulary bacteria which are located at the surface of the host cells and attached to membranes 
deu to the limitation of the purification processes. Those bacteria might have been pelleted with 
host cell debris after the lysis step and lost.   
The intracellular bacteria can be divided into four different stages (I-IV) based on metabolic 
activity and DNA synthesis. Stages II-IV represent the metabolically active bacteria and stages III-
IV represent bacteria that undergo DNA replication.  Several genes involved in protein synthesis, 
energy metabolism, and lipid metabolism are upregulated in intracellular bacteria. At this stage, 
the transcriptional and translational processes are activated during the active growth of bacterial 
cells. As Orientia exits the endosome into the host cytosol, it experiences a rapid change from an 
oxidizing to a reducing environment in the host cytosol. This study found that the metabolic 
activity of Orientia significantly diminishes when the degree of reducing environment is 
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decreased due to the inhibition of host glutathione (GSH) pools via BSO. Therefore, the reducing 
environment in the host cytoplasm triggers the activation of metabolic activity after entry into 
host cells. This host-derived GSH mechanism has been shown to trigger virulence factor and 
metabolic adaptation in other intracellular pathogens such as Listeria monocytogenes and 
Burkholderia pseudomallei (306, 316). Other possible factors that could trigger Orientia 
activation are redox stress and pH level. To understand the complex interaction between the host 
microenvironment and bacteria, future research in this area is needed.   
Orientia is generally described as having a coccobacillus shape with size 1-2 µM, however, 
this study shows that the morphology of intracellular bacteria (Stage II-IV) changes over time with 
considerable variation. Orientia presents as a coccoid bacterium and becomes elongated with a 
length up to 5 µM during active growth. Multiple septa were not found in elongated bacteria, 
suggesting that bacteria could grow continuously without cell division, though the number of 
nucleoids in one cell has never been measured. The morphology of Orientia does not change 
when grown in different cell lines (L929 and Ptk2). The mechanism of elongation in O. 
tsutsugamushi is unknown. In Rickettsia spp., R. felis has been found to exhibit a ‘long-form’ when 
propagated in a tick-derived cell line, and filamentous forms have been reported in R. prowazekii 
(75, 317). Given that nutrient availability, cell density, and host cell types may contribute to a 
long-form in Rickettsia spp., the elongation seen in Orientia might result from unfavorable 
environmental conditions such as limited nutrients or a change of pH rather than a distinct stage 
in the developmental cycle. The high infectivity of long-form R. felis promotes the entry into host 
cells and long-form bacteria are more stable than short-form. This suggests that the variation of 
cell morphology may contribute differently to virulence and invasion. Likewise, the elongated 
Orientia in this study becomes rod-shaped rather than round-shaped. The elongated shape of 
rod-bacterium may promote adherence during infection, while a small and round shape may 
allow for a better escape from the complement, a component of the host immune system, and 
allows bacteria to form a packed colony in a restricted host cell volume. In addition, a low amount 
of peptidoglycan-like structure in the surface membrane of elongated cells may help to avoid 
host immune recognition by immune system elements such as NOD1, a receptor of the innate 
immune system that senses fragments of bacterial peptidoglycan (105). However, the 
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distribution of peptidoglycan along the length of elongated cells is unknown. Orientia aggregates 
commonly form near the nucleus during binary fission. One study has proposed that Orientia 
secretes the polysaccharide polymer which promotes aggregation along with bacterial 
microcolony (157). In this work, the super-resolution imaging techniques (SIM and STORM) were 
used for studying bacterial shape and morphology. However, the aggregated bacteria are difficult 
to measure and quantify precisely by SIM and STORM.   
Both extracellular and intracellular stages of Orientia tsutsugamushi are infectious. This 
feature is different from the biphasic life cycle of Anaplasma spp., Ehrlichia spp. and others which 
present infectious extracellular and noninfectious intracellular stages. Orientia exhibits broad 
cellular tropism in which bacteria can infect several cell types, such as endothelial cells, 
macrophages, dendritic cells, and cardiac myocytes, and leads to multiple organs being affected 
during a disseminated infection (9). The infectious extracellular stage in O. tsutsugamushi may 
promote systematic dissemination during infection, though, the mechanisms of dissemination to 
cause systemic infection is unknown. In common with most intracellular life cycles, the 
intracellular pathogen is thought to infect the cell, replicate, re-enter the extracellular space and 
repeat the process. However, re-entering extracellular space risks exposure of the bacteria to 
host immune systems (i.e. antibodies, complement) and other factors that inhibit bacterial 
growth or block entry into new cells. To avoid this risk, intracellular pathogens prefer to transfer 
directly from infected cells to uninfected cells (318). Many intracellular bacterial pathogens, for 
example, Listeria monocytogenes, Shigella flexneri, and Rickettsia spp,. are known to transfer 
directly from cell to cell through an actin-based motility (ABM) process (319). Intracellular 
Orientia may also spread through a cell to cell transfer mechanism. Intracellular stage bacteria 
may mediate local disseminated infection via cell to cell transfer mechanism, and the 






Chapter 7: Developing genetic tools for O. tsutsugamushi. 
In this study a transposon-based vector (pCis-mRuby2-MurAHimar) was introduced into                                      
O. tsutsugamushi via electrotransformation. To improve the transformation efficiency, this 
vector was modified from pCis-mCherrySS-Himar, which has been successfully used in Anaplasma 
phagocytophilum (223), by replacing the promoters for antibiotic selection and fluorescent 
protein expression with a strong Orientia tsutsugamushi promoter. The vector “pCis-mRuby2-
MurA-Himar” only requires the expression of the Himar I transposase without additional host 
factors and encodes integrated elements containing the Himar repeated cassette, a fluorescent 
protein (mRuby2) and MurA (fosfomycin resistant gene). The integrated elements are driven by 
the strong promoter “Eftu”, a translation elongation factor which constantly expresses in                                       
O. tsutsugamushi (63). The transposon vector is expected to generate a single-insertion mutant 
in the Orientia chromosome. 
7.1 Introducing transposon-based vector into O. tsutsugamushi 
7.1.1 Optimizing the electroporation and other related conditions of O. tsutsugamushi  
To find the optimal sucrose concentrations for the preparation of electrocompetent cells, 
purified bacteria were resuspended in different sucrose concentrations (Fig. 31A). The bacterial 
growth was monitored for seven days post infection by qPCR using the TSA47 gene. The optimal 
sucrose concentration range that does not affect Orientia growth is 200 mM to 300 mM. Using a 
high sucrose concentration (500 mM) reduces bacteria growth compared with the control. In this 
study, sucrose 300 mM was used for all transformation experiments. 
Voltage and number of pulses are important factors for plasmid uptake during 
electroporation. The voltage generates a membrane potential which causes reversible cellular 
membrane breakdown which results in “pore formation” in cellular membranes, and these pores 
allow small molecules, i.e. DNA, RNA, protein, plasmid, to enter the cells (320). To measure 
plasmid uptake into the cells, Orientia was electroporated with two voltages (1.2 kV and 2 kV) 
and the plasmid uptake level was measured by qPCR (Fig. 31B). Use of a 2 kV voltage was 
associated with higher plasmid uptake than using 1.2 kV. At 2kV, multiple pulses improved 
124 
 
plasmid uptake around 20 fold compared with a single pulse. Because applying multiple pulses 
gradually increases cell membrane permeability and the cell membrane is less damaged, this 
allows small DNA molecules to pass through the membrane easily. However, using high voltage 
with multiple pulses is still harmful to cells, potentially leading to cell death.  Thus, using a low 
voltage (1.2 kV) with multiple pulses is the optimal condition in this experiment to achieve the 













Figure 31. (A) Optimizing sucrose to affect Orientia growth seven days post infection. Bacteria 
level was determined by qPCR using the TSA47 gene. (B) Plasmid uptake ratio between 
fluorescence gene and TSA47 gene. (C) Measuring the voltage to affect bacterial growth (1, 3, 5 
days post infection).  
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7.1.2 Optimizing antibiotic selection of O. tsutsugamushi 
The MIC (Minimum Inhibitory Concentration) of fosfomycin was optimized to find the 
concentration that could inhibit the growth of Orientia wild type strain. Bacteria were incubated 
with antibiotics for seven days and the growth was measured by qPCR. The results (Fig. 32A) 
showed that fosfomycin 40 μg/ml inhibits Orientia growth as the MIC of fosfomycin is 
approximately equal to the MIC of chloramphenicol, the first drug used to treat scrub typhus in 
patients. However, the MIC cannot inhibit the bacterial population to the minimum baseline 
(zero copies). It was decided to increase the fosfomycin concentration to about 10-fold of MIC to 
enhance the selection of the transformants. The day after electroporation, fosfomycin was added 
to transformant and was left for seven days. Bacteria were harvested to check the bacterial level 
and the fluorescence marker gene (mRuby) by qPCR. The result showed that no positive 
transformants were obtained in these experiments (Fig. 32B). This could be because the 







Figure 32. (A) Bacterial copy number after seven days growth in the presence of different drugs.                               
cam  = Chloramphenicol, dsc = D-cycloserine, fos = fosfomycin, pen = Penicillin. (B) Transformant 





7.2 Bridge nucleic acid (BNA) technology 
Since the transformation approach failed to manipulate the Orientia genome, BNA 
technology was chosen for downregulation of specific genes in O. tsutsugamushi due to its high 
efficiency in knocking-down the targeted genes. In this study, 2’,4’-BNANC (Fig.8) was designed to 
target TSA56, a major surface protein in Orientia, and BNA was expected to reduce the protein 
expression of TSA56, resulting in reduced infection of host cells. The BNA oligomer was 
synthesized by Bio Synthesis (Lewisville, TX). The oligomer was designed complementary to the 
DNA region of the tsa56 gene which is approximately 300 bp from the start codon and conjugated 
with cell-penetrating peptide or carrier peptide (CPP, KFFKFFKFFK) to increase uptake of BNA 
through both host and bacterial membrane (321).  
The specificity of BNA was determined in vitro using a PCR inhibition assay. The BNA 
concentration was varied before adding to the PCR reaction, which contained Orientia gDNA 
(0.125 ng), 56kDa primers (10 μM) that flanking BNA region, and 1x of Taq master mix (Qiagen). 
The result (Fig. 33) showed that BNA at 25 μM completely inhibited the amplification of the tsa56 
gene as assessed by PCR. This means BNA has a high binding affinity to the tsa56 gene and has 
the potential to inhibit transcription of TSA56 in vivo.  
BNA was further studied to determine whether it specifically binds to mRNA and inhibits 
the transcription process. To prove transcription inhibition, BNA was added into RT-PCR reactions 
during cDNA synthesis and the reduction of cDNA product was observed by RT-PCR. The tsa56 
gene was amplified from the cDNA samples to determine the inhibition pattern. The results (Fig. 
36) showed that there was no PCR product of tsa56 gene in the presence of BNA. This suggested 
that BNA can also bind to mRNA of TSA56 gene and blocks the transcription process.  
The BNA inhibition in Orientia was further determined in vivo using the electroporation 
technique. BNA 15 μM and BNA 50 μM were delivered into competent cells with voltage 1.2 kV, 
single pulse. Electroporated bacteria were incubated with host cells (L929) for three days. The 
expression of TSA56 was observed by western blot. The preliminary results (Fig. 34A) showed 
that BNA 15 μM reduced TSA56 expression compared with the control (No BNA/DNA), while 
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there was no reduction of TSA56 expression with a high concentration of BNA (50 μM). This may 
be due to self-complementary among BNA itself. The result from western blot (Fig.35B) suggests 
that BNA could bind to the DNA strand and/or mRNA resulting in inhibition of tsa56 transcription 
or translation. However, the mechanism of BNA binding is still unclear and needs further 
investigation.  
 
Figure 33. PCR inhibition by BNA.  BNA was diluted to different concentrations prior adding into 
PCR reaction. The optimal Tm is 55°C with 35 amplification cycles. The PCR product size of 






































Figure 34. BNA inhibition assays. A. RT-PCR inhibition assay. BNA was added into the RT-PCR 
reaction in order to see whether BNA could bind to mRNA and inhibit cDNA synthesis. The tsa56 
gene was amplified from cDNA samples. B. Western blot O. tsutsugamushi in the presence of 
BNA, using a monoclonal antibody against TSA56 protein. The protein loading volume was 





Well 1: OT+BNA 15 µM 
Well 2: OT + BNA 50 µM 
Well 3: Control no BNA 







The approaches to genetic manipulation for obligate intracellular bacteria are still limited 
compared to the number of methods that are available for free-living bacteria. Fortunately, the 
successful transformation via electroporation in many obligate intracellular bacteria (i.e. Coxiella, 
Anaplasma, and Rickettsia) has enabled genetic manipulation to be achieved and shown that it 
is possible within this class of organism (261, 322, 323). The HimarI transposon has been used in 
generating transformants expressing GFP and mcherry for studying host-pathogen interaction. 
For example, HimarI inactivated a novel virulence gene (sca2) in Rickettsia rickettsii (260), and in 
Rickettsia prowazekii disrupted the pld gene associated with phagosomal escape, using 
transformation (324).  
Using electrotransformation with a transposon-based vector (pCis-mRuby2-MurA-Himar) 
I was unable to successfully effect integration into the Orientia tsutsugamushi genome. Possible 
reasons why transformation was unsuccessful in Orientia include: (i) the Orientia genome 
contains many mobile genetic elements that may randomly insert gene/foreign DNA from its 
chromosome and reduce the stability of transformants. (ii) The efficiency of the transformant is 
low as Orientia requires long term propagation for one week. (iii) The antibiotics chosen were 
not strong enough to select transformants and could not suppress wild type growth. Therefore, 
transformants as a minority population cannot compete with the remaining wild type. This would 
be one reason for transformant loss during subculture selection. (iv) Lack of suitable plasmid for 
Orientia. Until now, there has been no plasmid/vector which has been used successfully for 
Orientia transformation. The inserted elements in the vector, such as strong promoters and 
fluorescent proteins, might need further development to see whether they are suitable for use 
with Orientia or not. 
Another major barrier of transformation in Orientia is the delivery of plasmid into 
bacterial cells. This process is important to improve the efficiency of the transformants. In future 
work, the plasmid could be mixed with dendrimers or alternative molecules that facilitate the 
plasmids to penetrate into host cells and bacterial cells and subsequently allow the transforming 
plasmid to integrate into the bacterial genome. 
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BNA technology is a new tool for down-regulation of targeted genes. Preliminary results 
show that an appropriately designed BNA could bind to Orientia DNA and RNA, and inhibit the 
expression of TSA56 in vitro and in vivo. BNA could be used as an alternative tool for studying 
virulence and the intracellular life cycle of Orientia. BNA inhibition in Orientia has never been 
tested before. This is a challenging technique that still requires further optimization. In this first 
observation of BNA inhibition in O. tsutsugamushi, BNA has strong inhibition in vitro and mild 
inhibition in vivo. However, the inhibition pattern and mechanism in vivo requires more study 




Chapter 8:  Dual RNA-seq provides insight into the biology of the neglected 
intracellular human pathogen O. tsutsugamushi 
The research in this chapter has been published in Nature Communications under the title 
of Dual RNA-seq of Orientia tsutsugamushi informs on host-pathogen interactions for this 
neglected intracellular human pathogen, Mika-Gospodorz B, Giengkam S, Westermann AJ, 
Wongsantichon J, Kion-Crosby W, Chuenklin S, et al. Nature Communications. 2020;11(1):1-
14. 
8.1 Growth of Orientia tsutsugamushi strain Karp and UT176  
Two clinical isolates of Orientia tsutsugamushi, Karp, and UT176, were used in this study. 
Karp was taken from a patient in New Guinea in 1943 (325), and UT176 was taken from a patient 
in northern Thailand in 2004 (326). Based on whole-genome sequencing, UT176 is closely related 
to Karp, sharing tsa56 sequence similarity of about 95% (327). HUVEC (human umbilical vein 
endothelial) cells were chosen because of the similarity of cell types related to early and 
advanced infection in human.  
Since Karp and UT176 have never been propagated in HUVEC cells, growth curves of both 
strains were measured over the 7-day infection cycle by qPCR (Fig. 35). The growth curve showed 
that the doubling time of Karp (19 hours) is faster than UT176 (27 hours), suggesting that the 
growth rate of Karp is slightly faster than UT176. Based on the model of variation in virulence, a 
high growth rate of bacteria tends to increase host mortality (virulence)(328). This implies that 
the virulence of Karp may be higher than that of UT176.  
Infection of both strains was further observed by confocal microscopy using metabolic 
probe (HPG) labeling (Fig. 36-37). The bacterial number increases over time and presents a heavy 
infection at 5-7 days post infection. To get enough RNA yield from the bacteria, the 5-day time 
point was chosen for RNA isolation, as a high bacterial load at this stage does not damage host 




Figure 35. Growth curve showing replication of Orientia in HUVEC cells. Bacteria were grown in 
24-well plates and the total bacterial copy number per well as measured by qPCR. Bacteria were 






























Figure 36. O. tsutsugamushi strain Karp time course. Confocal microscopy images of bacteria in 
HUVEC cells at 0-7 days post infection. The images are shown at each time point. Blue = DAPI 






Figure 37. O. tsutsugamushi strain UT176 time course. Confocal microscopy images of bacteria 
in HUVEC cells at 0-7 days post infection. Two representative images are shown at each time 





8.2 An overview of experiment and Dual RNA-seq outline  
O. tsutsugamushi strains Karp and UT176 were propagated in human umbilical vein 
endothelial cells (HUVEC) for 5 days. Control uninfected HUVEC cells were grown in parallel. Five 
days post infection, total RNA was isolated followed by depletion of rRNA (ribosomal RNA). rRNA-
free RNA was converted to cDNA and sequenced to approximately 35 million reads per library 
using Illumina technology (Fig. 38). Reads were mapped to the completed genomes of Karp, 
UT176, and the human genome, in parallel.  
 
 
Figure 38. The experimental overview and analysis of dual RNA-seq data. 
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8.3 Dual RNA-seq of Orientia tsutsugamushi infecting endothelial cells 
 Bacterial reads of each condition were observed as shown in Fig. 39. HUVEC infected with 
Karp and HUVEC infected with UT176 exhibit bacterial reads as a percentage of total cDNA of 
about 17.1 – 17.5% and 2.8-4.9%, respectively. This may be due to differences in both cell entry 
and growth rate between Karp and UT176. Read mapping to coding sequences (CDSs) were 
abundant in both the HUVEC data and bacterial reads, which allows for the performance of 
differential expression analysis.  
 Dual RNA-seq also detects several non-coding RNA classes from both bacteria and host 
(Fig. 40). Although non-coding RNA (ncRNAs) are thought not to translate into proteins, they may 
have other functions (329). It has been demonstrated that ncRNAs are involved in internal signals 
that control the different levels of gene expression, transcription, RNA splicing, including 
chromosome segregation and stress responses (330-332). Generally, bacterial genomes encode 
several ncRNAs. The most conserved ncRNAs include abundant housekeeping ncRNAs, the RNA 
components of ribonuclease P (RNaseP), the signal recognition particle (SRP), and transfer-
messenger RNA (tmRNA). Of those found in the Karp transcriptome data, tmRNA was shown to 
be expressed at unusually high levels, between 4.6% and 13% of total bacterial reads (Fig. 40). 
This suggests that tmRNA plays an essential role in Orientia survival in mammalian cells.   
 
 
Figure 39. RNA mapping statistics showing the fraction of host and Orientia RNA for each 














Figure 40. Percentage of RNA-seq reads assigned to different classes of RNA in Karp, UT176 and 
HUVEC. 
8.4 Differential expression of genes in Karp and UT176  
 Orientia is a genetically intractable bacteria, leading to little information about its 
antigenic surface proteins and effectors. This is a major barrier to the study of virulence 
mechanisms in Orientia. As much of the diversity of the Orientia genome is a result of gene 
duplication, any differences in virulence between strains may be caused by differences in 
expression. To demonstrate this hypothesis, differential expression analysis of Karp and UT176 
at five days post infection in HUVEC cells was performed. Pathway and gene ontology (GO) 
analyses of differentially expressed genes showed that most pathways were up-regulated in Karp 
compared with UT176, which is involved in DNA replication and metabolism (Fig. 41A). This data 
is consistent with the higher growth rate in Karp.   
At the gene level, many surface proteins (TSA22, TSA56), autotransporter protein (ScaE), 
and effectors proteins (Anks) were differentially regulated between the two strains (Fig. 41B). 
LogFC of ScaE, tsa56, and tsa22 in Karp over UT176 is 1.4, 3.08, and 3.86, respectively. Also, the 
ScaD level was increased in UT176 (0.99 logFC) compared with Karp. The different levels of 
expression of these surface proteins may affect the interaction with host cells through the 
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binding of host cell receptors (i.e., integrin, fibronectin), or activation of innate and adaptive 
immune receptors.  
Based on recently published genome data, Karp and UT176 contain 33(Ank)/29(TPR), and 
21(Ank)/22(TPR), respectively (60). Ank and TPR genes in Karp and UT176 were compared. The 
results showed that ank2, ank3, ank12, and two copies of tpr8 were upregulated in UT176 with 
a log FC > 1.5, while ank6, tpr1, tpr3, and tpr5 were upregulated in Karp with a log FC > 1.5. Anks 
are the key virulence factor in the intracellular pathogen, and some Anks function as effectors in 
eukaryotic cells (66, 333). However, many Anks are uncharacterized. When these ank genes 
ectopically express, the protein products of ank are localized to the endoplasmic reticulum or 
host cytoplasm (68). A recent report demonstrated that Ank6 blocks the accumulation of NFkB 
subunit (p65) in the nucleus and inhibits its transcriptional activation (334). The function of other 
differentially expressed Anks is unknown. Furthermore, Ank interacts directly with host proteins 







Figure 41. Differential bacterial expression. A. Heatmap demonstrating pathways enriched in 
differentially expressed genes. All illustrated groups are more highly expressed in Karp. B. 
Volcano plot representing differential expression of bacterial genes in Karp and UT176. Bacterial 
surface genes (red) and ankyrin repeat containing effector proteins (blue) with log fold change 
≥1 are highlighted. 
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8.5 Differential host response to Karp and UT176 
The inflammatory response activated by Orientia infection plays a key role in virulence 
during the infection. A network map of proinflammatory cytokines and chemokines in response 
to Karp and UT176 in HUVEC cells was produced (Fig. 42). Most of the genes involved in cytokine, 
chemokines, and cytokine receptors were differentially up-regulated in UT176 infection 
compared with Karp. UT176 strongly induced IL6-mediated proinflammatory response (Fig. 42A), 
while IL33 (Fig. 42B) was specifically up-regulated in Karp infection (5.1 logFC higher in Karp-
infected HUVEC cells). IL33 has been shown to be involved in pathogenicity in a mouse model of 
Orientia infection using Karp strain (335). The mutant IL33-/- gene in mice presented less severe 
disease symptoms, while mice recombinant IL33 (rIL33) strikingly increased severity and 
mortality. The difference in the inflammatory response is likely to relate to bacterial virulence. 
The reduction of IL33 in low virulence UT176 strain could suggest that cytokine (IL33) are involved 
in the pathogenesis of scrub typhus.  
Figure 42. Karp and UT176 lead to up-regulation of distinct networks in HUVECs. A. Up-regulation 
of multiple proinflammatory chemokines and cytokines in HUVECs infected with UT176. B. 




8.6 Karp and UT176 are different in virulent in a mouse model 
 To investigate whether Karp and UT176 exhibit differences in virulence in a host, a mouse 
infection model of scrub typhus was used. Freshly isolated bacteria (1.25x106 copies) were 
intravenously inoculated into female C57BL/6NJcl mice (6-8 weeks, 8 mice per group) and the 
disease symptoms were monitored for 12 days before euthanasia.  Karp-infected animals were 
found to have more severe clinical symptoms (Fig. 43B) and lower weight gain over 12 days (Fig. 
43A) compared to UT176-infected mouse. This evidence suggests that Karp is more virulent than 
UT176 in a mouse infection model. 
 Bacteria were isolated from blood and tissue from lung, liver, spleen, and kidneys, and 
the bacterial load was measured by qPCR. The bacterial copies number in blood (Fig. 43C) and 
tissues (Fig. 43D) was strikingly higher in Karp-infected mice.  The mouse tissues were stained by 
hematoxylin and eosin, and the tissue injury was subsequently carried out by histopathological 
scoring (Fig. 43E). Lesion scoring of Karp-infected mice was significantly more severe in lung, liver, 
spleen, and kidney than UT176-infected mice. The histology of airway and gas exchange areas 
(alveolus) of all infected mice was microscopically observed and in each group. The results (Fig. 
43F) illustrated diffuse thickening of alveolar septa, and infiltration of macrophages and 
lymphocytes in both Karp- and UT176-infected mice, however, the severity of white blood cells 
infiltrate condition was more predominantly shown in Karp-infected mice. Even though the 
pathological injuries of tissues were only observed at a single time point (12 days), the differences 
of pathological profiles could suggest that the disease dynamics ae different between the two 
strains. 
 Together the virulence data from mouse and observations in HUVEC  cells including the 
differential host response to Karp- and UT176-infected mice and specific adaptive immune 





















Figure 43. A mouse infection model showing that Karp is more virulent than UT176. A. Weight 
change over 12 days of infection. B. Clinical observation score of mice 12 days post infection. This 
number is a composite score based on appetite, activity, and hair coat with higher numbers 
representing low appetite, low activity, and ruffled fur. C Bacterial genome copy number in 100 
µl blood taken from euthanized mice 12 days post infection, measured by qPCR. D. The ratio of 
bacterial genome copy number to mouse genome copy number in lung, liver, spleen, and kidney 
of euthanized mice 12 days post infection, measured by qPCR. E. Lesion scores of hematoxylin 
and eosin-stained lung, liver, spleen, and kidneys of euthanized mice 12 days post infection. 
Scores range from 0 to 5 with 0 representing normal tissue and 5 representing severe lesion 
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damage. All graphs show mean and standard deviation. Statistical significance is calculated using 
unpaired Student t-test in GraphPad Prism software. **p ≤ 0.01 ***p ≤ 0.001 ****p ≤ 0.0001. F. 
Images of hematoxylin and eosin-stained lung tissue of mice infected with buffer, UT176 or Karp. 
Scale bars = 50 µm. * indicates airway and ** indicates blood vessel. Uninfected control: airway, 
blood vessel, and alveoli all appear normal. UT176-infected lungs: there are diffuse thickening 
and infiltration of alveolar septa with a mixed population of macrophages and lymphocytes 
(arrows). There is also mild perivascular lymphohistiocytic inflammation (open arrow). Karp-
infected lungs: there is diffuse moderate thickening and infiltration of alveolar septa with a mixed 
population of macrophages and lymphocytes. The airway (*) is unaffected and normal.  
8.7 Discussion  
 The goal of the work in this chapter was to determine which bacterial and host genes are 
expressed during Orientia tsutsugamushi infection of cultured cells, to observe differences in 
gene expression between two different clinical isolates, and to determine the relative virulence 
of these isolates in a mouse infection model. 
 The genome size of Orientia is 1.9-2.5 Mbp, almost 50% of which consists of repetitive 
regions of more than 1,000 bp in length (60). The complexity of rearrangements in the Orientia 
genome creates genome instability which makes it difficult to study the transcriptional profile. 
Dual RNA-seq provided the transcriptomic profiles which included protein-coding genes and also 
ncRNAs, tmRNA, and operonic transcripts. tmRNA is known to be associated with the virulence 
in pathogens, for example, ssrA (known as tmRNA) contributes to the pathogenesis of Salmonella 
Typhimurium (336) and Francisella tularensis (337). These studies demonstrated that tmRNA is 
involved in the growth, resistance to stress conditions, and may affect the expression of virulence 
genes. Future work could determine the role of tmRNA and other ncRNA in Orientia 
tsutsugamushi infection. 
The comparative genomics of Orientia reveals that the diversity in the Orientia genome 
arises from many gene duplications rather than the acquisition of new genes (70). This is likely to 
reflect the environmental niches associated with an obligate intracellular lifestyle. As a 
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consequence, strain-specific differences are likely to be associated with the relative gene 
expression rather than the absence or presence of virulence genes. Differential expression of 
genes in Karp and UT176 identified specific genes, especially Anks, TPR, and surface proteins that 
are associated with putative virulence differences between two strains.  
 The differential response of endothelial cells to Karp and UT176 demonstrated that the 
inflammatory response is a key driver of virulence during Orientia infection. The IL6-mediated 
proinflammatory response was strongly upregulated in UT176 whereas IL33 was induced in Karp. 
The stimulation of proinflammatory responses during Karp and UT176 infection has also been 
shown previously (118, 338, 339). It is important to note that this study cannot distinguish 
between the differential host responses to actively replicating bacteria and non-replicating 
bacteria.  
 Mouse model of Orientia infection was used in this study for understanding the 
pathogenesis correlating with human infections. The intraveneous inoculation was selected to 
inoculate bacteria in mice because the needle inoculation route is the most closely similar to the 
natural vector transmission. Even though natural chigger-bite infection would be ideal to monitor 
bacteria dissemination and host-pathogen interactions, the natural infection has several 
limitations, such as the limited access to infect Leptotrombidium mite, difficulty to maintain 
bacteria when they are outside host cells, and inability to control the dose of bacterial 
transmission (340). The infection of C57Bl/6 mice with O. tsutsugamushi Karp and UT176 strains 
results in sublethal disease which is supported by the evidence of weight loss and the presence 
of bacteria in target organs (lung, liver, spleen, and kidney) including, the clinical signs, bacterial 
load in blood, as well as the histopathologic events. Karp-infected mice significantly presented 
more severe symptoms and weight loss compared to UT176-infected mice. The lung 
inflammation was observed in all Orientia-infected mice, however, the accumulation of 
lymphocytes and macrophage including the thickening of alveolar septa were more presented in 
Karp-infected mice. The evidence in the mouse model indicated that Karp exhibited higher 




Chapter 9: Overall conclusions and future directions  
Characterization of O. tsutsugamushi subpopulations (extracellular and intracellular 
populations) 
The first research question was to understand how O. tsutsugamushi differentiates into 
distinct subpopulations between intracellular and extracellular populations. Both populations 
were characterized by observing the different degrees of morphology, protein profiles, and 
infectivity. The results from confocal microscopy, SIM, and STORM imaging, demonstrated that 
the morphology of extracellular Orientia bacteria is small and round throughout the infection 
cycle. The shape of intracellular bacteria has more variation and presents as small and round at 
early infection and becomes elongated during days 1 - 7 post infection. The septum in elongated 
bacteria was not found. The elongation process may occur when the bacterial replication is 
initiated without dividing due to changing host environment conditions. Orientia forms large 
aggregates near the nucleus of host cells. Due to this biological reason, it is difficult to precisely 
measure the shape and size of individual bacteria in a pack-microcolony. Using the Shotgun 
proteomics, the protein profiles of both populations at the mid stage (day 3- day5) of infection 
were different but were similar to each other at the late stage.  Similar to the protein profile, the 
infectivity is slightly different among both populations at mid stage but similar at the late stage 
of infection (day 6-day7).  
O. tsutsugamushi differentiates into a specific maturation stage (extracellular stage) 
The first key finding led to the second research question of how O. tsutsugamushi 
differentiates into a specific maturation stage (extracellular stage). A marker gene (ScaC) of the 
maturation stage was used to identify the transition-maturation stage of Orientia. By using 
fluorescent labelling, ScaC is only present in subpopulations that are located at the host 
membrane; bacteria which have just entered the cell and budding bacteria at the maturation 
stage. The labelling of bacteria by the ScaC antibody in this section should improve by colabelling 
anti-ScaC with the plasma membrane dye (CellMask). This will provide a clear image of bacteria 
at the surface of host cells. 
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O. tsutsugamushi becomes metabolically active shortly after entry into host cells 
The third research question focused on how O. tsutsugamushi senses the entry into the 
host cytoplasm. The findings illustrated that the extracellular bacteria are metabolically inactive 
and they start being active shortly after exiting the endosome. This process is regulated by the 
reducing environment of the host cytoplasm.  
The findings in chapters 3-5 allow us to distinguish the stages of growth in intracellular 
bacteria. The differences in metabolic activity, replication, and infectivity drive the progression 
of cellular infection through five distinct stages during the 5-7 days infection cycle; stage I (Early 
entry), stage II (Pre-replicative), stage III (Replicative), stage IV (Maturation) and stage V 
(Extracellular)(figure 44).  
The metabolic activity of intracellular and extracellular populations is based on their 
ability to incorporate a methionine derivative (HPG) into nascent proteins and subsequently 
measured by using click chemistry. In this work, the metabolically active bacteria were identified 
by the intensity of fluorescence of HPG. However,  some subpopulations that present a low 
metabolic level will not be detected by this method.  
Upon entry at 0-3 hours post infection, bacterial stage I has not yet undergone DNA and 
protein synthesis. Once bacteria are released from the endosome at 3-24 hours post infection 
(stage II), protein synthesis is active but DNA synthesis has not yet initiated. Bacteria move to the 
perinuclear region for replication (stage III) during 1-5 days post infection and start DNA and 
protein synthesis. In stage IV, the bacteria relocate from the perinuclear region to the host 
membrane, and become mature before exiting at 3-6 days post infection. ScaC, a marker for the 
maturation of intracellular bacteria, is present on the bacterial surface membrane at this stage. 
The mature bacteria (stage IV) is metabolically active but the status of DNA synthesis is still 
unknown. After exiting the host cell, the intracellular bacteria enters the extracellular stage 
(Stage V) when both DNA and protein synthesis are terminated.  
The active DNA synthesis during stage IV needs to be examined further because of the 
following limitation of the methods used: the measurement of active DNA and RNA synthesis via 
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clickable DNA and RNA probes failed because Orientia may not uptake the synthetic DNA/RNA 
nucleotides; and the isolation of stage IV bacteria from the other stages is very difficult due to 
the short duration of the maturation stage and the issue of mixing of different subpopulations. 
The intracellular stages III-IV and extracellular stage V are infectious, but the infectivity of 
intracellular stage I and II are unknown because it is difficult to isolate bacteria during this short 
period of the infection.   
In these research studies I describe bacterial differentiation in O. tsutsugamushi, leading 
to a greater understanding of the infection cycle and the regulation and mechanism of 
differentiation in scrub typhus. This new model system also provides us a fundamental 











Summary of studies to develop genetic tools in O. tsutsugamushi 
The modified transposon-based transformation vector (pCis-mRuby2-MurA-HimarI) was 
used for attempted molecular manipulation of Orientia tsutsugamushi. Electroporation was used 
to introduce the vector into O. tsutsugamushi. However, the transposon and transposase did not 
successfully integrate into the genome. There were several limitations that need further 
development such as low transformation efficiencies, appropriateness of the vector, 
optimisation of antibiotic selection, isolation of null mutants, etc.  
Given that transformation failed, use of BNA (bridge nucleic acid), a DNA analog, was 
chosen as an alternative approach to disrupt the target gene of Orientia tsutsugamushi. This 
study aimed to downregulate the major surface protein TSA56 in Orientia. BNA efficiently bound 
both targeted DNA and RNA as assessed by PCR. BNA was introduced into Orientia via 
electroporation and the immunoblot result demonstrated strong inhibition of DNA.  
Dual RNA-seq provides insight into the biology of the neglected intracellular human pathogen 
Orientia tsutsugamushi. 
 Dual RNA-seq is a novel approach for studying the mechanism of gene regulation of the 
genetically intractable bacteria Orientia tsutsugamushi, during infection in cultured human 
endothelial cells. RNA-seq data from infection using two clinical isolates infection, Karp and 
UT176, in HUVEC cells provided evidence of the transcriptional architecture, gene expression, 
and the discovery of distinct immune response networks in response to the infection in HUVEC 
cells. The relative induction of cytokine IL6 and IL33 based on gene networks in the host might 









The finding that during infection Orientia exists in five distinct subpopulations leads to several 
further questions about the infection mechanisms deployed by each stage. Much is still unknown 
and remains to be elucidated. How does Orientia escape from the phagosome? What are the 
unknown mechanisms that trigger the relocation of Orientia from the perinuclear region to 
adjacent to the host membrane? Which pathway controls the expression of ScaC, a marker for 
the maturation stage, during intracellular stages? What is the difference in the infection 
mechanism between intracellular and extracellular stages? Do intracellular bacteria infect the 
next cell without budding out and by what mechanisms and does intracellular bacteria become 
inactive or remain active when invading the next cells? How stable are host membranes in 
membrane-bound budding bacteria? Does membrane-bound Orientia re-infect the same host 
cells or prefer to infect new uninfected cells? If the membrane-bound Orientia enters into new 
cells, what mechanisms trigger the lysis from the endosome? How do bacteria regulate the 
progression between the stages? Orientia can replicate in several cell types and present a 
different level of pathogenicity in human and animal models; how might the behavior of the 
different bacterial stages differ by bacterial strain and host cell types? Lastly, is the timing of 
distinct bacterial stages important to differences in virulence? All these questions could facilitate 
future work with Orientia to elucidate disease mechanisms and contribute a better 


















Figure 45 A summary of unknown mechanisms in the intracellular infection cycle of                                          
O. tsutsugamushi.  
Since BNA can be used to inhibit both the transcriptional and translational process, BNA can 
be used for further studies. Firstly, the inhibition pattern of TSA56 in the presence of BNA 
throughout the Orientia life cycle and the reduction of TSA56 can be further monitored using 
immunofluorescence labeling. Secondly, there is an alternative way to improve a strong 
inhibition by using multiple BNA/DNA oligomers to target a single gene or using a single BNA/DNA 
oligomer to target multiple genes. Lastly, BNA can be used to inhibit or interfere with the 
virulence genes which are putatively involved in pathogenesis during the infection.  
The findings of the dual RNA-seq work could facilitate subsequent studies on the regulation 
of gene expression and mechanisms of pathogenesis in Orientia, such as studying the association 
between Orientia strains and host immune response by screening panels of Orientia strains and 
applying genome/transcriptome analysis or through use of immunomodulating agents (i.e., 
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